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ABSTRACT 
 
ROBERT MURRAY HUGHES IV: Non-Covalent Interactions In !-Hairpin Peptides 
And Small Molecule Model Systems 
(Under the direction of Marcey L. Waters) 
 
 
Post-translational modifications of proteins are a key component of cell signaling. In 
particular, post-translational modifications of histone tails are known to modulate 
transcription of DNA. These modifications function via a number of different non-
covalent interactions with both DNA and various nuclear proteins. Some relevant 
modifications include methylation or acylation of lysine and the methylation of arginine 
and are thought to trigger binding with aromatic rings (Trp, DNA bases) through cation-" 
and amide-" interactions. In order to characterize these biologically relevant interactions, 
they have been studied within the context of !-hairpin peptide model systems, which 
enable the description and quantification of specific sidechain-sidechain interactions. In 
our system, the interaction between Trp and trimethylated Lys is shown to be worth 1.0 
kcal/mol, a stabilization of about 0.7 kcal/mol over the nonmethylated Lys-Trp 
interaction. The methylated interaction occurs with an enhanced entropic driving force 
over the unmethylated interaction. Methylation of Arg is also shown to enhance its 
interaction with Trp, by about 0.5 kcal/mol. Additionally, the acyl Lys-Trp interaction is 
found to be equivalent in magnitude to the nonmethylated Lys-Trp interaction (0.3 
kcal/mol). Acylation of lysine in our model system is shown to induce a switch from a 
cation-" to an amide-" interaction. Investigations into neutral analogues of trimethylated 
 iv 
Lys reveals the critical nature of the cation-" interaction to the interaction of histone tails 
with chromodomain proteins. This is confirmed both in our !-hairpin model system and 
with binding studies with the HP1 chromodomain.  
Additional investigations in this thesis include mutational studies of a !-hairpin receptor 
for ATP and the study of a cation-" interaction within a small molecule model system. 
Through experimental and computational studies, the !-hairpin receptor for ATP is 
shown to form a well-defined binding pocket with a number of important electrostatic 
contacts. The cation-" interaction in the small molecule model system is found to prevail 
in both aqueous and organic solvent, despite the possible presence of competing non-
covalent interactions. X-ray and computational evidence suggests the possible presence 
of an oxy-arene interaction in organic solvent, but the interpretation of conformational 
differences from NMR data is ambiguous. 
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   CHAPTER I 
 
   INTRODUCTION 
 
 
i. Significance. Non-covalent interactions involving aromatic groups within 
proteins (!-!, cation-!, amide-!) are known to contribute to a wide array of biologically 
significant phenomena, including protein folding, protein-protein interactions, ligand 
binding, and protein-DNA interactions. The proposed importance of these interactions, 
relative to hydrophobic and hydrogen bonding interactions, is that they can retain both 
strength and specificity in solvent exposed environments, making them critical to 
numerous protein-mediated cell signaling pathways. Our goal is to quantify the 
magnitude and dynamics of these aromatic interactions using peptide models for protein 
structure in aqueous solution. By characterizing these interactions within an isolated 
model system, we are able to understand how they may individually contribute to overall 
protein structure and function. Through this work, we are able to see that indeed, non-
covalent interactions with aromatic groups are critical to various aspects of protein 
folding, cellular signaling, and gene transcription. 
ii. "-Hairpin peptides as model systems. Short peptides (<20 residues) that fold 
autonomously into monomeric, antiparallel "-sheet structures in aqueous solution have 
been known since the early 1990’s.
1
 Investigation of these types of structures was 
                                                
1
 Gellman, S. H. Curr. Opin. Struct. Biol. 1998, 2, 717-725. 
 2 
motivated by the prevalence of "-sheet motifs in protein structure, and the more poorly 
understood (relative to #-helices) factors contributing to their formation and stability. 
Since the discovery of these initial peptide sequences, much work has focused on 
elucidating the various contributions of "-turn and loop sequences, sidechain-sidechain 
interactions, and individual amino acid "-sheet propensities to the stability of the hairpin 
fold.
1,2,3
 Additionally, as the field has matured, many attempts have been made to 
incorporate functionality into "-hairpins and "-sheet mimics, many of which mimic the 
behaviour of "-sheet motifs found in protein structures. Some of these discoveries 
include anti-microbial peptides, the design of receptors for nucleotides and other 
biologically relevant molecules, the design of model systems for "-sheet dependent 
disease states (i.e., Alzheimer’s Disease), the incorporation of designed "-hairpin 
sequences into globular proteins, and their use in materials/nanotechnology 
applications.
3,4
  
Still, even with the explosion of the field, one of the most valuable applications of 
"-sheet model systems, such as "-hairpin peptides, remains as a framework for studying 
the non-covalent interactions that guide protein folding, molecular recognition, and 
biomolecular interactions. These interactions range from such common motifs as 
                                                
2
 Ramierz-Alvarado, M.; Kortemme, T.; Blanco, F. J.; Serrano, L. Bioorg. Med. Chem. 
1999, 7, 93-103. 
 
3
 Stotz, C. E.; Topp, E. M. J. Pharm. Sci. 2004, 93, 2881-2894. 
 
4
 Hughes, R. M.; Waters, M. L. Curr. Op. Struct. Biol. 2006, 16, 514-524. 
 
 3 
hydrogen bonding and salt-bridges
5
 to more subtle interactions, such as !-! stacking, 
cation-! and amide-! interactions, to name a few.
6
 As these interactions are often 
required to function in water-exposed environments in vivo,
7
 the "-hairpin model system 
provides an ideal framework for their investigation and quantification in aqueous 
solution. 
Some of the advantages of using "-hairpins as model systems for biologically 
relevant phenomena include their well-dispersed proton NMR spectra, which lends them 
analysis by conventional 1D and 2D NMR techniques, their two-state folding,
8
 which 
gives them an important common ground with globular proteins and allows the 
quantification of free energies, and the presence of isolatable sidechain-sidechain 
interactions in both the diagonal and cross-strand positions. Furthermore, "-hairpins are 
readily synthesized through solid-phase peptide synthesis and amenable to study in 
aqueous solution. 
iii. Some details regarding the structural analysis of "-Hairpin Peptides. It is 
important, at the outset, to briefly mention some of the methods of analysis used to 
investigate "-hairpin structure (additional details are provided in the Experimental 
Section at the end of each chapter). Of particular note is the turn sequence that nucleates 
                                                
5
 a) Searle, M. S.; Griffiths-Jones, S. R.; Skinner-Smith, H., J. Am. Chem. Soc. 1999, 121, 
(50), 11615-11620. b) Sharman, G. J.; Searle, M. S., J. Am. Chem. Soc. 1998, 120, (21), 
5291-5300. 
 
6
 (a) Hughes, R. M.; Waters, M. L., J. Am. Chem. Soc. 2005, 127, 6518 - 6519. (b) 
Hughes, R. M.; Waters, M. L., J. Am. Chem. Soc. 2006, 128, 12735 - 12742. (c) Tatko, C. 
D.; Waters, M. L., Prot. Sci. 2003, 12, 2443 - 2452. (d) Tatko, C. D.; Waters, M. L., J. 
Am. Chem. Soc. 2004, 126, 2028 - 2034. 
 
7
 Gallivan, J. P.; Dougherty, D. A. Proc. Nat. Acad. Sci. USA 1999, 96, 9459 – 9464. 
 
8
 Streicher, W. W.; Makhatadze, G. I. J. Am. Chem. Soc. 2006, 128, 30–31. 
 4 
a "-hairpin turn structure. In structurally biology, strands in "-sheets are often linked by 
loops and bulges of various length and amino acid composition. Turn sequences 
containing two amino acids are also present in protein structures, generally assuming 
Type I and Type II conformations (turn types based on the $ and % angles present in the 
turn), imbuing a left-handed twist to the "-turn, which opposes the right-handed twist of 
the strands (Figure 1.1). In the systems employed in this thesis, the turn types are Type I’ 
(with inverse $ and % angles from the Type I turn sequence), thereby giving a right-
handed twist to the hairpin sequence and resulting in a stable, isolated "-sheet.
1
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Figure 1.1. (a) Diagram of "-hairpin peptide. Hydrogen bonds shown in red. Turn residues shown in 
blue. (b) Type I and I’ turns (source: http://e106.life.nctu.edu.tw/~hwhuang/dssp/type1turn.gif). 
 
 A number of methods are used to both confirm "-hairpin structure and quantify "-
hairpin stability. To confirm structure, the chemical shifts of the H# residues are 
measured and compared to random coil values. Relative chemical shifts of greater than 
0.1 ppm are indicative of "-hairpin structure (Figure 1.2a). Additionally, the Type I’ turn 
sequence is composed of the sequence Asn-Gly. The Gly sidechain protons are 
diastereotopic and their chemical shifts differ significantly in the "-hairpin conformation. 
The more rigid, or better folded, the hairpin, the greater the splitting is between the two 
 5 
protons (Figure 1.2b). This difference, when compared to the splitting of the Gly protons 
in a cyclic "-hairpin (our approximation of the fully folded stated) has been shown to be 
an accurate indicator of the degree of "-hairpin structure.
9
 Finally, the expected 
antiparallel hydrogen bonding pattern of a folded "-hairpin can be demonstrated through 
the shifts of backbone amide protons (Figure 1.2c). While used less frequently in this 
thesis to demonstrate "-hairpin structure, backbone amide shifts are also excellent 
indicators of whether the "-hairpin is folded within the correct register and can indicate 
the overall degree of structure of the hairpin.
10
  
a) b)  
c) P P M   4.06     4.04     4.02     4.00     3.98     3.96     3.94     3.92     3.90     3.88     3.86     3.84     3.82     3.80     3.78     3.76     3.74     3.72    
 
Figure 1.2. (a) Example H# shifts for a 12-residue "-hairpin peptide. (b) Example 
backbone amide shifts from a "-hairpin peptide (hydrogen bonded sites in red squares). 
(c) Example Gly splitting from a Type I’ Asn-Gly turn in a "-hairpin. 
  
                                                
9
 Searle, M. S.; Griffiths-Jones, S. R.; Skinner-Smith, H. J. Am. Chem. Soc. 1999, 121, 
11615-11620. 
 
10
 Fesinmeyer, R. M.; Hudson, F. M.; Olsen, K. A.; White, G. W. N.; Euser, A.; 
Andersen, N. H. Journal of Biomolecular Nmr 2005, 33, (4), 213-231. 
& ppm 
 6 
NOEs are another common indicator of "-hairpin structure. They can show 
proximity between residues on opposing strands, indicating the presence of a folded state. 
However, their presence or absence must be evaluated carefully, as the lack of NOEs can 
be due to a folded, yet highly dynamic "-hairpin structure. As a result, even well-folded 
"-hairpins typically display critical NOEs and ROEs, but not an overabundance of them, 
in aqueous solution. 
iv. Introduction to the Cation – !  interaction. Of the numerous non-covalent 
interactions discussed in this thesis, the cation-! interaction is the most discussed and its 
early introduction will therefore serve as a springboard for the discussion of other 
interactions throughout the text. The presence and functionality of the cation-! 
interaction in structural biology is now an undisputed fact. This has been established 
through early statistical analyses by Burley and Petsko and by later, more detailed, work 
by Dougherty and co-workers.
11
 The cation-! interaction is generally defined as a charge-
quadrupole interaction between a positively charged species and an aromatic ring that is 
primarily electrostatic in nature.
11e,12
 Additional factors such as charge-transfer, 
dispersion energies, and polarizabilities can contribute to the interaction, depending on its 
context.
11e
 The electrostatic potential surfaces of both the cationic species and the 
aromatic species are generally the best way to visualize the potential for cation-! binding 
                                                
11
 a) Burley, S. K.; Petsko, G. A., FEBS Letters 1986, 203, 139 - 143. b) Burley, S. K.; 
Petsko, G. A., Adv. Prot. Chem. 1988, 39, 125 - 189. c) Gallivan, J. P.; Dougherty, D. A., 
Proc. Natl. Acad. Sci. USA 1999, 96, 9459 - 9464. d) Gallivan, J. P.; Dougherty, D. A., J. 
Am. Chem. Soc. 2000, 122, 870 - 874. e) Ma, J. C.; Dougherty, D. A., Chem. Rev. 1997, 
97, 1303 - 1324. 
 
12
 Minoux, H.; Chipot, C. J. Am. Chem. Soc. 1999, 121, 10366-10372. 
 7 
(Figure 1.3a).
13
 In the gas phase, the interaction has been measured to be stronger than 
various hydrogen bonding interactions.
11e
 Additionally, the cation-! interaction has been 
demonstrated in the function of ion channels,
14
 protein-ligand interactions,
15
 and protein-
DNA interactions.
16
 In protein structures, the cation-! interaction is found between 
positively charged sidechains (Lys, Arg) and aromatic groups (Phe, Trp, Tyr). Among the 
potential participants in proteogenic cation-! interactions, Trp has been shown to bind 
more tightly to cations than either phenylalanine or tyrosine.
17
 Specific examples of the 
cation-! in biology include the operation of acetylcholine esterase and the nicotinic 
acetylcholine receptor, both of which use pockets of aromatic residues to bind 
acetylcholine (Figure 1.3b).
11e
  
a)    b)  
Figure 1.3. a) Electrostatic potential maps showing the predicted binding site of a cation-! binding pair 
(indole ring and alkali metal cation; MacSpartan 2004; range: -30 to +60 kcal/mol). (b) Key cation-
aromatic contacts from structure of decamethonium bound to acetylcholine esterase (PDB ID: 1ACL). 
                                                
13
 Mecozzi, S.; West, A. P.; Dougherty, D. A. Proc. Nat. Acad. Sci. USA 1996, 93, (20), 
10566-10571. 
 
14
 Kumpf, R. A.; Dougherty, D. A. Science 1993, 261, 1708-1710. 
 
15
 a) Susman, J. L.; Harel, M.; Folow, f.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. 
Science 1991, 253, 872-879. b) Zhong, W.; Gallivan, J. P.; Zhang, Y.; Li, L.; Lester, H. 
A.; Dougherty, D. A. Proc. Nat. Acad. Sci. USA 1998, 95, 12088-12093. c) Satow, Y.; 
Cohen, G. H.; Padlan, E. A.; Davis, D. R. J. Mol. Biol. 1986, 190, 593-604. 
 
16
 Wintjens, R.; Lievin, J.; Rooman, M.; Buisine, E. J. Mol. Biol. 2000, 302, 395-410. 
 
17
 a) Shepodd, T. J.; Petti, M. A.; Dougherty, D. A. J. Am. Chem. Soc. 1988, 110, 1983-
1985. b) Okada, A.; Miura, T.; Takeuchi, H. Biochemistry 2001, 40, 6053-6060. 
 8 
 
While the cation-! interaction is a firmly established phenomenon in structural 
biology, our model systems are useful in demonstrating the magnitude, orientation, and 
selectivity of the cation-! interaction in a solvent exposed environment. For example, 
research in the Waters group has demonstrated the orientation and magnitude of cation-! 
interactions between Lys-Trp, Lys-Phe, and Arg-Trp pairs within "-hairpin and #-helical 
model systems in aqueous solution.
18
  
Model systems enable the quantification of the interaction through studies that 
might not be feasible using complex proteins. Additionally, computational models tend to 
overestimate the magnitude of the interaction, so our data is a valuable benchmark for the 
accuracy of various theoretical models of solvation.
19,12
 It is important to note that 
optimized geometries calculated for cation-! interactions in the gas phase are different 
than those observed experimentally in aqueous solution (For instance, stacking is 
observed experimentally between Arg and Trp, while gas phase calculations favor T-
shaped orientations) (Figure 1.4a).  This phenomenon has been neglected in a number of 
papers that pair gas-phase optimized geometries with various solvation models in order to 
estimate binding energies in solution.
11d,20
 For instance, the orientation of a 
methylammonium ion bound to an aromatic ring occurs through N-H----! interactions in 
the gas phase, but through C-H----! interactions in aqueous solution (Figure 1.4b). 
                                                
18
 a) Tatko, C. D.; Waters, M. L., J. Am. Chem. Soc.  2004, 126, (7), 2028-2034. b) Tatko, 
C. D.; Waters, M. L., Protein Science 2003, 12, (11), 2443-2452. c) Tsou, L. K.; Tatko, 
C. D.; Waters, M. L., J. Am. Chem. Soc. 2002, 124, (50), 14917-14921. 
 
19
 Slutsky, M. M.; Marsh, E. N. G. Prot. Sci. 2004, 13, 2244-2251. 
 
20
 Minoux, H.; Chipot, C. J. Am. Chem. Soc. 1999, 121, 10366-10372. 
 9 
Numerous examples of this interaction in aqueous solution are demonstrated within this 
thesis. 
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Figure 1.4. a) (above) T-shaped and stacking orientations of Arg with aromatic ring. (b) 
(below) N-H and C-H orientations of dimethylammonium group with aromatic ring.  
 
v. Introduction to Post-translational Modifications.  Since many of the non-
covalent interactions explored in this work occur within the biological context of post-
translational modifications of proteins and, more specifically, the post-translational 
modification of histone tails, some attempt will be made to introduce the extremely broad 
field of post-translational modifications and their relevance to the oft bandied-about 
“histone code”. Post-translation modifications occur in both eukaryotic and prokaryotic 
organisms, and include phosphorylation, methylation, acylation, ubiquitination, and 
glycosylation, among others.
21
 They run the gamut of functionality, and are involved in 
processes ranging from signaling (phosphorylation and acylation where reversibility is 
paramount) to targeting (glycosylation points proteins towards the lysosome) to tagging 
proteins for degradation (ubiquitination). 
22
 
                                                
21
 Zhang, Y.; Reinberg, D. Genes & Development 2001, 15, 2343-2360. 
 
22
 (a) Strahl, B. D.; Allis, D. C. Nature, 2000, 403, 41-45. (b) Shilatifard, A. Annu. Rev. 
Biochem. 2006, 75, 243-269. 
a) 
b) 
 10 
 Histones (H3, H4, H2A, H2B) are the protein framework for packaging genetic 
material (DNA) (Figure 1.5). Originally thought to be primarily structural, it is now 
apparent that histone proteins are actively involved in controlling the activity of DNA, 
and in the switch from inactive genetic material (heterochromatin) to actively transcribed 
genetic material (euchromatin).
22a
 Whilst DNA is wrapped around a core of histone 
proteins in the nucleosome, peptide tails extend from the histone protein core into 
solution, making them available for post-translational modification by a variety of 
enzymatic processes. Modifications of these tails have a number of different effects: 
Acylation of lysine is thought to negate the favorable electrostatic interaction between 
lysine and the phosphate backbone of DNA, resulting in the loosening of chromatin 
structure, making it available for transcription. Other modifications, such as methylation 
of lysine, cause the recruitment of other proteins through specific binding interactions 
with the modified histone tail, resulting in further condensation of the chromatin. These 
modifications do not occur in isolation, and are therefore thought to work together in an 
elaborate signaling pathway that is commonly deemed the “histone code”. The code, as it 
were, specifies when and where various portions of the genetic material are transcribed. 
Numerous modifications, functioning in concert, are thought to amplify the transcription 
signal, thereby increasing the efficiency of this complex process.  
 
 11 
a)   b)  
Figure 1.5. (a) Packaging of DNA within the nucleus. (b) Crystal structure of a histone-
DNA complex (1EQZ). 
 
 
vi. Conclusion. Since it is clear that non-covalent interactions are important to the 
function of histone tails, a primary thrust of this thesis is to isolate and study some of the 
potentially most important interactions within an isolated model system. As described 
earlier, the "-hairpin peptide provides an ideal framework for such an investigation. 
Therefore, a number of transcriptionally relevant non-covalent interactions (cation-!, 
amide-!, etc.) have been selected for investigation within the context of a "-hairpin 
model system.  It is our goal to quantitate the magnitude of these interactions in a solvent 
exposed environment, and to describe their effects on the two-state folding dynamics of 
the "-hairpin. Hopefully this leads to a better understanding of the fundamental forces 
underlying the behaviour of modified histone proteins. Furthermore, this document 
contains tangentially related studies of the cation-! interaction in a small-molecule model 
system, and studies on the binding of ATP with a "-hairpin receptor. These studies are 
also carried out with the same goal, to enhance our understanding of the non-covalent 
interactions that can determine both orientation and function in molecular systems, and to 
serve as a source of knowledge and inspiration for the design of future model systems.  
CHAPTER II 
CATION-! INTERACTIONS AND THE EFFECTS OF N-METHYLATION OF THE 
CATION 
(Reproduced, in part, with permission from Hughes, R.M.; Waters, M.L. J. Am. Chem. 
Soc. 2005, 127, 6518 – 6519 and Hughes, R.M.; Waters, M.L. J. Am. Chem. Soc. 2006, 
128, 12735 – 12742.) 
 
A. Lysine methylation and the cation-!  interaction. 
i. Background and significance.  
The role of the cation-! interaction between a cationic residue (lysine or arginine) 
and an aromatic residue (tryptophan, tyrosine, or phenylalanine) in proteins is a topic of 
continuing interest due to its relevance to protein structure,1 the mediation of protein-
protein interactions,2 and protein-ligand interactions.1 These interactions have been 
observed in statistical analyses of protein structures1 and even in de novo designed 
proteins.3 Post-translational modifications of cationic residues in proteins play important 
roles in cellular processes through the mediation of protein-protein interactions. One 
                                                
1
 (a) Ma, J. C.; Dougherty, D. A. Chem. Rev. 1997, 97, 1303-1324. (b) Gallivan, J. P.; 
Dougherty, D. A. Proc. Nat. Acad. Sci. 1999, 96, 9459-9464. 
2 Crowley, P.B.; Golovin, A. Prot. Struct. Funct. Bioinform. 2005, 59, 231-239. 
3 Dai, Q.; Tommos, C.; Fuentes, E. J.; Blomberg, M. R. A.; Dutton, P. L.; Wand, A. J. J. 
Am. Chem. Soc. 2002, 124, 10952 – 10953. 
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example of this phenomenon is the methylation of lysine in histone proteins. The 
methylation of lysine in histone proteins is a post-translational modification that 
functions in the histone modulated process of chromatin condensation.4 This 
phenomenon is associated with epigenetic silencing and, in a broader sense, has 
implications for designed mediators of protein-protein interactions. In particular, the 
methylated lysines in histone tails have been shown to trigger protein-protein interactions 
with several proteins containing the chromodomain.  In each case, the binding of the 
Lys(Me)n
+ (n = 1-3) occurs in an aromatic pocket composed of three aromatic sidechains, 
suggesting that cation-! interactions are important for selective recognition of the N-
methylated sidechain.4(d) In general, the binding of small molecules containing quaternary 
ammonium ions in protein binding pockets lined with aromatic residues, such as the 
binding of acetylcholine to acetylcholine esterase, is a well known event in structural 
biology and has been utilized in seminal studies of molecular recognition.5 
We have previously reported a "-hairpin peptide that is stabilized by a specific 
cation-! interaction between Trp2 and Lys9 in which the #-methylene of Lys9 is packed 
                                                
4 (a) Lindroth, A. M.; Shultis, D.; Jasencakova, Z.; Fuchs, J.; Johnson, L.; Schubert, D.; 
Patnaik, D; Pradhan, S.; Goodrich, J.; Schubert, Il; Jenuwein, T.; Khorasanizadeh, S.; 
Jacobsen, S. E. Embo. J. 2004, 23, 4286 – 4296. (b) Khorasanizadeh, S. Biophysical J. 
2003, 84, 485A. (c) Jacobs, S.; Harp, J.; Khorasanizadeh, S. Biophysical J. 2003, 84, 
503A. (d) Fischle, W.; Wang, Y. M.; Jacobs, S. A.; Kim, Y. C.; Allis, C. D.; 
Khorasanizadeh, S. Genes and Development 2003, 17, 1870 – 1881. (e) Jacobs, S. A.; 
Khorasanizadeh, S. Science 2002, 295, 2080 – 2083. 
5
 (a) Scharer, K.; Morgenthaler, M.; Paulini, R.; Obst-Sander, U.; Banner, D.W.; 
Schlatter, D.; Benz, J.; Stihle, M.; Diederich, F. Angew. Chem. Int. Ed. 2005, 44, 2-6. (b) 
Kearney, P.C.; Mizoue, L.S.; Kumpf, R.A.; Forman, J.E.; McCurdy, A.E.; Dougherty, 
D.A. J. Am. Chem. Soc. 1993, 115, 9907-9919. (c) McCurdy, A.; Dougherty, D.A. J. Am. 
Chem. Soc. 1992, 114, 10314-10321. 
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against the face of the aromatic ring.6  In our current study, we investigate the effects of 
lysine methylation on the magnitude of this cation-! interaction and the stability of the 
designed "-hairpin. We wish to use our designed "-hairpin as a model system for Lys 
methylation in histone proteins, because, as previously discussed, the methylation of 
lysine is known to trigger binding to aromatic pockets in chromodomain proteins. By 
characterizing the interaction between methyl Lys and Trp, and comparing it to our data 
for the Lys-Trp interaction, we hope to gather more detailed information about the nature 
of the cation-! interaction in structural biology, and to observe how post-translational 
modification may alter its dynamics and magnitude in biological systems.  
ii. Results and Discussion. 
        a)  Design. Peptides WK and WKMe3 (Figure 2.1) possess a Trp residue that 
is oriented diagonally with respect to a cationic residue. We have previously shown that 
when X = Lys, these two residues are in close proximity and interact in a favorable 
manner via a cation-! interaction, resulting in stabilization of the folded peptide.6 The 
overall charge of peptides WK and WKMe3 is +3, lending increased water solubility and 
decreased aggregation to both. The peptides also include an Asn-Gly sequence, which has 
been shown to promote hairpin formation via a type I’ turn.7 The peptides were 
synthesized by Fmoc solid phase peptide synthesis, with the trimethylated lysine hairpin 
synthesized following the procedure of Kretsinger and Schneider.8 Peptides were 
                                                
6 (a) Tatko, C. D.; Waters, M. L. Protein Science 2003, 12, 2443 – 2452. (b) Tatko, C. D.; 
Waters, M. L. J. Am. Chem. Soc. 2004, 126, 2028 – 2034. 
7 Griffiths-Jones, S. R.; Maynard, A. J.; Sharman, G. J.; Searle, M. S. Chem. Commun. 
1998, 789 – 790. 
8 Kretsinger, J. T.; Schneider, J. P. J. Am. Chem. Soc. 2003, 125, 7907 – 7913. 
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characterized by MALDI mass spectrometry and NMR as reported previously.6  
Numerous NOEs between cross-strand pairs of sidechains were observed, consistent with 
"-hairpin formation (See Experimental Information). 
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Figure 2.1. (a) "-hairpin peptides WK and WKMe3. (b) Control peptides for the fully 
folded state cyclised with a Cys disulfide bond.  (c) and (d) Control peptides for the 
unfolded state. (e) and (f) Lys and LysMe3 sidechains. 
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Both downfield shifting of the "-sheet H$ protons and the separation of the Gly H$ 
protons have been shown to correlate with the extent of folding in "-hairpins.9 Inspection 
of the H$ chemical shifts relative to unfolded controls indicates that both peptides WK 
and WKMe3 take on a "-hairpin structure, (Figure 2.2) as downfield shifting of the 
strand residues by ! 0.1 ppm is taken to represent a well-folded "-hairpin.9b Moreover, 
the H$ shifts indicate peptide WKMe3 is more folded than peptide WK at all positions 
along the strand, with the exception of the residues nearest the termini, which are 
typically frayed.10 
 
 
Figure 2.2. H$ shifts of peptides WK and WKMe3. The Gly bars reflect the H$  
separation in the hairpin. 
 
                                                
9 (a) Maynard, A. J.; Sharman, G. J.; Searle, M. S. J. Am. Chem. Soc. 1998, 120, 1996 – 
2007. (b) Griffiths-Jones, S. R.; Maynard, A. J.; Searle, M. S. J. Mol. Biol. 1999, 121, 
11577 – 11578. 
10 Note that H$ for Asn 6 is upfield shifted due to its position in the turn, and H$ for Leu 
11 is upfield shifted due to ring current effects by the cross-strand Trp residue. 
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The extent of folding of peptides WK and WKMe3 was quantified from the Gly H$ 
splitting relative to the fully folded and random coil control compounds, peptides 3-7, as 
described previously (Eqn 1).6 Peptides WK and WKMe3 are found to be 78% and 92% 
folded, respectively.11 This translates into %Gf values of -0.75 and -1.45 kcal/mol. Hence, 
methylation increases the overall stability of the "-hairpin by about 0.7 kcal/mol. This is 
significant given the modest changes in the hairpin structure.  
 
% folded = [&obs - &0]/ [&100 - &0] x 100  [1] 
 
b)  Interaction Energies.  Double mutant cycles were performed to determine the 
magnitude of the sidechain-sidechain interaction in isolation. Double mutant cycles are 
necessary because in each of the single mutants the Lys···Trp interaction is disrupted, but 
other changes occur as well, such as the "-sheet propensities of the substituted residues.  
A double mutant containing corrects for any of the unintentional changes, such that the 
magnitude of the KMe3···Trp interaction can be determined as shown in Figure 2.3.  
Using the same substitutions at positions 2 and 9 that were reported previously for the 
parent peptide, WK: Val was substituted for Trp at position 2 and Ser was substituted for 
KMe3 at position 9 (Figure 2.3).29 Analysis of the sidechain-sidechain interaction via 
double mutant cycles,12 using Val and Ser as the control residues in positions 2 and 9,6 
                                                
11 The fraction folded as determined by the average H$ shift corresponds very well to 
that of the Gly splitting, with values of 77% and 90% for peptides WK and WKMe3, 
respectively.  See reference 6 and Experimental Section. 
12 (a) Blanco, F. J.; Serrano, L. Eur. J. Biochem. 1995, 230, 634 – 649. (b) Sharman, G. 
J.; Searle, M. S. J. Am. Chem. Soc. 1998, 120, 5291 – 5300. (c) Searle, M. S.; Griffiths-
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gives a value of -0.3 ± 0.1 kcal/mol for the Lys···Trp interaction and -1.0 ± 0.1 kcal/mol 
for the Lys(Me)3
+···Trp interaction.  Thus, the change in stability of the "-hairpin is 
primarily due to the increase in the magnitude of the cation-! interaction upon 
methylation. 
W
X
W
S
V
X
V
S
!G3
!G2
!G4
!G1
!!G (W-X) = !G1 - !G2 - !G3 + !G4  
Figure 2.3.  Double mutant cycle to measure the interaction energy between Trp and 
residue X. 
 
c) Analysis of Interaction Geometry. We have previously demonstrated that the Lys 
residue of peptide WK interacts preferentially with the face of the Trp ring through its 
polarized #-methylene group (Figure 2.4).6 Analysis of the KMe3 sidechain upfield shift 
from peptide WKMe3 indicates there is significant interaction of both the #-methylene 
and its methylammonium group with the indole ring (Figure 2.5).  In peptide WK, the #-
methylene group is upfield shifted by 0.4 ppm, whereas in peptide WKMe3, it is shifted 
by almost 1 ppm.  The methyl groups in KMe3 are also significantly shifted by almost 
0.6 ppm, indicating they are also in close proximity to the face of the indole ring. We 
propose an interaction geometry for the Lys-Trp pairs such as that shown in Figure 2.4. 
                                                                                                                                            
Jones, S. R.; Skinner-Smith, H. J. Am. Chem. Soc. 1999, 121, 11615 – 11620. (d) Shi, Z. 
S.; Olson, C. A.; Kallenbach, N. R. J. Am. Chem. Soc. 2002, 124, 3284 – 3291. 
 19 
NH
N
H H
H
H H
H3C CH3
NH
N
H H
H
H H
 
Figure 2.4.  Possible interaction geometries for Trp···Lys and Trp···Lys(Me3)
+ 
interactions. 
 
 
 
Figure 2.5. Side chain chemical shifts of Lys (peptide WK) and Lys(Me)3
' (peptide 
WKMe3). 
 
The Leu11 sidechain, which is cross-strand from Trp, is also significantly upfield 
shifted at its ( and & positions, indicating packing against the Trp ring (Figure 2.6). 
However, the degree of upfield shifting of the Leu changes little between peptides WK 
and WKMe3, indicating that, as a whole, the peptide experiences only minor 
conformational changes upon methylation of the Lys residue. 
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Figure 2.6. Leu sidechain upfield shifts. 
 
Thermal denaturation of peptides WK and WKMe3 reveal that methylation of Lys 
results in a remarkably thermally stable "-hairpin (Figure 2.7a). Other reported well-
folded "-hairpins with high thermal stabilities such as trpzip4 (sequence: 
GEWTWDDATKTWTWTE-NH2)
13 and HP5W4 (sequence: 
KKWTWNPATGKWTWQE)14 have similar stabilities at 298 K (92% and 96% folded, 
respectively) to peptide WKMe3. However, both denature more quickly at higher 
temperatures. For example, at 75°C, peptide WKMe3 is 74% folded, while trpzip 4 is 
about 40% folded and HP5W4 about 60% folded. This implies that peptide WKMe3 has 
a higher melting temperature than either previously reported sequence. Notably, peptide 
                                                
13 Cochran, A. G.; Skelton, N. J.; Starovasnik, M. A. PNAS 2001, 98, 5578 – 5583. 
14 Fesinmeyer, R. M.; Hudson, F. M.; Andersen, N. H. J. Am. Chem. Soc. 2004, 126, 
7238 – 7234. 
 21 
WKMe3 accomplishes high thermal stability without the four Trp cluster that stabilizes 
both trpzip4 and HP5W4. 
Fitting of the thermal denaturation of peptides WK and WKMe3 with a non-linear 
form of the van’t Hoff equation indicates that the trimethylation of Lys makes the folding 
of peptide WKMe3 more entropically favorable and less enthalpically favorable than 
folding of the unmethylated peptide (Table 2.1).9 It appears that the methylation of Lys 
creates a tighter hydrophobic cluster with Trp, resulting in a stonger entropic driving 
force for folding, as evidenced by the observed enhancement of the cation-! interaction. 
Additionally, methylation of lysine increases the number of potential sites of favorable 
interaction with Trp. This is also reflected in the stronger entropic driving force. It is 
important to note that the folding of WKMe3 still retains a favorable, though diminished 
enthalpic term. This would support the notion of hydrophobically-enhanced yet still 
electrostatically viable cation-! interaction between Trp and KMe3 being the primary 
source of hairpin stability. The increased strength of the cation-! interaction between 
tetraalkylammonium guests and cyclophane hosts versus dialkylammonium guests in 
aqueous solution has been documented by Dougherty and co-workers.15  This effect has 
been attributed to the added hydrophobic component to the cation-! interaction upon 
increased methylation of the cation, which is in agreement with our thermodyamic 
analysis of peptides WK and WKMe3. 
 
                                                
15 (a) Kearney, P. C.; Mizoue, L. S.; Kumpf, R. A.; Forman, J. E.; McCurdy, A. E.; 
Dougherty, D. A. J. Am. Chem. Soc. 1993, 115, 9907 – 9919. (b) McCurdy, A.; Jimenez, 
L.; Stauffer, D. A.; Dougherty, D. A. J. Am. Chem. Soc. 1992, 114, 10314 – 10321. 
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Figure 2.7.  (a) Thermal denaturation of peptides WK (circles) and WKMe3 (squares). 
(b) Chemical denaturation of peptide WKMe3 as determined by change in Trp 
fluorescence. 
 
 
Table 2.1. Thermodynamic Parametersa for Folding at 298 K10 
Peptide %H° 
(kcal/mol) 
%S° 
(cal/mol K) 
%Cp° 
(cal/mol K) 
WK -2.8 -6.8 -163 
WKMe3 -0.2 4.3 -241 
a Determined from the temperature dependence of the Gly chemical shift from 0 to 60 
°C for peptide WK and from 0 to 80 °C for peptide WKMe3.  
 
We also performed a chemical denaturation of the "-hairpin with GdnHCl (Figure 
2.7b).  This denaturation plot clearly demonstrates the two-state nature of folding.  Fitting 
results in a %Gf of –1.3 kcal/mol with m = 0.8.
16  This is in reasonable agreement with the 
%Gf determined from Gly chemical shifts, particularly given the error associated with the 
chemical denaturation. 
                                                
16 Kortemme, T.; Ramirez-Alvarado, M.; Serrano, L. Science 1998, 281, 253 – 256. (b) 
Pace, C. N. Methods in Enzymology 1986, 131, 266 – 280.  
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iii. Conclusions. 
In conclusion, an investigation of the influence of Lys methylation on a cation-! 
interaction has resulted in the synthesis of an extremely stable "-hairpin peptide. 
Trimethylation enhances the interaction of Lys with Trp by about 0.7 kcal/mol. In 
agreement with this data, NMR shows enhanced upfield shifting of the Lys sidechain 
upon methylation, particularly at the # and N-methylated sites. This indicates that the 
orientation of the Lys with respect to the Trp remains the same upon methylation, but that 
the two sidechains form a tighter hydrophobic cluster. This is consistent with our thermal 
denaturation data, which reveals a greater entropic driving force for folding upon Lys 
methylation, with the retention some degree of enthalpic favorability. Hence, the 
methylation of lysine results in a hydrophobically-enhanced cation-! interaction. We 
expect that further exploration of this sequence will not only help elucidate the role of 
Lys methylation in the function of histone tails, but also will be of use to the engineering 
of "-turns in designed proteins and mediators of protein-protein interactions. 
Investigation of the incremental effects of Lys monomethylation and dimethylation will 
be discussed later in this chapter. 
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B. ARGININE METHYLATION AND THE CATION-!   INTERACTION 
 
i. Background and significance.  
Arginine methylation is a common post-translational modification that has 
recently been identified as playing a significant role in the regulation of cellular 
processes.17 Both arginine (Arg) mono- and dimethylation have been shown to play a role 
in cell signaling through mediation of protein-protein interactions.18 In particular, 
methylated arginines have been shown to function, in concert with other post-
translational modifications, in chromatin restructuring and transcriptional activation.17b 
There is still little structural information on record for methylated arginine, and so little is 
known about how such a subtle change in structure may mediate biomolecular 
recognition and signaling.  However, several recent studies of proteins containing 
dimethylarginine, DMA, as well as recent structural information on the role of the related 
posttranslational modification trimethyllysine, KMe3, in protein-protein interactions 
suggests a possible mechanism for recognition of the modified amino acid: the specific 
recognition of methylated arginine may depend on its interaction with aromatic rings 
(Figure 2.8). For example, the Tudor domain, a common 60 amino acid protein domain 
with highly conserved tryptophan, tyrosine, and phenylalanine residues, has been shown 
to bind preferentially to symmetrically methylated arginine-containing proteins.19 In the 
                                                
17 (a) McBride, A.E.; Silver, P.A. Cell, 2001, 106, 5-8. (b) Lee, D.Y.; Teyssier, C.; Strahl, 
B.D.; Stallcup, M.R. Endocrine Reviews 2005, 26, 147-170. (c) Bedford, M. T.; Richard, 
S. Molecular Cell 2005, 18, 263-272. 
18 Cosgrove, M.S.; Boeke, J.D.; Wolberger, C. Nat. Struct. Mol. Biol. 2004, 11, 1037-
1043.  
19 Cote, J.; Richard, S. J. Biol. Chem. 2005, 280, 28476-28483. 
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two examples of methylated arginine in the Protein Data Bank, it is found to stack with a 
tryptophan residue in a histone/chromodomain protein complex (Figure 2.8b)20 and with 
an iron-containing heme (not shown).  
 
(a)    (b)  
 
Figure 2.8.  (a) Arg-Trp pair in typical cation-! geometry (Human growth hormone 
and receptor complex: 3HHR).21 (b) DMAa-Trp pair from histone H3-chromodomain 
complex (2B2U).20  
 
There is significant precedence for Arg stacking with aromatic residues.  In surveys of 
protein crystal structures, cation-! interactions are often observed between the guanidine 
groups of arginine sidechains and the aromatic rings of tyrosine, tryptophan, and 
phenylalanine (Figure 2.8a).22 Gallivan and Dougherty’s survey of 593 protein crystal 
structures found that about 74% of arginine residues are in close proximity to an aromatic 
                                                
20 Flanagan IV, J.F.; Mi, L.-Z.; Chruszcz, M.; Cymborowski, M.; Clines, K.L.;  Kim, Y.; 
Minor, W.; Rastinejad, F.; Khorasanizadeh, S.  Nature 2005, 438, 1181-1185. 
21 de Vos, A.M.; Ultsch, M.; Kossiakoff, A.A. Science 1992, 255, 306-312. 
22 (a) Burley, S.K.; Petsko, G.A. FEBS Letters 1986, 203, 139-143. (b) Flocco, M. M.; 
Mowbray, S. L. J. Mol. Biol. 1994, 235, 709-717. (c) Mitchell, J. B. O.; Nandi, C. L.; 
McDonald, I. K.; Thornton, J. M.; Price, S. L. J. Mol. Biol. 1994, 239, 315-331. (d) 
Gallivan, J. P.; Dougherty, D. A. Proc. Natl. Acad. Sci. USA 1999, 96, 9459-9464. 
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sidechain, compared to 43% for Lys.22d This statistical preference is due to arginine’s 
unique ability to interact with aromatic rings with a hybrid of the cation-! and !-! 
stacking interactions, which lends both favorable dispersion and electrostatic character to 
the interaction without a significant desolvation penalty. Additional surveys of protein 
structures have identified a specific preference for the stacking of arginine residues with 
the 6-membered portion of the tryptophan indole ring.23 Cation-! interactions involving 
arginine have been identified and investigated within the context of protein structure22,24 
and ligand binding,25 protein-protein26 and protein-nucleotide interactions,27 peptide 
folding,28,29 and in model receptor systems.30  As with Lys, methylation of Arg may 
                                                
23 (a) Broccheiri, L.; Karlin, S. Proc. Nat. Acad. Sci. USA 1994, 91, 9297-9301. (b) 
Karlin, S.; Zuker, M.; Brocchieri, L. J. Mol. Biol. 1994, 239, 227-248. 
24 (a) Wei, Y.; Horng, J.; Vendel, A.C.; Raleigh, D.P.; Lumb, K.J. Biochemistry 2003, 42, 
7044-7049. (b) Luque, L.E.; Grape, K.P.; Junker, M. Biochemistry 2002, 41, 13663-
13671. (c) St. Charles, R.; Padmanabhan, K.; Arni, R.V.; Padmanabhan, K.P.; Tulinsky, 
A. Protein Sci. 2000, 9, 265-272. 
25 (a) Cumpstey, I.; Sundin, A.; Leffler, H.; Nilsson, U. J. Angew. Chem. Int. Ed. 2005, 
44, 5110-5112. (b) Woods, A. S. J. Proteome Res. 2004, 3, 478-484. (c) Pellequer, J.; 
Zhao, B.; Kao, H.; Bell, C.W.; Li, K.; Li, Q.X.; Karu, A. E.; Roberts, V.A. J. Mol. Biol. 
2000, 302, 691-699.  
26 Crowley, R.B.; Golovin, A. Proteins: Struct. Funct. Bioinform. 2005, 59, 231-239. 
27 (a) Kumaki, Y.; Nitta, K.; Hikichi, K.; Matsumoto, T.; Matsushima, N. J. Biochemistry 
2004, 136, 29-37. (b) Wintjens, R.; Lievin, J.; Rooman, M.; Buisine, E. J. Mol. Biol. 
2000, 302, 395-410.  
28 Shi, Z. S.; Olson, C. A.; Kallenbach, N. R. J. Am. Chem. Soc. 2002, 124, 3284-3291. 
29 Tatko, C. D.; Waters, M. L. Pro. Sci. 2003, 12, 2443-2452 
30 (a) Ngola, S.M.; Kearney, P.C.; Mecozzi, S.; Russell, K.; Dougherty, D. A. J. Am. 
Chem. Soc. 1999, 121, 1192 – 1201. (b) Rensing, S.; Arendt, M.; Springer, A.; Grawe, T.; 
Schrader, T. J. Org. Chem. 2001, 66, 5814-5821. (c) Thompson, S.E.; Smithrud, D.B. J. 
Am. Chem. Soc. 2002, 124, 442-449. (d) Nishihara, M.; Perret, F.; Takeuchi, T.; Futaki, 
S.; Lazar, A.N.; Coleman, A.W.; Sakai, N.; Matile, S. Org. Biomol. Chem. 2005, 3, 1659-
1669.  
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significantly enhance the magnitude of the Arg-! interaction while also making the 
residue more hydrophobic, thus providing a mechanism to mediate biomolecular 
recognition. 
To probe this possibility, we have investigated the interaction between Trp and 
symmetrically or asymmetrically dimethylated arginine residues (DMAs and DMAa, 
respectively) within the context of a "-hairpin peptide (Figure 2.9). This system has 
previously been shown to be an excellent model system for studying noncovalent 
interactions in an aqueous environment.29,31,32 We find that, in comparison to the 
Arg···Trp interaction, methylation of arginine significantly enhances peptide stability 
while maintaining the stacked geometry with tryptophan. Thermodynamic analysis of 
hairpin folding indicates that methylation of Arg results in a decreased entropic penalty 
for folding with a concomitant decrease in enthalpic driving force.  Furthermore, our 
analysis suggests that inclusion of a temperature-dependent %Cp is necessary in some 
cases for a full accounting of the observed cold denaturation.  These results suggest that 
the enhanced interaction of methyl arginines with aromatic rings may be a key driving 
force in the mediation of protein-protein interactions by proteins containing methylated 
arginine.  
                                                
31 Tatko, C.D.; Waters, M.L. J. Am. Chem. Soc. 2004, 126, 2028-2034. 
32 Hughes, R.M.; Waters, M.L. J. Am. Chem. Soc. 2005, 127, 6518-6519. 
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Figure 2.9. (a) "-Hairpin peptides containing arginine (Arg), symmetrically and 
asymmetrically dimethylated Arg (DMAs and DMAa, respectively), and trimethylated 
Lys (KMe3); peptides are referred to in the text by their residues in position 2 (Trp) and 
position 9 (X).  (b) Amino acids at position X. 
 
ii. Results and Discussion 
(a) Design, Synthesis, and Characterization. To study the Trp-dimethylarginine 
(DMA) interactions, we utilized the same "-hairpin peptide system that we had 
previously used to investigate Trp···Lys, Trp···Arg, and Trp···KMe3 interactions (Figure 
2.9).29,31,32 Fmoc-DMAs and Fmoc-DMAa were purchased from Bachem and 
incorporated into the peptide via standard Fmoc solid phase peptide synthesis. The 
peptides were characterized by mass spectrometry and NMR as reported previously.29 $-
Hydrogen (H$) chemical shifts, glycine splitting, amide shifts, and NOEs were used to 
characterize the hairpins and their respective stabilities.33 As discussed earlier in this 
                                                
33 Maynard, A. J.; Sharman, G. J.; Searle, M. S. J. Am. Chem. Soc. 1998, 120, 1996-2007. 
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chapter, the $-hydrogen chemical shifts of the hairpins relative to random coil values 
(Fig. 2.10a) indicate the degree of "-sheet structure at each position along the strand, 
where downfield shifting of greater than 0.1 ppm is taken to indicate a "-sheet structure.34 
The magnitude of glycine splitting has also been shown to be a good indicator of overall 
hairpin stability.33 The extent of folding can be quantified from both the H$ chemical 
shift and Gly splitting through comparison to a cyclic peptide which represents the fully 
folded state. Furthermore, NOEs between cross-strand pairs of sidechains were 
investigated to confirm "-hairpin formation as well as the specific sidechain-sidechain 
interaction between Trp and DMA (see Experimental). Lastly, upfield shifting of the 
DMA sidechain provides information about its proximity to the face of the Trp residue. 
(b) Effect of Methylation on Hairpin Stability and Structure.  Incorporation of 
DMAs or DMAa results in an increase in hairpin stability relative to the parent peptide. 
This is demonstrated by a measurable increase in the $-hydrogen shifts relative to 
random coil, as shown in Figure 2.10a. Based on the glycine splitting (Table 2.2), 
fraction folded of WDMAs is 94%35 and WDMAa is 93%, versus 84% for the peptide 
WR at 298K, indicating that both symmetric and asymmetric dimethylation enhance 
hairpin stability similarly, by about 0.6 kcal/mol relative to WR. Values determined from 
the H$ chemical shifts are in good agreement with the values determined from the Gly 
splitting (Table 2.2).  Additionally, the chemical shifts for the arginine sidechains show 
enhanced upfield shifting upon methylation (Figure 2.10b). The magnitude of upfield 
                                                
34 Griffith-Jones, S. R.; Maynard, A. J.; Searle, M. S. J. Mol. Biol. 1999, 292, 1051-1069. 
35 Percent folded from Ha shifts comes from the average of the percent folded from 
residues 2-5 and 8-11, excluding the turn residues and the terminal residues.  See 
supporting information. 
 30 
shifting across the guanidinium functionality is consistent with a stacking interaction 
between arginine and tryptophan that is enhanced by methylation (Figure 2.10c). 
Interestingly, for DMAs, the interaction is shifted towards the NHCH3 groups, whereas 
for DMAa, there is similar upfield shifting at the #-NH, NH2, and methyl groups, 
suggesting a difference in the orientation of stacking for the two different DMA residues.  
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Figure 2.10.  (a) WR, WDMAa, and WDMAs $H shifts relative to random coil 
values. Glycine shifts reflect the splitting. (b) Arg, DMAa, and DMAs sidechain upfield 
proton shifts relative to random coil values. Conditions: 298K, 50 mM NaOAc buffer, pH 
4.0 (uncorrected), referenced to DSS. (c) Proposed geometry for the Trp···DMA 
interaction. 
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Table 2.2.  Fraction Folded and Stability of Hairpins at 298 K. 
Peptide % Folded  
(Gly)a 
% Folded  
(H$)b 
%G, kcal/molc 
WDMAs 94 (1) 93 (3) -1.6 (-1.5) 
WDMAa 93 (1) 90 (6) -1.5 (-1.3) 
WR 84 (1) 78 (7) -1.0 (-0.7) 
(a)  Error is ± 1% as determined from the error in chemical shift. (b) Percent folded 
from Ha shifts is the average of the values from residues 2-5 and 8-11, excluding the turn 
residues and the termini. The standard deviation is in parenthesis. (c)  Determined from 
the Gly splitting; values in parentheses are from the H$ data. Error is ± 0.05 kcal/mol, as 
determined from the error in the chemical shift. 
 
(c) Interaction Energies.  Double mutant cycles were performed to determine the 
magnitude of the sidechain-sidechain interaction in isolation, using the same substitutions 
at positions 2 and 9 that were reported previously for the parent peptide, WR: Val was 
substituted for Trp at position 2 and Ser was substituted for DMA at position 9 (Figure 
2.3).29 This gave energies of –1.0 (±0.1) kcal/mol for the cation-! interaction with both 
DMAs and DMAa.  Thus, methylation enhances the Arg-Trp interaction by about a factor 
of two.29  Interestingly, the interaction between Trp and DMA is equal to that of Trp and 
KMe3 .32  
(d) Effects of Arg Methylation on Thermodynamic Analysis and Implications for 
the Temperature Depencdence of %Cp.  The thermodynamic driving force for hairpin 
folding was investigated by performing thermal denaturation studies on each of the 
peptides, followed by NMR (Figure 2.11).  Methylation of Arg resulted in a substantial 
increase in thermal stability of the hairpin, with no observable difference between 
WDMAs and WDMAa.  The temperature of maximum stability (Tmax) for WR is about 
 32 
275 K, versus about 295 K for WDMAs and WDMAa, amounting to a 20° increase.  
Moreover, WDMAa and WDMAs exhibit cold denaturation below 295 K, which is 
related to the change in buried hydrophobic surface area and is typically associated with a 
hydrophobic driving force for folding.   
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Figure 2.11.  Thermal denaturation of peptides WR, WDMAs, and WDMAa as 
measured by the temperature dependence of the Gly splitting. 
 
We fit the data to extract %H°, %S°, and %Cp° of folding using the method reported by 
Searle (equation [2]), which assumes a temperature-independent %Cp°:
33 
 
 Fraction Folded = [exp(x/RT)]/[1 + exp(x/RT)]    [2] 
where x = [T(%Sº298 + %Cºp ln (T/298)) – (%Hº298 + %Cºp (T – 298))] 
 
This expression has been shown to fit non-cold denatured "-hairpin data well (see for 
example WR in Figure 2.12a), but for WDMAa and WDMAs, the fit to the cold-
denatured portion of the curve was not as good, based on visual inspection (Figure 2.12b, 
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c).  Andersen has recently shown that the cold-denatured state of a "-hairpin differs from 
that of the heat-denatured state and that it retains some hydrophobic interactions.36  The 
change in heat capacity upon folding, %Cp°, is an indicator of the importance of 
hydrophobic contacts to the folding event (i.e., sidechain interactions), where, a negative 
%Cp° of folding (or a positive %Cp° of unfolding) is an indication of hydrophobic 
clustering within the folded state of the hairpin.37 If there are differences between the 
cold- and heat-denatured states, such as residual structure, then the %Cp° would be 
expected to vary with temperature.  Hence, we considered the possibility that the %Cp° is 
not temperature-independent across the entire temperature range.  We re-derived the 
Searle equation assuming a temperature-dependent %Cp°, using an empirical expression 
for the temperature dependence of the heat capacity as shown below.38 
 
Cp,m = a + bT + c/T
2         [3] 
%Hº = %Hº298 + )Cp,m dT        [4] 
)Cp,m dT = a (T – 298) + (b/2) (T
2 – 2982) – c (1/T – 1/298)   [5] 
%Hº = %Hº298 + a (T – 298) + (b/2) (T
2 – 2982) – c (1/T – 1/298)   [6] 
%Sº = %Sº298 + )(Cp,m/T) dT        [7] 
)(Cp,m/T) dT = a ln(T/298) + b (T – 298) – (c/2) (1/T
2 – 1/2982)   [8] 
%Sº = %Sº298 + a ln(T/298) + b (T – 298) – (c/2) (1/T
2 – 1/2982)       [9] 
                                                
36 Dyer, R. B.; Maness, S. J.; Franzen, S.; Fesinmeyer, R. M.; Olsen, K. A.; Andersen, N. 
H. Biochemistry 2005, 44, 10406-10415. 
37 Prabhu, N. V,; Sharp, K. A. Annu. Rev. Phys. Chem. 2005, 56, 521-48. 
38 Atkins, P. W. Chapter 2, Physical Chemistry, 6th ed.; Oxford University Press: Oxford, 
U.K., 1998. 
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Substituting equations [6] and [9] into equation [2] gives the following expression: 
 
Fraction Folded = [exp(x/RT)]/[1 + exp(x/RT)]     [10] 
where x = T(%Sº298 + a ln(T/298) + b (T – 298) – (c/2) (1/T
2 – 1/2982)) –  
(%Hº298 + a (T – 298) + (b/2) (T
2 – 2982) – c (1/T – 1/298))]. 
 
Using equation 10, which allows %Cp to vary with temperature, we re-analyzed the 
data.  The effect on WR was first investigated, as this peptide does not exhibit noticeable 
cold denaturation.  Fitting of its thermal denaturation data is marginally better using 
equation 9, based on visual inspection (Figure 2.12a). We performed an F test to 
determine whether the better fit is significant, and found that it is significant within 95% 
confidence limits (see Experimental).39 Nonetheless, equation 10 gives values for %H°, 
%S°, within error of those from equation 2 in this case, with a somewhat more negative 
%Cp° (Table 2.3).  This indicates that in the absence of noticeable cold denaturation, the 
assumption that %Cp° is independent of temperature is generally reasonable, and the 
simplified equation reported by Searle is satisfactory. 
 
                                                
39 (a) Shoemaker, D. Pl, Garland, C. W., and Nibler, J. W. Experiments in Physical 
Chemistry, 4th Ed.; McGraw Hill; 1981, 727-730. (b) Moore, D. S. The Basic Principles 
of Statistics, W. H. Freeman and Co.: New York, NY, 1995, 630-633. (c) Foster, J. E.; 
Holmes, S. F.; Erie, D. A. Cell, 2001, 106, 243-252. 
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Figure 2.12. Fitting of thermal denaturation profiles of (a) WR, (b) WDMAs, and (c) 
WDMAa peptides using equation 1 with a temperature independent DCp° (red line) and 
equation 9 which allows %Cp to vary with temperature (black line).  The fraction folded 
was determined from the Gly splitting. Error is ±0.5 K in temperature and ±1% in 
fraction folded. Conditions: 50 mM NaOAc-d4 buffer, pD 4.0 (uncorrected). 
 
Table 2.3. Thermodynamic Parametersa for Hairpin Folding at 298 K Peptides WR, 
WDMAs, and WDMAa using Equation 1  (temperature-independent %Cp°) and Equation 
9 (temperature-dependent %Cp°). 
 
 Equation 1 Equation 9 
Peptide %H° %S° %Cp° %H° %S° %Cp° 
WR -3.6 (0.1) -8.8 (0.3) -152 (6) -3.7 (0.1) -9.1 (0.2) -193 (29) 
WDMAs -2.4 (0.3) -2.9 (1.2)    -260 (18) -2.4 (0.2) -2.6 (0.8) -409 (61) 
WDMAa -2.2 (0.2)  -2.1 (0.6) -280 (10) -2.3 (0.1) -2.1 (0.4) -355 (53) 
 
(a) Determined from the temperature dependence of the Gly chemical shift from 0 to 80 
°C. Units are: DH°: kcal/mol; DS°: cal/mol K; DCp°: cal/mol K. Errors (in parentheses) 
are determined from the fit. Error for DCp° values from equation 10 estimated at 15%. 
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Comparison of fits for WDMAs and WDMAa with equations 2 and 10 indicates that 
in these cases, in which cold denaturation is observed, a noticeably better fit is obtained 
with equation 10 (Figures 2.12b and c).  This was verified using the F-test.  Nonetheless, 
fitting with equation 10 has no significant effect on the values of %H° and %S° (Table 
2.3).  In each case, the errors for %H° and %S° are smaller using equation 10, and the 
values for %Cp° are more negative than with equation 2. This is likely due to a better 
accounting of the cold denatured state.37  
Comparison of the thermodynamics of hairpin folding for WDMAs and WDMAa 
obtained from equation 10 indicates that the two hairpins are very similar, with a reduced 
enthalpic driving force for folding relative to WR and with a lower entropic cost for 
folding, as well as a more negative %Cp° (Table 2.3).  This data suggests that methylation 
of Arg results in a reduced electrostatic driving force for interaction with Trp and an 
enhanced hydrophobic component.37  
Examination of the electrostatic potential maps of arginine and methylated arginine 
sidechains provides additional insight into the observed effects (Figure 2.13).  Upon 
methylation, two changes are apparent: the surface area of the guanidinium group is 
significantly increased and the positive charge (indicated by the blue regions) is further 
distributed across the methyl functionality. For example, on the central carbon of the 
guanidinium group, the charge decreases from = +1.16 for Arg to +0.54 for DMAs and 
+0.76 for DMAa, as determined from the Merz-Kollman atomic charges (Figure 2.14).   
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Figure 2.13.  Electrostatic potential maps of sidechains: (a) Arg; (b) DMAa; (c) 
DMAs; (d) Structure of the Arg sidechain indicating its orientation in the electrostatic 
potential maps.  Electrostatic potential maps were generated with MacSpartan: HF/6-
31g*; Isodensity value = 0.02; range = 50 (red, electron rich) to 200 kcal/mol (blue, 
electron poor). 
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Figure 2.14. Changes in Merz-Kollman charges upon methylation of lysine and 
arginine (G03: HF/6-31g**).40 
                                                
40
 Gaussian 03, Revision B.04, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. 
E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, Jr., J. A.; Vreven, T.; Kudin, K. N.; 
Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, 
M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; 
Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; 
Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; 
Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; 
Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; 
Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, 
M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; 
Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; 
Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, 
M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; 
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This distribution of charge is expected to diminish the electrostatic interaction between 
the arginine guanidinium and the tryptophan indole ring, resulting in a reduced enthalpic 
driving force, as is observed.  The increased surface area may increase the dispersion 
forces between the two systems, which would be enthalpically favorable, counteracting 
the effect of the greater charge distribution.  However, it will also make the residue more 
hydrophobic, such that folding would be more entropically favorable.  The fact that the 
entropy of folding becomes more favorable upon methylation and that the %Cp° for 
folding becomes more negative argues in favor of an increased hydrophobic effect 
relative to the parent Arg···Trp interaction (Table 2.3).  
 
 
(e) Comparison to Trimethylated Lysine. The peptide WKMe3 has been previously 
reported to be a highly thermally stable "-hairpin due to a methylation-enhanced 
Lys···Trp interaction (see Chapter 2, section A).32 Its comparison to the dimethylated 
arginine peptides is particularly interesting since trimethylation of lysine is also a 
common post-translational modification, and has been shown to induce binding to an 
aromatic pocket in the protein chromodomain.41 While the DMA- and KMe3-containing 
                                                                                                                                            
Chen, W.; Wong, M. W.; Gonzalez, C.; and Pople, J. A.; Gaussian, Inc., Wallingford CT, 
2004. 
 
41 (a) Lachner, M.; Jenuwein, T. Curr. Opin. Cell. Biol. 2002, 14, 286 – 298. (b)  
Lindroth, A. M.; Shultis, D.; Jasencakova, Z.; Fuchs, J.; Johnson, L.; Schubert, D.; 
Patnaik, D; Pradhan, S.; Goodrich, J.; Schubert, Il; Jenuwein, T.; Khorasanizadeh, S.; 
Jacobsen, S. E. Embo. J. 2004, 23, 4286 – 4296. (c) Fischle, W.; Wang, Y. M.; Jacobs, S. 
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peptides are of similar stability at 298 K (Figure 2.16a), they have distinctly different 
modes of interaction with tryptophan. The trimethylated lysine interacts with tryptophan 
primarily by packing its #-CH2 and terminal methyl groups into the face of the indole ring 
with the predominant site for interaction at the #-CH2 group, as evidenced by the upfield 
shifting of the #-CH2 by nearly 1 ppm (Figure 2.15b).
32 In contrast, the dimethylated 
arginine derivatives undergo stacking interactions, as evidenced by the relatively even 
distribution of proton upfield shifting across the guanidinium and methyl groups (Figure 
2.15b).  
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Figure 2.15.  (a) WDMAa, WDMAs, and WKMe3 $H shifts relative to random coil values. Glycine 
shifts reflect the splitting. (b) DMAa, DMAs, and KMe3 sidechain upfield proton shifts relative to random 
coil values. Conditions: 298K, 50 mM NaOAc-d4 buffer, pD 4.0 (uncorrected), referenced to DSS. (c) 
Proposed geometry for the Trp···KMe3 interaction.  
  
 
                                                                                                                                            
A.; Kim, Y. C.; Allis, C. D.; Khorasanizadeh, S. Genes and Development 2003, 17, 1870 
– 1881. (d) Jacobs, S. A.; Khorasanizadeh, S. Science 2002, 295, 2080 – 2083. 
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 Both sets of peptides demonstrate high thermal stability, with melting 
temperatures (Tm) greater than 75° C, although NMR studies indication that WKMe3 
remains more folded at high temperatures (Figure 2.16). Since WKMe3 exhibits 
significant cold denaturation, we re-fit its thermal denaturation data using equation 10, 
and also re-fit the parent peptide WK for comparison.42 In the case of WK, which shows 
no cold denaturation, the fit with Equation 10 was no better than the fit with Equation 2 
according to the F test (Figure 2.16b).  However, a better fit was obtained for WKMe3 
with Equation 10 than Equation 2 (Figure 2.16c), as was found with WDMAa and 
WDMAs. Interestingly, in this case the temperature-dependent fit resulted in variation of 
the values for %H° and %S°, but with no change in %Cp° (Table 2.4).  This may be 
because equation 2 appears to overestimate the cold denaturation in this case. 
 
 
 
 
 
 
 
 
 
                                                
42 The values for %H°, %S°, and %Cp° reported for WKMe3 with equation 2 differ 
slightly from those in reference 29 because the data here comes from the average of four 
runs rather than the average of two runs in reference 29.  Nonetheless, the difference in 
fraction folded in any one data point in the thermal denaturation from different data sets 
was less than 1%. 
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Figure 2.16. (a) Comparison of thermal denaturation profiles of WDMAa, WDMAs, 
and WKMe3 peptides.  (b and c) Fitting of the thermal denaturation profiles of WK and 
WKMe3 using Equation 2 with a temperature-independent %Cp° (red lines) and Equation 
10 which allows %Cp to vary with temperature (black lines).  The fraction folded was 
determined from the Gly splitting. Error is ±0.5 K in temperature and ±1% in fraction 
folded. Conditions: 50 mM NaOAc-d4 buffer, pD 4.0 (uncorrected). 
 
 
 
Table 2.4. Thermodynamic Parametersa for Hairpin Folding at 298 K for Peptides WK 
and WKMe3 using Equation 2 (temperature-independent %Cp°) and Equation 10 
(temperature-dependent %Cp°). 
 
 Equation 2 Equation 10 
Peptide %H° %S° %Cp° %H° %S° %Cp° 
WK -2.8 (0.1) -6.7 (0.1) -166 (4) -2.6 (0.1) -6.2 (0.2) -182 (27) 
WKMe3 -0.6 (0.1) +2.7 (0.3) -237 (5) -0.1 (0.1) +4.5 (0.3) -243 (36) 
 
(a) Determined from the temperature dependence of the Gly chemical shift from 0 to 80 
°C. Units are: %H°: kcal/mol; %S°: cal/mol K; %Cp°: cal/mol K. Errors (in parentheses) 
are determined from the fit. Error for %Cp° values from equation 10 estimated at 15%. 
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Whereas methylation of Arg has a modest effect on %H° and %S° of hairpin folding, 
methylation of Lys has a more considerable effect, resulting in a less favorable enthalpy 
of folding and a more favorable entropy (Tables 2.3 and 2.4). 32,42  The more favorable 
entropy of folding for WKMe3 can be explained by the greater conformational freedom 
of the KMe3-Trp interaction versus that of a DMA-Trp interaction, where the rotor-like 
KMe3 has more sites of interaction with planar Trp than DMA, which is confined 
primarily to a stacked orientation with Trp in the folded state. Additionally, %Cp° of 
folding, which is generally recognized as a better indicator of the hydrophobic driving 
force in proteins than %S°,37 is more favorable for DMA than for KMe3. The greater 
hydrophobic driving force for the DMA-Trp interaction over the KMe3-Trp interaction is 
consistent with our electrostatic potential maps (Figures 2.13 and 2.17) and our calculated 
Merz-Kollman atomic charges (Figure 2.14), which both show greater polarization of the 
KMe3 methyl hydrogens versus the DMA methyl hydrogens. Another likely component 
of the more favorable %Cp° of folding for DMA may be due to differences in the solvent-
accessible surface area of KMe3 and DMA in the folded state. Finally, the greater 
enthalphic driving force of the DMA···Trp interaction versus that of KMe3 is likely due 
to the !-system of the guanidinium functionality, which results in less charge distribution 
onto the methyl groups (see Figures 2.13 and 2.17) and lends an additional !-! stacking 
component to the interaction with Trp. 22d,29 
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(a)  (b) 
H3C
N
CH3
CH3
H3C  
Figure 2.17.  (a) Electrostatic potential map of the KMe3 sidechain. (b) Structure 
KMe3 sidechain indicating its orientation in the electrostatic potential map.  The 
electrostatic potential map was generated with MacSpartan: HF/6-31g*; Isodensity value 
= 0.02; range = 50 (red, electron rich) to 200 kcal/mol (blue, electron poor). 
 
iii. Conclusions 
 Using a "-hairpin model system we have found that methylation of Arg enhances 
its interaction with a neighboring aromatic residue.  The interaction involves the stacking 
of DMA residue with the face of the Trp sidechain.  The interaction provides –1.0 
kcal/mol in stability to the hairpin, about twice as much as that of the unmethylated Arg, 
and equal to that of the interaction of Trp with KMe3. The methylation of Arg results in a 
decreased enthalpic driving force for folding with a concomitant decrease in entropic 
cost, , consistent with an increased hydrophobic component to the Arg···Trp interaction.  
Inclusion of the temperature-dependent %Cp° term improves the thermodynamic analysis 
for peptides exhibiting cold denaturation, and may better account for hydrophobic 
interactions in the cold denatured state.  It is noteworthy that such subtleties in %Cp° are 
observable in this system.  Indeed, this system may prove to be a useful model system for 
addressing questions about the role of heat capacity in protein folding.   
In comparison to KMe3, DMA has less charge dispersion onto the methyl groups and 
can interact with a larger portion of the Trp indole ring, but with fewer possible 
orientations. This has clear implications for the observed trends in %S° and %Cp°. The 
fact that such subtleties seem to be well accounted for in our highly stable model system 
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indicates that they may indeed be useful for correlating thermodynamic properties such as 
%S° and %Cp° with concepts such as conformational freedom and hydrophobicity. 
The role of Arg methylation in biological systems is just beginning to be determined, 
and these findings suggest a possible role for enhanced Arg···Trp interactions in the 
mediation of protein-protein interactions by Arg methylation.  Although Arg methylation 
may not provide a large change in interaction energy with Trp, noncovalent interactions 
rarely function in isolation.  Hence, we expect that a binding pocket which can 
accommodate a polarized methyl group in DMA via enhanced cation-! interactions, but 
would not provide hydrogen-bonding sites for an unmethylated Arg, provides the high 
selectivity necessary for such a subtle post-translational modification to act as a chemical 
switch for mediating a protein-protein interaction. While our data does not explain the 
preference, in some cases, for the recognition of asymmetrically methylated arginine over 
symmetrically methylated arginine, it is clear that DMAs and DMAa interact with Trp in 
different geometries, which implies that differently shaped binding sites could easily 
provide specificity for one form of methylation over the other.  We expect that this work 
will have relevance to the role of Arg methylation in the “histone code”.   
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C. DISTANCE DEPENDENCE STUDY OF THE CATION-!  INTERACTION 
 
i. Introduction.  
In a section 1A, we have shown that the trimethylation of lysine significantly 
increases the magnitude of the cation-! interaction between a lysine and a tryptophan 
residue in the context of a well-folded "-hairpin peptide.43 Our current study has two 
aims: (1) to systematically explore both the effect of mono, di, and trimethylation of 
lysine on the magnitude of the interaction; and (2) study the influence of proximity of the 
methylated ammonium group to tryptophan with the lysine (Lys) analogues ornithine 
(Orn) and diaminobutyric acid (Dab), in which the alkyl chain is shortened by one and 
two methylenes, respectively (Figure 2.18).  By incrementally methylating the Orn and 
Dab sidechains in the same manner as Lys, we investigated the optimal length for 
interaction of the unmethylated cationic sidechain with tryptophan and determined 
whether the same chain length was still optimal upon methylation. As a result, this study 
allows us to investigate the maximal interaction energy of the cation-! interaction within 
our model system. Additionally, this study reveals the interplay between the contributions 
of sidechain-sidechain interactions and "-sheet propensity to overall "-hairpin stability. 
Both "-sheet propensity, which is the statistical preference for a particular amino acid to 
adopt a "-sheet conformation, and sidechain-sidechain interactions have been shown to 
contribute to " -hairpin stability.44 In this study, we find that while " -sheet propensity 
                                                
43 Hughes, R.M.; Waters, M.L. J. Am. Chem. Soc. 2005, 127, 6518-6519. 
44 (a) Stotz, C. E.; Topp, E. M. J. Pharm. Sci. 2004, 93, 2881 – 2894. (b) Gellman, S. H. 
Curr. Opin. Chem. Biol. 1998, 2, 717 – 725, (c) Ramirez-Alvarado, M.; Kortemme, T.; 
Blanco, F. J.; Serrano, L. Biorg. Med. Chem. 1999, 7, 93 – 103. 
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decreases in the order Lys > Orn > Dab, the magnitude of the cation-! interaction 
between the truncated cationic residues and Trp still increases with N-methylation, 
lending stability to the hairpin and offsetting much of the destabilizing effects of low "-
sheet propensity. 
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Figure 2.18. (a) "-Hairpin peptides WXL containing Lys, Orn, and Dab at position 9, and their methylated 
analogues. (b) "-hairpin peptides WXT containing Lys and its methylated analogues at position 9, with Leu 
11 mutated to Thr. (c) Cyclic peptides WXLcyc are disulfide bridged at the hairpin termini to represent the 
fully folded state. 7mers (not shown) are used to determine the random coil chemical shifts (see Supporting 
Information). (d) Structure of Lys, Orn, and Dab. (e) Single mutant peptides VXL, in which Trp 2 has been 
replaced with Val. (f) Single mutant peptide WSL in which residue X at position 9 has been replaced with 
Ser.  (g) Double mutant peptide VSL in which Trp 2 has been replaced by Val and residue X at position 9 
has been replaced with Ser. 
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ii. Results and Discussion 
(a) Design, Synthesis, and Characterization. Peptides were designed to exploit a 
known energetically favorable cation-! interaction between Lys and Trp in diagonally 
oriented non-hydrogen bonded positions on the same face of the "-hairpin (Figure 
2.17).45 Due to the right-handed twist of the hairpin fold, the cross strand diagonal 
positions 2 (Trp) and 9 (Lys) place their respective sidechains in closer proximity than 
the diagonal positions 4 (Glu) and 11 (Leu).44 This creates a favorable environment for 
the sidechains to interact if an attractive force exists between them. We initially studied 
peptides with Leu and position 11, laterally cross-strand from Trp 2 (Figure 2.17a). Due 
to the very high stability of the original Leu-containing peptide series (and therefore 
small differences in fraction folded, which result in large differences in %G when near 
fully folded), Leu was mutated to Thr to create a less stable series of "-hairpins (Figure 
2.17b), such that variation in hairpin stability could be measured more accurately.  
Methylated amino acids were synthesized as shown in Schemes 2.1 and 2.2.  
Monomethylated species were synthesized starting with either Boc-Orn-OH (1a) or Boc-
Dab-OH (1b) (Scheme 2.1). Following protection of the sidechain with o-nitrobenzene 
sulfonic acid, amino acid 2 was selectively methylated in the presence of NaOH with 
dimethyl sulfate. Deprotection of 3 with TFA and reprotection with Fmoc-Cl gave 4. 
After solid phase peptide synthesis, the o-nitrobenzenesulfonyl moiety was selectively 
                                                
45
 (a) Tatko, C. D.; Waters, M. L. Protein Science 2003, 12, 2443 – 2452. (b) Tatko, 
C.D.; Waters, M.L. J. Am. Chem. Soc. 2004, 126, 2028-2034. 
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cleaved in the presence of 2-mercaptoethanol and DBU46, followed by cleavage from the 
resin with TFA.  Boc-dimethyl Orn (6a) and Boc-dimethyl Dab (6b) were prepared from 
Boc-Orn (1a) and Boc-Dab (1b) by reductive methylation in the presence of 
formaldehyde and H2/Pd/C (Scheme 2.2).
47 The Boc-protected amino acids were 
deprotected with TFA,  reprotected with Fmoc-OSu, and incorporated into peptides via 
standard Fmoc solid-phase peptide synthesis. Trimethylated species were achieved by 
methylation of dimethyllysine with methyl iodide and MTBD (7-Methyl-1,5,7-
triazabicyclo[4.4.0]dec-5-ene) after peptide synthesis, followed by cleavage from the 
resin.48  
Peptides were characterized by mass spectrometry and NMR as reported previously.45 
Alpha hydrogen (H$) chemical shifts, glycine splitting, and NOEs were used to 
characterize the hairpin structure and their respective stabilities. The degree of H$ 
chemical shifts of the hairpins relative to random coil values (Figure 2.17c-d) are used as 
indicators of the degree of "-sheet structure at each position along the strand.49 In the 
folded state, H$ are shifted downfield relative to random coil due to the inductive effects 
of the amide-carbonyl cross-strand hydrogen bonds present in "-sheets.50 Hence, 
increased downfield H$ shifting is evidence of increased hairpin stability. Also, the 
magnitude of glycine splitting has been shown to be a good indicator of overall hairpin 
                                                
46
 Miller, S.C.; Scanlan, T.S. J. Am. Chem. Soc. 1997, 119, 2301-2302. 
47 (a) Benoiton, L. Can. J. Chem.1964, 42, 2043.(b)Lamar, J., et al. Bioorg. & Med. 
Chem. Lett. 2004, 14, 239 – 243. 
48 Kretsinger, J.K.; Schneider, J.P. J. Am. Chem. Soc. 2003, 125, 7907-7913. 
49 Griffith-Jones, S. R.; Maynard, A. J.; Searle, M. S. J. Mol. Biol. 1999, 292, 1051-1069. 
50 Guo, H.; Karplus, M. J. Phys. Chem. 1994, 98, 7104 – 7105. 
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stability.51 The extent of folding can be quantified by calculating the fraction folded, as 
shown by the following equation: fraction folded (f) = [&obs – &0]/[ &100 – &0], where &0 
represents the random coil chemical shift determined from 7mer peptides and &100 the 
fully folded chemical shift determined from the cyclic peptides (Figure 2.17). Free energy 
of folding is determined from the fraction folded value by the equation %G = -RTln(f/(1-
f)).  
Sidechain chemical shifts were used to evaluate the proximity of the cationic sidechain 
to the Trp indole ring. Due to the anisotropy of the aromatic ring, protons that are in close 
proximity to the electron rich face of an aromatic ring are shifted upfield. As a result, the 
degree of Lys sidechain upfield shifting is an indicator of the degree of contact between 
the alkyl side chain and the face of the tryptophan ring. Finally, NOEs between cross-
strand pairs of sidechains provide evidence for hairpin folding within the correct register. 
These are provided in the experimental section.  
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Scheme 2.1. Synthesis of Monomethylated Orn and Dab containing peptides. 
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Scheme 2.2. Synthesis of Di- and Trimethylated Orn and Dab containing peptides. 
Effects of Chain Length in Unmethylated Sidechains. Comparison of WKL, 
WOrnL, and WDabL allows for the influence of the chain length on the cation-! 
interaction to be determined.  To correct for differences in "-sheet propensities of Dab, 
Orn, and Lys, double mutant cycles were performed,52 indicating that the cation-! 
interactions for WKL and WOrnL are –0.3 and –0.2 (± 0.1) kcal/mol, respectively.  Due 
to the instability of the Dab single mutant hairpin VKL (fraction folded = 13%), large 
errors in the double mutant cycles complicate a direct analysis of the contribution of the 
sidechain-Trp interaction to hairpin stability for WDabL. However, based on the trends 
in upfield shifting of the Lys, Orn, and Dab sidechains (Figure 2.19), the available 
evidence suggests that the cation-! component of the sidechain-Trp interaction decreases 
with each truncation of the sidechain.  Indeed, for Dab it appears that there is little or no 
interaction with Trp, as the upfield shifting is < 0.05 ppm at any position in the Dab 
sidechain (Figure 2.19).  This suggests that Dab is too short to interact with Trp in a 
diagonal orientation.  The upfield shifting of Orn suggests that the &-position is the most 
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 Hunter, C. A.; Tomas, S. Chemistry and Biology 2003, 10, 1023-1032. 
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favorable for interaction with Trp, but that it is not as favorable as the #-position of Lys.  
Hence, Lys appears to be of the optimal length for a diagonal cation-! interaction. 
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Figure 2.19. Upfield shift profiles of Lys, Orn, and Dab sidechains. 
 
The fraction folded of the control peptides, VKL, VOrnL, and VDabL, in which a 
cation-! interaction is not possible, provides information about the inherent "-sheet 
propensity of Orn and Dab relative to Lys. As the sidechain is shortened, its "-sheet 
propensity decreases, resulting in a decreased fraction folded [from 37% for VKL to 29% 
for VOrnL to 13% for VDabL].  Hence, mutation of Lys to Orn and Dab results in 
destabilization of the "-hairpin due to the reduced "-sheet propensity even in the absence 
of a cation-! interaction. Additionally, the fraction folded of the single mutant peptides 
does not change significantly upon methylation [for example, VKL (37%) and VKMe3L 
(38%)]. This indicates that in the case of the WXL peptides, it is indeed enhancement of 
the sidechain-sidechain interaction via methylation, and not a change in "-sheet 
propensity upon methylation , that lends added stability to the peptide (see discussions of 
methylated peptides below).  
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Effects of Lysine Methylation: Peptides WK(Me)nL (n = 0-3). The lysine-
containing peptides WKL, WKMeL, WKMe2L, and WKMe3L show an increase in 
hairpin stability with each addition of a methyl group to the lysine sidechain, revealing 
that even monomethylation significantly stabilizes the folded peptide (Table 2.5 and 
Figure 2.20a). This trend is also evident in the H$ shifts, which are further downfield 
upon methylation, with the exception of the frayed terminal residues arginine and 
glutamine, which are not significantly affected by methylation, and Asn in the "-turn 
(Figure 2.20b).  
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Figure 2.20.  (a) Fraction folded derived from the glycine splitting (b) WK(Me)nL H$ shifts relative to 
random coil values. Glycine shifts reflect the splitting. (c) WK(Me)nL sidechain upfield proton shifts 
relative to random coil values. 
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Table 2.5.  Fraction Folded and Stability of Hairpins at 298 K. 
Peptide % Folded  
(Gly)a 
% Folded  
(Ha)b 
DG, kcal/molc 
WKL 78 (1) 76 (1) -0.76 (-0.7) 
WKMeL 86 (1) 84 (13) -1.06 (-1.0) 
WKMe2L 89 (1) 84 (16) -1.26 (-1.0) 
WKMe3L 92 (1) 91 (15) -1.45 (-1.4) 
(a)  Error is ± 1% as determined from the error in chemical shift. (b) Percent folded from Ha shifts is the 
average of the values from residues 2-5 and 8-11, excluding the turn residues and the termini. The standard 
deviation is in parenthesis. (c)  Determined from the Gly splitting; values in parentheses are from the Ha 
data. Error is ± 0.05 kcal/mol, as determined from the error in the chemical shift; Average error for Ha data 
(as calculated from the standard deviation) is ± 0.4 kcal/mol. 
 
The lysine sidechain also exhibits increased upfield shifting with each additional 
methylation, indicating a greater degree of interaction with the tryptophan indole ring 
(Figure 2.20c). The #-methylene is the most upfield shifted portion of the sidechain in 
each peptide, indicating its close proximity to the indole ring. In the case of Lys, the #-
protons are polarized by the neighboring cationic ammonium group, which creates a site 
of favorable interaction with the face of the aromatic ring (Figure 2.21). This is consistent 
with the orientation of Lys-Trp pairs commonly observed in protein crystal structures.53  
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Figure 2.21.  Possible interaction geometries for Trp-Lys and Trp-KMe3 interactions. 
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 Gallivan, J.P.; Dougherty, D.A. Proc. Natl. Acad. Sci. 1999, 96, 9459-9464. 
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To quantitatively assess the Lys-Trp interaction, double mutant cycles were performed, 
using the non-interacting residues Ser and Val in place of Trp and Lys, respectively 
(Figure 2.18).45 Double mutant cycles isolate the interaction energy of the residues in 
question (in this case, Lys and Trp), and extracts the contribution of this interaction to the 
overall %G of hairpin folding. The single mutant peptides (Trp2Ser and Lys9Val) account 
for the contribution of each residue in the interacting pair (Trp or Lys) to "-hairpin 
stability, while the double mutant peptide accounts for changes in stability that may be 
due to differences in "-sheet propensities, etc. between the native and mutant sidechains. 
Double mutant cycles provide Lys-Trp interaction energies for WKL, WKMeL, 
WKMe2L, and WKMe3L of -0.3, -0.5, -0.7, and -1.0 kcal/mol (+/-0.1 kcal/mol), 
respectively. This amounts to an enhancement of the cation-! interaction of about 0.2 - 
0.3 kcal/mol per methylation. The value of -1.0 kcal/mol for the interaction of 
trimethylated lysine with tryptophan compares well with other literature values for the 
binding of tetra-alkyl ammonium species to aromatic rings in water: approximately 0.9 
kcal/mol per aromatic residue in Diederich’s study of a Factor Xa binder5a, and 
approximately 1.1 kcal/mol per aromatic residue in Dougherty’s cyclophane receptor.54b 
The methylated hairpins WKMeL, WKMe2L, and WKMe3L show a significant 
increase in thermal stability in comparison to the parent peptide WKL (Figure 2.22a). By 
NMR, WKMe3L appears to be ~72% folded at 70 °C. Interestingly, the trimethylated 
peptide WKMe3L shows little or no thermal denaturation by CD over the range 0 to 90 
°C (Figure 2.22b). The peptide WKMe3L also shows no unfolding transition over the 20 
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 (a) Stauffer, M.; Dougherty, D.A. Tett. Lett. 1988, 29, 6039.; (b) Stauffer, M; 
Dougherty, D.A. Science 1990, 250, 1558. 
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to 90 °C range when monitored by DSC. These results corroborate a recent FTIR study of 
the thermal denaturation of the "-hairpin peptide trpzip2, which maintains substantial 
residual native structure when heated to 82 °C.55 Taken together, these results support the 
notion that the global "-sheet structure of WKMe3L changes little over a wide 
temperature range, making it impractical to measure a thermal transition with traditional 
calorimetry techniques such as DSC. The CD spectrum gives insight into global stability 
of the hairpin, while the NMR spectrum can reveal detailed structural changes 
indistinguishable by CD. Notable exceptions to this are the trpzip peptides, which 
display large exciton couplings, enabling accurate determination of thermodynamic 
parameters from thermal CD studies.56 
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Figure 2.22. (a) Thermal denaturation profiles of WK(Me)nL peptides by NMR. (b) CD 
spectra of WKMe3L at 0 and 90° C. 
  
Analysis of the thermodynamics of folding derived from NMR thermal 
denaturation reveals increasingly favorable entropy of folding and increasingly 
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 Smith, A.W.; Chung, H.S.; Ganim, Z.; Tokmakoff, A. J. Phys. Chem. B 2005, 109, 
17025-17027. 
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 Cochran, A. G.; Skelton, N. J.; Starovasnik, M. A. Proc. Nat. Acad. Sci. 2001, 98, 
5578 – 5583. 
 56 
unfavorable enthalpy of folding with each methylation step (Table 2.6). The decrease in 
enthalpic favorability can be explained by the greater dispersion of the positive charge 
across the N-methyl groups in KMe3, as can be seen from the electrostatic potential maps 
in Figure 2.23. The increase in entropic favorability is consistent with additional sites of 
interaction with the aromatic ring with each additional methyl group: while the lysine 
sidechain in hairpin WKL has one preferred site of interaction (the polarized #-
methylene), the methylated peptides WKMeL, WKMe2L, and WKMe3L have additional 
polarized methyl groups that can interact favorably with the aromatic ring. In addition, 
the enhanced hydrophobicity of the sidechain upon methylation is also reflected by the 
trend in %S. There is also a trend of increasingly favorable  %Cp° with each methylation, 
which is usually associated with an increased hydrophobic effect and may be the result of 
increased burial of the lysine sidechain with each methylation.57 
Table 2.6. Thermodynamic Parametersa for WK(Me)nL (n = 0-3) peptides at 298 K
10 
Peptide %H° 
(kcal/mol) 
%S° 
(cal/mol K) 
%Cp° 
(cal/mol K) 
WKL -2.8 (0.03) -6.8 (0.1) -163 (3) 
WKMeL -1.7 (0.1) -2.2 (0.3) -221 (33) 
WKMe2L -0.7 (0.1) +1.8 (0.4) -207 (31) 
WKMe3L -0.1 (0.1)  +4.5 (0.3) -243 (36) 
a Determined from the temperature dependence of the Gly chemical shift from 0 to 60 
°C for peptide WKL, WKMeL, and WKMe2L and from 0 to 80 °C for the peptide 
WKMe3L. Conditions: 50 mM sodium acetate-d4, pH 4.0 (uncorrected) at 298 K, 
referenced to DSS. Errors (in parentheses) are determined from the fit. 
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Figure 2.23.  Electrostatic potential maps of (a) lysine sidechain analogue and (b) 
trimethylated lysine sidechain analogue (Spartan: HF/6-31g*; Scale = 50 to 200 
kcal/mol).58 Chemdraw structures are included to show the orientation of the sidechain. 
 
WK(Me)nT (n = 0-3) Peptides.  Because the series of methylated WK(Me)nL 
peptides are so well folded, we had some concern about the accuracy of the %G’s 
determined from the fraction folded, since near 100% folded, small changes in fraction 
folded result in larger changes in %G than near 50% folded.  Hence, we reinvestigated the 
Trp-Lys(Me)n (n = 1-3) interactions using a peptide series in which the fraction folded of 
the peptide containing unmethylated Lys was only modestly folded. In addition to the 
cation-! interaction, another stabilizing structural feature of this family of "-hairpins is 
the hydrophobic packing of the Trp residue with the cross-strand Leu. This interaction 
stabilizes the hydrophobic core of the folded peptide, as demonstrated by a series of 
lysine-containing peptides in which Leu is mutated to Thr (Figure 2.18b), leading to a 
less well-folded family of "-hairpins (Figure 2.24). Thr has been observed to have a 
lower "-sheet propensity than Leu in other "-hairpin model systems.59  It is also clear 
from the chemical shifts of the Thr and Leu sidechains from WK(Me)nT and WK(Me)nL 
peptides that Thr does not interact with Trp as strongly as does Leu (Figure 2.25).  
                                                
58 MacSpartan 2004 (Wavefunction, Inc.) 
59
 (a) Cochran, A.G.; Tong, R. T.; Starovasnik, M. A.; Park, E. J.; McDowell, R. S.; 
Theaker, J. E.; Skelton, N. J. J. Am. Chem. Soc. 2001, 123, 625 – 632. (b) Russell, S. J.; 
Blandl, T.; Skelton, N.; Cochran, A. G. J. Am. Chem. Soc. 2003, 125, 388 – 395. 
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Hence, the observed destabilization of the hairpin appears to be a combination of 
sidechain-sidechain interaction and "-sheet propensity effects. 
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Figure 2.24. Fraction Folded (based on glycine splitting) of WK(Me)nT and WK(Me)nL 
(n=0-3) "-hairpins. 
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Figure 2.25. (a) Upfield shifts of Leu in WK(Me)nL peptides (n=0-3). (b) Upfield shifts 
of Leu in WK(Me)nT peptides (n=0-3). (c) Labeled sidechains of Leu and Thr. (c) 
Structures of Leu and Thr with sidechain positions labeled. 
Comparison of the free energies of folding from the WK(Me)nL series of 
peptides and the WK(Me)nT series indicate that the differences in energy upon each 
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methylation are within error in the two series (Table 2.7).  This indicates that the values 
determined from the WK(Me)nL series are reliable, and hence,  the double mutant data 
discussed above for the WK(Me)nL series is correct.  Moreover, this demonstrates the 
modular nature of these systems for studying noncovalent interactions, in that two 
different peptide systems provide the same information on cation-! interactions.   
Table 2.7.  Comparison of Hairpin Stabilities in the WKL and WKT Series. 
Peptide Fraction Folded 
 
%G° 
(kcal/mol) 
%%G°a 
(kcal/mol) 
WKL 0.78 -0.76 -- 
WKMeL 0.85 -1.04 -0.28 
WKMe2L 0.89 -1.26 -0.22 
WKMe3L 0.92 -1.44 -0.18 
WKT 0.39 0.27 -- 
WKMeT 0.50 -0.01 -0.27 
WKMe2T 0.63 -0.32 -0.31 
WKMe3T 0.73 -0.58 -0.26 
(a) %%G° = %G°(WK(Me)nX) – %G°(WK(Me)n-1X), where n = 0-3 and X = Leu or Thr. 
 
WOrn(Me)nL Peptides (n = 0-3). From the ornithine-containing peptide series  
(WOrnL, WOrnMeL, WOrnMe2L, WOrnMe3L), it is apparent that shortening the 
length of the sidechain by one methylene destabilizes the folded peptide (Figure 2.26a). 
The %G° of folding for WKL is -0.77 kcal/mol, while the %G° of WOrnL is -0.42 
kcal/mol. As seen with the lysine series, hairpin stability increases with each methylation 
of Orn, so that the stability of the trimethylated Orn hairpin WOrnMe3L is 
approximately that of the unmethylated lysine hairpin WKL (Figure 2.26b). As 
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compared to the methylated lysine series, the methylated Orn sidechains show similar 
trends in their upfield shifting relative to random coil due to their proximity to the 
aromatic ring (Figure 2.26c). However, with ornithine the polarized & position is the most 
upfield shifted portion of the sidechain, indicating that it is the preferred side of 
interaction with the indole ring. This is directly analogous to the Lys-Trp interaction, 
where the methylene adjacent to the ammonium group is the preferred site of interaction 
with Trp. As seen in the methylated lysines, the N-terminal methyl groups are 
significantly upfield shifted, but less so than the & protons (Figure 2.26c).  
Double mutant cycles performed for the peptides WOrnL and WOrnMe3L show 
that methylation of the Orn sidechain lends added stability to the Trp-Orn interaction, just 
as in the case of the Lys-Trp interaction, with the cation-! interaction worth -0.2 kcal/mol 
in WOrnL and -0.8 kcal/mol in WOrnMe3L (±0.1 kcal/mol). That the cation-! 
interaction is worth slightly less in the Orn peptides versus the Lys peptides is born out 
by the upfield shifting profiles, which show less upfield shifting for the Orn sidechains 
than for the Lys sidechains (Figure 2.27). 
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Figure 2.26.  (a) WOrn(Me)nL and WK(Me)nL fraction folded from the glycine splitting (b) 
WOrn(Me)nL H$ shifts relative to random coil values. Glycine shifts reflect the splitting. (c) 
WOrn(Me)nL sidechain upfield proton shifts relative to random coil values. 
-1
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
! " # $ % &%
Sidechain Proton
'
$
 H
!
 (
p
p
m
)
WOrnMe3L
WKMe3
 
Figure 2.27. Comparison of OrnMe3 and LysMe3 sidechain upfield shifting profiles. 
WDab(Me)nL Peptides (n = 0-3). In the diaminobutyric acid (Dab)-containing 
peptides (WDabL, WDabMeL, WDabMe2L, and WDabMe3L), the trends in global 
hairpin stability observed for the methylation of Lys and Orn continue (Figure 2.28a): 
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Dab is less stable than Orn or Lys. This is evident from both the fraction folded derived 
from the glycine splitting and the H$ downfield shifts (Figure 2.28b). However,  due to 
the shortened sidechain of Dab, the preferred site of interaction with Trp changes in 
comparison to Orn and Lys. While there is some upfield shifting along the Dab sidechain 
(Figure 2.28c), the magnitude of the methylene shifts proximal to the cation is minor 
compared to those observed for both the Lys and Orn peptides (-0.95 ppm for the #-
methylene of WKMe3L and -0.72 ppm for the &-methylene of WOrnMe3L versus -0.1 
ppm for the  (-methylene of WDabMe3L). Additionally, while the N-methyl groups of 
Orn(Me)n and Lys(Me)n are less upfield shifted than their & and #-methylenes, 
respectively (Orn: -0.4 ppm versus -0.7 ppm; Lys: -0.6 ppm versus -1.0 ppm), the 
Dab(Me)n methyl groups are by far the most upfield shifted portion of the Dab sidechain 
(-0.4 ppm). The Dab N-methyl groups are at the same location as the Lys #-methylene. 
Thus, it appears that due to length restriction, the Dab N-terminal methyl groups are the 
only portion of the sidechain to experience significant contact with the indole ring. 
Double mutant cycles for the Trp-Dab interaction possess higher error (0.2 kcal/mol) due 
to the instability of the Trp to Val single mutant peptides in the Dab series (fraction 
folded ~ 14%). Thus, they give numbers that are within error for those of the Orn and Lys 
peptides (%%G  = -0.3 kcal/mol for Trp-Dab interaction in WDabL and %%G  = -0.9 
kcal/mol for Trp-DabMe3 interaction in WDabMe3L, all values ±0.2 kcal/mol). 
Nonetheless, the magnitude of the Trp-DabMe3 interaction, despite the decreased upfield 
shifting relative to LysMe3 and OrnMe3 sidechains, suggests that it may be able to 
interact with the Trp sidechain in a non-specific, hydrophobic fashion (i.e., packing 
against the side of the ring) in addition to undergoing a cation-! interaction with the face 
 63 
of the indole ring via its N-terminal methyl groups. Additionally, given the similarity of 
the interaction magnitudes of the cationic residues with Trp, the trends in overall hairpin 
stability suggest that the Dab residues also have lower "-sheet propensities than their Orn 
and Lys analogues.   
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Figure 2.28.  (a) WDab(Me)nL and WK(Me)nL fraction folded comparison (b) WDab(Me)nL $H shifts 
relative to random coil values. Glycine shifts reflect the splitting. (c) WDab(Me)nL sidechain upfield proton 
shifts relative to random coil values. 
 
pH Studies. It is conceivable that the shortening of the lysine sidechain to 
diaminobutyric acid might actually favor the formation of a salt bridge with the cross 
strand glutamic acid (Figure 2.18a). We have previously demonstrated the effect of 
protonating the Glu in WKL by showing that lowering the pH increases hairpin 
stability.45 Consistent with our initial observations, all peptides in the series show an 
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increase in stability upon lowering the pH, which is consistent with hydrophobic packing 
of the alkyl chains of Lys, Orn, and Dab with the alkyl group of the Glu sidechain, rather 
than the formation of a traditional salt-bridge (Figure 2.29). Furthermore, mutation of Glu 
to Gln eliminates the pH dependence of stability. Similar hydrophobic interactions 
between lysine and glutamic acid have been observed in related coiled-coil systems.60,61 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
W
D
ab
L
W
O
rn
L
W
K
L
W
O
rn
M
e3
L
W
K
M
e3
L
W
K
M
e3
E4
Q
F
r
a
c
t
io
n
 F
o
ld
e
d
pH 1.1
pH 4
pH 7.4
 
Figure 2.29. pH study of hairpin stability (based on glycine splitting). 
NMR Structure Calculation. The calculation of NMR solution structures was 
undertaken in order to further confirm our experimental observations. Using the program 
CNSSolve, a simulated annealing protocol was used in conjuction with NMR chemical 
shift and NOE data to generate a number of low energy structures for the "-hairpins 
WKL and WKMe3L.
62 Shown below are selected 10 lowest energy structures from the 
simulated annealing runs (Figure 2.30). The superimposed backbone structures show the 
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hydrogen-bonding pattern expected for "-hairpin structure and the experimentally 
observed fraying at the termini (Figure 2.30a-b). The sidechain orientations in the 
average structure shown in Figure 2.31 also reflect what has been observed 
experimentally: orientation of the lysine sidechain near the face of the tryptophan ring, 
with the #-CH2 packed into the ring, packing of the leucine with the tryptophan residue, 
and packing of the glutamic acid sidechain against the lysine methylenes, with the 
carboxyl functionality directed away from the hydrophobic cluster. Unrestrained 
molecular dynamics simulations of these average structures in explicit water with the 
AMBER package indicates that these structures are stable over several nanoseconds of 
simulation time and are therefore not overly biased by the experimental restraints in our 
NMR structure calculations (Figure 2.32). The overall conclusion from the computational 
data is that 1) our initial hypothesis regarding the orientation of the lysine sidechain with 
respect to the tryptophan is correct and 2) these hairpins contain a tightly packed 
hydrophobic cluster between residues in the non-hydrogen bonding sites that is 
accurately described by both experimental and computational data. 
  
Figure 2.30. Backbones of superimposed NMR structures from simulated annealing runs. 
(a) WKL and (b) WKMe3L. 
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Figure 2.31. Averages of selected NMR structures from simulated annealing runs. (a) 
WKL and (b) WKMe3L. 
 
Figure 2.32. Low energy structure of peptide WKMe3L from a 2 nanosecond MD 
simulation in AMBER. 
 
iii. Conclusion 
 The enhancement of the cation-! interaction via N-methylation within the context 
of a "-hairpin has been thoroughly investigated. Shortening the sidechain decreases the 
magnitude of the observed interaction and substantially decreases hairpin stability. Other 
key factors of fold stability, including the formation of a hydrophobic cluster between 
Trp, Leu, Glu, and the methylated cationic sidechain, have been shown to contribute 
substantially to the overall stability of the peptides studied. The incremental modulation 
of the thermodynamic profile of hairpin folding with increasing methylation reveals the 
contribution of each additional methyl group to the interaction and suggests a 
thermodynamic basis for discrimination between mono-, di-, and trimethylation in 
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biological systems, as seen in the preferential binding of trimethylated lysines by PhD 
domains and chromodomains.63 On a fundamental level, this study shows the ability of 
the Lys, Orn, and Dab sidechains to maintain a favorable interaction with Trp, even as the 
geometry of the interaction appears to be changing. This is due in part to the flexibility of 
our "-hairpin model system, and due to the broad recognition surface of Trp, which 
makes it an easy target to hit. Furthermore, the examination of Orn and Dab residues 
versus Lys presents another means of stability control in designed proteins and receptors 
via the cation-! interaction. One can imagine the use of these three interactions to lend 
varying degrees of strength and specificity to designed systems. Studying these effects in 
a less solvent-exposed environment might lead to even better control of the interaction. 
Finally, this study highlights the interplay between "-sheet propensities, specific, and 
non-specific hydrophobic interactions in determining the overall stability of "-hairpin 
model systems.  
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D. Experimental Section 
i. Small Molecule and Peptide Synthesis 
Synthesis of Fmoc-Monomethyl-(oNBS)-Ornithine and Fmoc-Monomethyl-
(oNBS)-Diaminobutyric Acid 4. Boc-ornithine-OH (0.358g; 1.5 mmol) was taken up 
into 15 mL of 1N NaOH in a 100 mL round bottom flask and cooled in an ice bath. O-
nitrobenzenesufonyl chloride (2.05g; mmol) was dissolved in 30 mL of diethyl ether and 
added dropwise over a ten minute period with stirring to the chilled aqueous solution via 
separatory funnel. After addition was complete, the two-phase solution was allowed to 
warm slowly to room temperature with vigorous stirring over 14 hours. Next, the reaction 
mixture was transferred to a separatory funnel, and the aqueous and organic layers 
separated. The aqueous layer was washed with ether (2 X 25mL), and then chilled to 0 
°C. Gradual addition of 1N HCl to pH 4 resulted in the formation of a white precipitate. 
The chilled aqueous mixture was extracted with several volumes of ethyl acetate (3 X 50 
mL). The ethyl acetate was dried with MgSO4 and rotovapped to dryness, yielding a clear 
oil (0.327g). The oil was subsequently taken up in 10 mL of 1N NaOH with stirring in a 
100 mL roundbottom flask. Dimethyl sulfate (1 mL) was added and the solution was 
allowed to stir for 3 hours. The reaction was followed by TLC (10:1 CH2Cl2: MeOH). 
The resulting aqueous solution was chilled to 0 °C and carefully acidified to pH 4 with 
1N HCl, resulting in the formation of a white precipitate. The acidic mixture was 
extracted with several volumes of ethyl acetate, which was dried with MgSO4 and 
evaporated in vacuo to give a yellowish oil, which was purified vi silica gel 
chromatography (10:1 CH2Cl2:MeOH) to give compound 3. (Yield: 0.215g, 0.5 mmol, 
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33% yield). NMR (600 MHz, CDCl3): 7.96 (d, 1H), 7.68 (m, 2H), 7.60 (d, 1H), 5.27 
(broad s, 1H), 4.2 (m, 1H), 3.26 (m, 2H). 2.87 (s, 3H), 1.68 (m, 4H), 1.43 (s, 9H). ESI-
MS: calculated = 431.14 actual = 431.2 
Compound 3 was taken up into a solution of 5mL of trifluoroacetic acid in 15 mL of 
methylene chloride and stirred for 30 minutes to remove the BOC group. After removing 
the solvent in vacuo, the remaining residue was triturated with ether, resulting in a white 
solid. The material was extracted into water (10 mL), frozen, and lyophilized. The 
resulting compound was dissolved in 25 mL THF and chilled to ice temperature. DIPEA 
was added (causing compound to precipitate out of solution), followed by gradual 
addition of Fmoc-Cl in THF (20 mL). Upon completion of addition of Fmoc-Cl, the 
precipitated compound disappeared and the solution was removed from the ice bath and 
stirred for 10 hours. The resulting solution was rotovapped and the residue was washed 
with several volumes of ether, which was carefully decanted. The remaining residue was 
taken up into ethyl acetate (50 mL) and washed with water (2 X 10 mL). The resulting 
organic solution was dried with MgSO4 and evaporated to dryness, resulting in a clear oil. 
Compound 4 was purified via silica gel chromatography (column flushed with 100 mL 
methylene chloride; product eluted with 10:1 methylene chloride:methanol) to give 0.200 
g of a white solid (0.362 mmol; 72% yield for two steps). ESI-MS: calculated = 553.15; 
actual = 553.2 NMR (600 MHz): 7.954 (d, 1H), 7.748 (d, 2H), 7.652 (m, 2H), 7.58 (m, 
3H), 7.384 (dd, 2H), 7.299 (dd, 2H), 5.325 (d, 1H), 4.405 (s, 2H), 4.208 (t, 1H), 3.320 
(m, 1H), 3.238 (m, 1H), 2.862 (s, 1H), 2.00 – 1.80 (m, 4H). 
An identical procedure was followed for the synthesis of Fmoc-
monomethyldiaminobutyric acid (oNBS), using Boc-diaminobutyric acid (0.358 g;  1.64 
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mmol). The product was isolated as a clear oil ( 0.180 g;  0.334 mmol). ESI-MS: 
calculated = 539.14; actual = 539.2  NMR (600 MHz): 8.027 (d, 1H), 7.748 (d, 2H), 
7.652 (m, 2H), 7.58 (m, 3H), 7.384 (dd, 2H), 7.299 (dd, 2H), 5.427 (d, 1H), 4.403 (s, 
2H), 4.170 (t, 1H), 3.269 (m, 1H), 3.153 (m, 1H), 2.822 (s, 1H), 2.125 (m, 2H). 
Synthesis of Fmoc-Dimethyl Ornithine and Fmoc-Dimethyl Diaminobutyric Acid 
7. Boc-ornithine 5 (0.175 g; 0.75 mmol) was taken up in 10 mL of methanol in a 100 mL 
round bottom flask with stirring. 340 µL of 37% formaldehyde (11 mmol) was added to 
the solution, which was then allowed to stir for 5 minutes. The flask was flushed with N2, 
followed by the addition of 0.33 g of 10% Pd/C. Next, the flask was plugged with a 
rubber septum and flushed with H2 gas. A balloon of H2 was attached, and the reaction 
stirred for 24 hours. The contents of the flask were then filtered to remove the catalyst 
and rotovapped to dryness to give compound 6a. The reaction was monitored by TLC 
(5:1 CH2Cl2: MeOH) with ninhydrin staining. Reaction completion was confirmed with 
RP-HPLC (C18 column; gradient of 5% CH3CN – 60% CH3CN in water over 30 
minutes). ESI-MS: calculated = 260.17; actual = 260.2 NMR (600 MHz,CDCl3): 5.70 (s, 
1H), 4.08 (s, 1H), 2.98 (t, 1H), 2.80 (t, 1H), 2.70 (s, 6H), 1.81-1.59 (m, 4H), 1.42 (s, 9H). 
Compound 6a was taken up into a solution of 5 mL of trifluoroacetic acid and 250 mL of 
triisopropylsilane in 15 mL of methylene chloride and stirred for 30 minutes to remove 
the BOC group. After removing the solvent in vacuo, the remaining residue was triturated 
with ether, resulting in an oily precipitate. The material was extracted into water (10 mL), 
frozen, and lyophilized to dryness. The resulting oil was then dissolved in water (10 mL) 
and added to a 100 mL round bottom flask equipped with a stirbar. Sodium carbonate 
(2.3 mmol; 0.240 g) was added to the solution, followed by 5 mL of dioxane. The 
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resulting solution was stirred for 10 minutes at 0 °C. Fmoc-OSu (0.825 mmol; 0.278 g) 
was dissolved in 5 mL dioxane and added dropwise to the ice-cold solution over 10 
minutes. The resulting mixture was stirred for 1 hour at 0 °C and 16 hours at room 
temperature. The reaction was followed by TLC (10:1 CH2Cl2:MeOH; Ninhydrin 
staining). The mixture was then washed with ether (2 X 25 mL) and acidified with 1N 
HCl to pH 3. The acidic solution was extracted with ethyl acetate (4 X 50 mL), dried with 
sodium sulfate, and the solvent was removed in vacuo to give 0.252 g (0.659 mmol; 88% 
yield for two steps) of compound 7a as an amorphous white solid. ESI-MS: calculated = 
382.19; actual = 382.3 NMR (600 MHz,CDCl3): 7.711 (d, 2H), 7.559 (m, 2H), 7.346 (dd, 
2H), 7.252 (dd, 2H), 6.149 (s, 1H), 4.304 (m, 2H), 4.150 (t, 1H), 3.111 (m, 1H), 2.984 
(m, 1H), 2.746 (s, 6H), 1.95 – 1.80 (m, 4H). 
An identical procedure was followed for the synthesis of Fmoc-
dimethyldiaminobutyric acid, using Boc-diaminobutyric acid (0.164 g; 0.75 mmol), 30% 
formaldehyde (340 uL), Pd/C (0.033 g) in MeOH (10 mL) and H2O (1 mL). ESI-MS: 
calculated = 246.16; actual = 246.2 NMR (600 MHz,CDCl3): 5.89 (s, 1H), 3.99 (s, 1H), 
3.15 (t, 1H), 3.00 (t, 1H), 2.72 (s, 6H), 2.19-2.14 (m, 2H), 1.44 (s, 9H). Deprotection with 
TFA and reprotection with Fmoc-OSu via an identical procedure gave 0.173 g of 
compound 7b as a clear oil (0.47 mmol; 63% yield for two steps). ESI-MS: calculated = 
368.17; actual = 368.2 NMR (600 MHz,CDCl3): 7.737 (d, 2H), 7.590 (m, 2H), 7.374 (dd, 
2H), 7.289 (dd, 2H), 6.239 (s, 1H), 4.331 (m, 2H), 4.185 (t, 1H), 3.160 (m, 1H), 3.045 
(m, 1H), 2.739(s, 6H), 2.28 – 2.16 (m, 2H). 
Synthesis of Trimethylated Lysine, Ornithine, and Diaminobutyric acid. 
Trimethylated amino acids were synthesized following the procedure of Kretsinger and 
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Schneider.64 The peptides were synthesized using Fmoc-Lys(Me)2-OH purchased from 
either Anaspec or Bachem or Fmoc-Orn(Me)2-OH or Fmoc-Dab(Me)2-OH synthesized 
by methods described above. The dimethylated amino acid-containing peptides (0.100 
mmol scale) were reacted prior to cleavage from the resin with MTBD (18 µL, 0.125 
mmol) and methyl iodide (62 µL, 1 mmol) in DMF (5 mL) for 4 hours with bubbling N2 
in a peptide synthesis flask stoppered with a vented septum. After washing the resin with 
DMF (3X), CH2Cl2 (3X), and drying, the peptide was cleaved with a cocktail of 90% 
TFA/5% Triisopropylsilane/5% H2O for 3 hours. The peptide was then purified by 
standard HPLC methods. 
Peptide Synthesis and Purification. Peptide synthesis was performed on an Applied 
Biosystems Pioneer peptide synthesizer using standard FMOC solid phase peptide 
synthesis methodology. Non-commercially available amino acids were in some cases 
coupled by hand.  Peptides were purified with reverse phase HPLC, lyophilized, and 
characterized by MALDI or ESI-TOF mass spectroscopy  and NMR. 
ii. NMR Spectroscopy.  
NMR samples were made in concentrations of approximately 1 mM and analyzed 
on a Varian Inova 600 MHz spectrometer. Samples were dissolved in D2O buffered to pD 
4.0 (uncorrected) with 50 mM NaOAc-d3, unless otherwise noted. Amine and amide 
resonances were assigned in 60% H2O solutions. 1D NMR spectra were collected using 
32K data points and between 8 and 64 scans using a    1-3 sec presaturation. All 2D NMR 
experiments used pulse sequences from the Chempack software including TOCSY, 
DQCOSY, gCOSY, and NOESY. 2D NMR scans were taken with 16-64 scans in the first 
                                                
64 Kretsinter, J. K.; Schneider, J. P. J. Am. Chem. Soc. 2003, 125, 7907 – 7913. 
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dimension and 64-256 scans in the 2nd dimension. All spectra were analyzed using 
standard window functions (sinebell and gaussian). Mixing times of 0.5 or 0.6 sec were 
used in the NOESY spectra. Assignments were made using standard methods as 
described by Wurthrich (ref). Temperature calibrations were made using methanol and 
ethylene glycol standards. 
iii. pH Studies.   
Three buffer solutions in D2O were used to analyze the sensitivity of peptide 
stability to changes in pH: pH 7.4 (10 mM Sodium Phosphate buffer), pH 4 (50 mM 
Sodium Acetate buffer), and pH1.10 (Phosphoric Acid buffer). pH values uncorrected for 
deuterium isotope effects. 
iv. NMR Structure Calculation and MD Simulation.  
NOEs were classified as strong, medium, or weak by visual inspection. 
Accordingly, upper bounds for distance restraints were set at 5.0, 3.5, or 2.5 Å.65 NMR 
structures were calculated using a simulated annealing protocol within the program 
CNS_Solve.62 Hydrogen bonds were enforced with upper limits of 2.0 Å and assigned 
based on backbone amide shifts. 23 non-sequential NOEs were used in the calculation of 
WKL and 34 non-sequential NOEs were used in the calculation of the structure of 
WKMe3L. All available backbone amide, H$, and sidechain 
1H chemical shifts were also 
employed in the calculations via a harmonic potential with a primary chemical shift force 
value of 10 (61 observed chemical shifts; random coil values taken from 7mers). Two 
rounds of simulated annealing were employed in each calculation. In the first, 200 
structures were generated from an extended starting structure. In the second, 50 structures 
                                                
65 Mahalakshmi, R.; Raghothama, S.; Balaram, P. J. Am. Chem. Soc. 2006, 128, 1125-
1138. 
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were generated starting from an averaged folded structure taken from the initial run. The 
best structures were selected from the second run based on total energy and visual 
inspection and averaged. The average structures were subjected to an additional 
unconstrained conjugate gradient minimization. 
The resulting average structure for WKMe3L was used as the starting structure for an 
MD run in explicit water in AMBER.66 Non-natural residues were constructed in xLeap 
and parameterized based on existing residues with scaled Merz-Kollman atomic charges. 
The starting structure was solvated in an octahedral box using TIP3P water and the 
system charge neutralized with two chloride ions. The solvated system was equilibrated 
by heating from 0 to 300K over 20 ps. Finally, production MD were run at 300K using 
PME electrostatics and periodic boundary conditions within Amber ff99. The lowest 
energy structure was selected from the 2 ns run for demonstrative purposes.  
Atomic charges of trimethylated lysine for use in Amber ff99 were parameterized using 
Merz-Kollman charge calculated with Gaussian 03 [b3lyp/cc-pvDZ SCF=Tight Test 
Pop=MK iop(6/33=2,6/41=10,6/42=10) Nosymm] and processed using Antechamber. 
Charges were averaged for equivalent groups (i.e., methyls on ammonium headgroup) 
and are shown below (Figure 2.33): 
 
                                                
66 D.A. Case, T.A. Darden, T.E. Cheatham, III, C.L. Simmerling, J. Wang, R.E. Duke, R. 
Luo, K.M. Merz, B. Wang, D.A. Pearlman, M. Crowley, S. Brozell, V. Tsui, H. Gohlke, 
J. Mongan, V. Hornak, G. Cui, P. Beroza, C. Schafmeister, J.W. Caldwell, W.S. Ross, 
and P.A. Kollman (2004), AMBER 8, University of California, San Francisco. 
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Figure 2.33. Xleap visualization of KMe3 atomic charges calculated for Amber ff99. 
  
Pre-production runs included minimization of the solvent (TIP3P water) and counterions, 
minimization of the entire system, and heating of the system from 0 to 300K over 20 
ps.The 2 ns MD simulation was run under constant temperature (300K; Langevin 
temperature) and pressure (1 atm), using the SHAKE algorithm and a timestep of 2 fs. 
Plots of Energy, Temperature, and Pressure from the simulation are shown below (Figure 
2.34).  
 
 
Figure 2.34.  (a) Energy plots from the 2 ns simulation (Kinetic Energy: Red; Potential Energy: Black; 
Total Energy: Green) (b) Temperature during the simulation. (c) Pressure fluctuation during the simulation. 
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v. Determination of Fraction Folded.   
To determine the chemical shifts of the fully folded state, 14-residue disulfide-
linked analogs of peptides were synthesized with the sequence of Ac-
CRWVEVNGOXILQC-NH2, where X = cationic residue (Arg, DMAa, DMAs, K, KMe, 
KMe2, KMe3, etc.) and characterized by NMR. The disulfide bond between Cys1 and 
Cys14 constrains the peptide to a "-hairpin. To determine the unfolded chemical shifts, 7-
mers were synthesized with sequences Ac-RWVEVNG-NH2 and Ac-NGOXILQ-NH2, 
where X = (Arg, DMAa, DMAs, K, KMe, KMe2, KMe3, etc.). The chemical shifts for 
residues in the strand and one turn residue were obtained from each 7-mer peptide.  The 
fraction folded was determined from equation [11].  
Fraction Folded = [&obs – &0]/[ &100 – &0],       [11] 
where &obs is the observed chemical shift, &100 is the chemical shift of the cyclic peptide, 
and &0 is the chemical shift of the unfolded 7-mers.  
The free energy of folding can be calculated using equation [12] 
%G = -RTln(f/(1-f)), where T = 298K; f = fraction folded    [12] 
vi. Double Mutant Cycles.  
Single and double mutants of "-hairpin peptides were synthesized by mutating 
Trp to Val and the cationic residue (Arg, DMAa, DMAs, K, KMe, KMe2, KMe3, etc.) to 
Ser. This resulted in the following peptides, where X = (Arg, DMAa, DMAs, K, KMe, 
KMe2, KMe3, etc.): Ac-RVVEVNGOXILQ-NH2, Ac-CRVVEVNGOXILQC-NH2, Ac-
RWVEVNGOSILQ-NH2, and Ac-RVVEVNGOSILQ-NH2.  The stability of each mutant 
hairpin was determined from equations 10 and 11 as described above, using the following 
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cyclic peptides as controls for the fully folded state: Ac-CRVVEVNGOXILQC-NH2, 
Ac-CRWVEVNGOSILQC-NH2, and Ac-CRVVEVNGOSILQC-NH2.  The magnitude of 
the sidechain-sidechain interaction was then determined as shown in Figure 1.4. 
vii. Thermal Denaturations.  
Thermal denaturations were conducted following the change in glycine splitting 
with a 600 MHz Varian NMR spectrometer. Samples were allowed to equilibrate for 
seven minutes at each temperature. Spectra were acquired using 16-32 scans with 72000 
data points at each temperature. Solvent suppression was achieved using presaturation. 
Denaturation experiments were run in duplicate, and the temperature was calibrated using 
methanol and ethylene glycol standards. Thermodynamic data was determined using a 
non-linear least squares fitting algorithm to equations [2] and [10] using Origin 7.5.67  
An F test was performed to determine if the improvement in fit from Equation [10] was 
statistically significant.39 In this case, one cannot rely on comparison of the chi-squared 
values, since the fit from Equation [10] will necessarily be better because it contains two 
more parameters than Equation [2].  F is defined by equation [13]: 
F = 1/2[(N-3)*1
2/*9
2 – (N-5)]   [13] 
where N is the number of points in the data set and *1
2 and *9
2 are the chi-squared 
values for Equations [2] and [10], respectively.  For data sets containing 12 or more data 
points (the smallest number of points in any of the data sets), an F value of > 3.9 
indicates that the fit from Equation [10] is better than with Equation [2] within 95% 
confidence limits, and a value of > 6.8 indicates > 99% confidence.39b  For the peptides 
                                                
67 Origin 7.5,  OriginLab Corporation, One Roundhouse Plaza, Northampton, MA 01060, 
U.S.A. 
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reported here, only WKL gave an F value of less than 3.9, indicating that Equation [2] is 
satisfactory.  Of the other peptides, all gave F values at the > 95% confidence level. 
 
viii. Characterization of Structure.  
Methods used to indicate the formation of "-hairpin structure in peptide WK*L, 
WK*T, WOrn*L, WDab*L, WR, and WDMA* include the analysis of H$ shifting 
relative to random coil, backbone amide shifts relative to random coil, and the 
identification of cross strand NOEs. The "-hairpin should have backbone hydrogen 
bonded amides between cross-strand residue pairs Arg-Gln, Val-Ile, and Val-Orn in all 
hairpin peptides. The presence of these hydrogen bonds is readily demonstrated by 
downfield shifting of the amide hydrogens in these positions relative to random coil. As 
seen below, the selected peptides exhibit significant downfield shifting at key positions 
along the strand (Figure 2.35). As expected for "-hairpins, the termini are frayed and 
show little or no amide shifting.  The Asn amide shows significant downfield shifting as 
expected for a Type I’ turn. 
 
 
Figure 2.35. Backbone amide shifts for selected "-hairpin peptides. 
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Furthermore, analysis of the H$ fraction folded plot for selected peptides WKL, WKMeL, 
WKMe3L, WOrnL, WDabL, WKT, WR, and WDMA* as calculated by equation [11], 
shows cooperative folding along the entire strand, with the exception of fraying at the 
termini.  
 
 
Figure 2.36. Fraction folded data for selected "-hairpin peptides. 
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Finally, the identification of numerous cross-strand NOEs indicates that all peptides have 
"-hairpin structure.  
 
Figure 2.37. WKL Cross-strand NOEs. 
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Figure 2.38. WKMe3L Cross-strand NOEs. 
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Figure 2.39. WOrnL Cross-strand NOEs. 
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Figure 2.40. WOrnMeL Cross-strand NOEs. 
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Figure 2.41. WOrnMe3L Cross-strand NOEs. 
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Figure 2.42. WKT Cross-strand NOEs. 
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Figure 2.43. WKMeT Cross-strand NOEs. 
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Figure 2.44. WKMe2T Cross-strand NOEs. 
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Figure 2.45. WKMe3T Cross-strand NOEs. 
 
 
 
 
 
Figure 2.46. WKLcyc Cross-strand NOEs. 
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Figure 2.47. WKMeLcyc Cross-strand NOEs. 
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Figure 2.48. WKMe3Lcyc Cross-strand NOEs. 
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Figure 2.49. WOrnLcyc Cross-strand NOEs. 
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Figure 2.50. WDabLcyc Cross-strand NOEs. 
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Figure 2.51. WKMeTcyc Cross-strand NOEs. 
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Figure 2.52. WDMAaCyc Intra- and Interstrand NOEs. 
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 88 
 
Figure 2.53. WDMAsCyc Intra- and Interstrand NOEs. 
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(a) Trp – DMAa NOEs 
(b) Cross-strand NOEs 
(c) Trp – Leu NOEs 
Solid line = Strong or Medium NOE 
Dashed line = Weak NOE 
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Tables 2.8 a-f. NOEs observed in Peptides WKL, WKMe3L, WKLCyc, 
WKMe3LCyc, WDMAaCyc, WDMAsCyc at 298 K (S=Strong; M=Medium; 
W=Weak). 
 
Table 2.8a. Peptide WKL:  Table 2.8b. Peptide WKMe3L: 
Ac-RWVEVNGOKILQ-NH2  Ac-RWVEVNGOK(Me)3
'ILQ-NH2 
 
Trp 2 Ar 5 Ile 10  $ M   Trp 2  Ar 5 Ile 10  $ M   
Trp 2 Ar 5 Lys 9 " W   Trp 2  Ar 5 Lys 9  ( M 
Trp 2 Ar 5 Leu 11 " W   Trp 2  Ar 5 Lys 9  & M 
Trp 2 Ar 6 Lys 9  # VW   Trp 2  Ar 5 Leu 11 ( W 
Trp 2 Ar 5 Leu 11 & M   Trp 2  Ar 6 Arg 1 $ M 
Trp 2 Ar 6 Lys 9 " W   Trp 2  Ar 6 Leu 11 $ W 
Trp 2 Ar 6 Leu 11 ( M     
Trp 2 Ar 6 Leu 11 & M   Trp 2  Ar 6 Lys 9 (CH3)3 M 
Trp 2 Ar 7 Ile 10  $ M   Trp 2  Ar 6 Lys 9 " W 
Trp 2 Ar 7 Leu 11 $ M   Trp 2  Ar 6 Lys 9 & W 
Trp 2 Ar 7 Lys 9 " S   Trp 2  Ar 6 Lys 9 ( W 
Trp 2 Ar 7 Lys 9 & M   Trp 2  Ar 6 Leu 11 ( W 
Trp 2 Ar 7 Lys 9 ( M   Trp 2  Ar 6 Leu 11 & W 
Trp 2 Ar 4 Leu 11 & W   Trp 2  Ar 7 Leu 11 $ M 
      Trp 2  Ar 7 Leu 11 & W 
Trp 2 $ Leu 11 $ S   Trp 2  Ar 7 Lys 9 " S 
Trp 2 $ Leu 11 & M   Trp 2  Ar 7 Lys 9 & S 
Ile 10 $ Trp 2 Ar 7 W   Trp 2  Ar 7 Lys 9  ( S  
Ile 10 $ Trp 2 Ar 5 W   Trp 2 Ar 4 Leu 11 & M 
Leu 11 $ Trp 2 " W   Trp 2 Ar 4 Lys 9 (CH3)3 M 
Leu 11 $ Trp 2 $ S   Trp 2 $ Leu 11 $ S 
Leu 11 $ Trp 2 Ar 7 W   Trp 2 $ Leu 11 & W 
      Trp 2 $ Val 3 $ W 
Ile 10 NH Trp 2 $ M   Leu 11 $ Trp 2  $ S 
 
      Val 3 NH Trp 2  $ S 
      Val 5 NH Glu 4 $ S 
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Table 2.8c. Peptide WKLcyc:  Table 2.8d. Peptide WKMe3Lcyc: 
Ac-CRWVEVNGOKILQC-NH2  Ac-CRWVEVNGOK(Me)3
'ILQC-NH2 
 
Trp 3 Ar 7 Trp 3  NH2 M  Trp 3 Ar 4 Lys 10 (CH3)3 M 
Trp 3 Ar 6 Leu 12 $ M   Trp 3 Ar 4 Leu 12 & M 
Trp 3 Ar 6 Lys 10 & M    Trp 3 Ar 4 Leu 12 ( M 
Trp 3 Ar 6 Leu 12 & W   Trp 3 Ar 7 Cys 14 NH M 
Trp 3 Ar 6 Lys 10 " M   Trp 3 Ar 7 Lys 10 (CH3)3 M 
Trp 3 Ar 5 Leu 12 & M   Trp 3 Ar 7 Leu 12 & M 
      Trp 3 Ar 7 Val  4 NH M 
Trp 3 $ Leu 12 $ S   Trp 3 Ar 7 Cys 14 $ W 
      Trp 3 Ar 7 Leu 12 $ M 
Val 4 NH Trp 3  $ S   Trp 3 Ar 7 Lys 10 ( S 
Ile 11 NH Lys 10 $ S   Trp 3 Ar 6 Lys 10 & M 
Val 6 NH Gln 13 $ S   Trp 3 Ar 6 Cys 14 " W 
Gln 13 NH Leu 12 $ S   Trp 3 Ar 5 Ile   11 $ W 
Arg 2 NH Cys 14 $ M   Trp 3 Ar 7 Lys 10 & S 
Arg 2 NH Cys 14 " W   Trp 3 Ar 5 Lys 10 " W  
Trp 3 NH Arg 2  $ M   Trp 3 Ar 5 Lys 10 & S 
Trp 3 NH Arg 2  " W   Trp 3 Ar 7 Leu 12 ( M 
Lys 10 NH Val 4 $ W   Trp 3 Ar 7 Lys 10 NH M 
      Trp 3 Ar 5 Leu 12 ( S 
      Trp 3 Ar 5 Leu 12 & W 
      Val 6 NH Cys 14 $ S 
      Asn 7 NH Trp 3 $ M 
      Ile 11 NH Val 4 NH M 
      Ile 11 NH Lys 10 $ M 
      Val 6 NH Glu 5 $ S 
      Val 6 NH Leu 12 $ S 
      Val 6 NH Glu 5 " M 
      Val 6 NH Leu 12 & M 
      Arg 2 NH Cys 14 $ S 
      Arg 2 NH Cys 14 " M 
      Arg 2 NH Leu 12 & M 
      Trp 3 NH Arg 2  $ M 
      Cys 14 NH Trp 3 Ar 6 M 
      Cys 14 NH Arg 2  $ S 
      Cys 14 NH Arg 2  " M 
      Leu 12 NH Ile 11 " M 
      Orn 9 NH Gln 13 NH W 
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Table 2.8e. Peptide WDMAaCyc: 
Ac-CRWVEVNGOR(Me)2
'ILQC-NH2  
   
Residue Proton Residue Proton Intensity 
Trp 3 Ar 2 DMAa 10 (CH3)2 M 
Trp 3 Ar 2 Trp 3 $ W 
Trp 3 Ar 2 Val 4 $ W 
Trp 3 Ar 2 Leu 12 &  W 
Trp 3 Ar 4 DMAa 10 (CH3)2 W 
Trp 3 Ar 4 Leu 12 &  W 
Trp 3 Ar 4 Leu 12 (  W 
Trp 3 Ar 5 DMAa 10 & S 
Trp 3 Ar 5 DMAa 10 ( S 
Trp 3 Ar 5 Trp 3 $ S 
Trp 3 Ar 5 Leu 12 $ S 
Trp 3 Ar 6 Leu 12 &  M 
Trp 3 Ar 7 DMAa 10 ( M 
Trp 3 Ar 7 Ile 11 $ W 
Trp 3 Ar 7 Leu 12 &  M 
Val 4 NH Trp 3 $  S 
Val 4 NH Trp 3 5H W 
Val 4 NH Arg 2 $  W 
Val 4 NH Leu 12 $  W 
Val 4 NH Trp 3 "  W 
Ile 11 NH DMAa 10 $  S 
Ile 11 NH Trp 3 5H W 
Gln 13 NH Leu 12 $  M 
Trp 3 $ Leu 12 $  S 
Trp 3 $ Val 4 NH S 
Trp 3 $ Val 4 ( W 
DMAa 10 $ Ile 11 $ S 
Val 4 $ Leu 12 &  W 
Leu 12 $ Trp 3 $  S 
Leu 12 $ Val 4 NH M 
Leu 12 $ Gln 13 NH M 
Leu 12 $ Trp 3 5H W 
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Table 2.8f. Peptide WDMAsCyc: 
Ac-CRWVEVNGOR(Me)2
'ILQC-NH2 
 
    
Residue Proton Residue Proton Intensity 
Trp 3 Ar 2 DMAa 10 & S 
Trp 3 Ar 2 DMAa 10 " W 
Trp 3 Ar 2 DMAa 10 ( W 
Trp 3 Ar 2 Leu 12 " W 
Trp 3 Ar 2 Leu 12 ( W 
Trp 3 Ar 2 Leu 12 &  W 
Trp 3 Ar 4 DMAa 10 (CH3)2 W 
Trp 3 Ar 4 Leu 12 &  W 
Trp 3 Ar 4 Leu 12 (  W 
Trp 3 Ar 5 DMAa 10 (CH3)2 W 
Trp 3 Ar 5 DMAa 10 ( W 
Trp 3 Ar 5 DMAa 10 " W 
Trp 3 Ar 5 Leu 12 ( W 
Trp 3 Ar 5 Leu 12 & W 
Trp 3 Ar 6 Trp 3 $  S 
Trp 3 Ar 6 Trp 3 "  S 
Trp 3 Ar 6 Leu 12 $  S 
Trp 3 Ar 6 DMAa 10 & S 
Trp 3 Ar 6 Leu 12 & W 
Trp 3 Ar 7 DMAa 10 ( M 
Trp 3 Ar 7 DMAa 10 & W 
Trp 3 Ar 7 Leu 12 &  W 
Val 4 NH Trp 3 $  S 
Val 4 NH Trp 3 2H M 
Val 4 NH Leu 12 $  M 
Ile 11 NH DMAa 10 $  S 
Ile 11 NH Trp 3 6H W 
Val 6 NH Glu 5 $  M 
Gln 13 NH Leu 12 $  S 
Gln 13 NH Leu 12 & W 
Gln 13 NH Leu 12 ( W 
Arg 2 NH Cys 1 $  S 
Arg 2 NH Cys 1 "  W 
Trp 3 $ Leu 12 $  S 
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ix. Thermodynamic Analysis  
 
Peptides were analyzed assuming a two-state system.  The equilibrium constant was 
determined from the fraction folded (f) by K = f/(1-f).  The free energy was then 
calculated from "G° = - RTlnK.  In order to determine the thermodynamic parameters, 
"H°, "S°, and "Cp°, the temperature dependence of the Gly chemical shift difference 
was fit to one of the following equations, as described earlier in the text:68  
 
Fraction folded = [exp(x/RT)]/[1 + exp(x/RT)]    
 
Where x = [T("S°298 + "Cp° ln(T/298)) – ("H°298 + "Cp°(T - 298))]   [2] 
 
Or  
 
Fraction folded = [exp(x/RT)]/[1 + exp(x/RT)] 
 
 
where x = T(%Sº298 + a ln(T/298) + b (T – 298) – (c/2) (1/T
2 – 1/2982)) –   [10] 
(%Hº298 + a (T – 298) + (b/2) (T
2 – 2982) – c (1/T – 1/298))]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
68 Maynard, A.J. Sharman, G. J. and Searle, M. S. J. Am. Chem. Soc. 1998, 120, 1996-
2007. 
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Table 2.9. Temperature Dependence of the Fraction Folded from Glycine Chemical Shift 
Data for the WKL series peptides:  
 
 
WKL:   WKMeL:  WKMe2L:  WKMe3L: 
 
Temp 
(K) 
fraction 
folded 
Temp 
(K) 
fraction 
folded 
Temp 
(K) 
fraction 
folded 
Temp 
(K) 
fraction 
folded 
276 0.806 276 0.849 276 0.883 276 0.894 
281 0.806 281 0.856 281 0.886 281 0.901 
285 0.804 285 0.855 285 0.894 285 0.908 
289 0.801 289 0.859 289 0.893 290 0.912 
294 0.793 294 0.855 294 0.896 294 0.918 
298 0.783 298 0.853 298 0.894 299 0.919 
302 0.773 302 0.844 302 0.892 303 0.919 
307 0.754 307 0.834 307 0.886 308 0.915 
311 0.734 311 0.820 311 0.878 312 0.910 
316 0.709 316 0.798 316 0.865 317 0.903 
320 0.680 320 0.776 320 0.849 321 0.892 
324 0.650 324 0.751 324 0.830 325 0.878 
329 0.615 329 0.718 329 0.803 330 0.859 
      334 0.832 
      339 0.804 
      343 0.773 
      348 0.737 
 
 
 
Table 2.10. Temperature Dependence of the Fraction Folded from Glycine Chemical 
Shift Data for the WOrnL and WDabL peptides:  
 
WOrnL:   WDabL:   
 
Temp 
(K) 
fraction 
folded 
Temp 
(K) 
fraction 
folded 
275 0.722 275 0.557 
280 0.717 280 0.547 
284 0.711 284 0.533 
289 0.701 289 0.514 
293 0.688 293 0.492 
298 0.671 298 0.468 
303 0.649 303 0.441 
307 0.622 307 0.410 
312 0.594 312 0.380 
316 0.564 316 0.346 
321 0.530 321 0.315 
325 0.493 325 0.279 
330 0.454 330 0.244 
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Table 2.11. Temperature Dependence of the Fraction Folded from Glycine Chemical 
Shift Data for WK*T series peptides:  
 
 WKT WKMeT WKMe2T WKMe3T 
Temp (K) 
fraction 
folded 
fraction 
folded 
fraction 
folded fraction folded 
276 0.453 0.583 0.706 0.784 
280 0.449 0.573 0.701 0.780 
285 0.438 0.564 0.692 0.778 
289 0.426 0.549 0.680 0.769 
294 0.414 0.531 0.664 0.760 
298 0.398 0.514 0.647 0.744 
303 0.379 0.491 0.624 0.729 
307 0.358 0.467 0.602 0.707 
312 0.337 0.441 0.571 0.684 
316 0.315 0.420 0.542 0.656 
321 0.292 0.388 0.510 0.626 
326 0.270 0.359 0.477 0.595 
330 0.245 0.331 0.445 0.559 
     
 
 
Table 2.12. Parameters Derived from Fitting of Thermal Denaturation Data for Peptides 
WK*T at 298 K(Errors shown in parenthesis):  
 
 WKT WKMeT WKMe2T WKMe3T 
%S (cal/mol*K) -10.2 (0.04) -10.4(0.1) -10.1(0.1) -8.3 (0.1) 
%Cp(cal/mol*K) -99 (2) -98 (3) -116 (3) -134 (3) 
%H (kcal/mol) -2.8 (0.01) -3.1(0.02) -3.4(0.03) -3.11 (0.03) 
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Table 2.13. Temperature Dependence of the Fraction Folded from Glycine Chemical 
Shift Data for WDMAa, WDMAs, and WKMe3:  
 
 
WDMAa:  WDMAs:  WKMe3: 
 
Temp (K) fraction folded Temp (K) fraction folded Temp (K) fraction folded 
277 0.927 276 0.923 276 0.894 
281 0.933 281 0.931 281 0.901 
285 0.936 285 0.936 285 0.908 
289 0.939 290 0.939 290 0.912 
294 0.939 294 0.941 294 0.918 
298 0.940 298 0.941 299 0.919 
302 0.938 303 0.937 303 0.919 
307 0.931 307 0.930 308 0.915 
311 0.922 311 0.920 312 0.910 
315 0.907 316 0.905 317 0.903 
319 0.889 320 0.886 321 0.892 
324 0.870 325 0.861 325 0.878 
328 0.842 329 0.832 330 0.859 
332 0.810 333 0.788 334 0.832 
337 0.772 338 0.760 339 0.804 
341 0.731 342 0.717 343 0.773 
345 0.677 347 0.670 348 0.737 
 
 
 
 
 
 
Table 2.14. Temperature Dependence of the Fraction Folded from Glycine Chemical 
Shift Data for WR:  
 
WR: 
   
Temp 
(K) 
fraction 
folded 
276 0.870 
281 0.868 
285 0.865 
290 0.860 
294 0.850 
299 0.830 
303 0.810 
308 0.780 
312 0.740 
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Figure 2.54. 1HNMR of Peptide WKL: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-Lys-Ile-
Leu-Gln-NH2 
  
 
Table 2.15. Proton Chemical Shift Assignments for Peptide WKL. 
 $ " ( & # Amide Amine 
R 4.38 1.69 1.51, 1.65 3.14  8.05 6.62,7.09 
W 5.09 3.10 7.23,7.49 7.07,7.23 7.23 8.29 10.17 
V 4.43 2.03 0.87   8.92  
E 4.92 2.02,1.91 2.28   8.49  
V 4.21 1.95 0.91   8.82  
N 4.47 3.05,2.76    9.35  
G 4.08,3.73     8.59  
O 4.61 1.86 1.75 3.04  7.84 7.64 
K 4.77 1.69 1.24 1.35 2.56 8.46 7.28 
I 4.57 1.88 0.89,1.42,1.19 0.89  9.05  
L 4.08 1.36,1.06 0.77 0.3,0.51  8.30  
Q 4.32 2.04,1.88 2.27   8.62  
 
 
 
 
 
 
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.55. 1HNMR of Peptide WKMeL: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys(Me)-Ile-Leu-Gln-NH2 
  
 
Table 2.16. Proton Chemical Shift Assignments for Peptide WKMeL. 
 
 $ " ( & # Amide Amine 
R 4.39 1.72 1.53 3.14  8.05 7.11,6.64 
W 5.14 3.08    8.28 10.19 
V 4.48 2.03 0.87   9.06  
E 5.01 1.97 2.28   8.51  
V 4.23 1.93 0.91   8.90  
N 4.45 3.06,2.75    9.44  
G 4.09,3.70     8.63  
O 4.64 1.83 1.75 3.03  7.82 7.62 
K(Me) 4.73 1.67 1.28 1.28 2.33 
CH3=2.21 
8.46 7.66 
I 4.58 1.88 0.87,1.43,1.18 0.87  9.16  
L 4.11 1.36,1.06 0.87 0.34  8.37  
Q 4.32 1.93 2.23   8.66  
P P M
  6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.56. 1HNMR of Peptide WKMe2L: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys(Me)2-Ile-Leu-Gln-NH2  
 
Table 2.17. Proton Chemical Shift Assignments for Peptide WKMe2L. 
 $ " ( & # Amide Amine 
R 4.38 1.73 1.59 3.08  8.05 7.10 
W 5.18 3.08    8.27 10.21 
V 4.48 2.02 0.86   9.16  
E 5.05 1.96 2.27   8.54  
V 4.22 1.92 0.90   8.91  
N 4.42 3.00    9.51  
G 4.08,3.68      8.64  
O 4.62 1.78 1.78 3.00  7.81 7.66 
K(Me)2 4.75 1.67 1.25 1.25 2.27 
(CH3)2=2.32, 
          2.29 
8.47 8.40 
I 4.62 1.80 0.88,1.43,1.18 0.88  9.22  
L 4.11 1.37 0.89 0.36  8.42  
Q 4.31 1.96 2.27   8.68  
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.57. 1HNMR of Peptide WKMe3L: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys(Me)3
'-Ile-Leu-Gln-NH2 
 
Table 2.18. Proton Chemical Shift Assignments for Peptide WKMe3L. 
 $ " ( & # Amide Amine 
R 4.39 1.72 1.63, 1.52 3.14   8.03 7.11,6.64 
W 5.23 3.12,2.96 7.05,7.23,7.30,7.5   8.27 10.22 
V 4.51 2.05 0.87   9.23  
E 5.09 1.96 2.30   8.52  
V 4.25 1.92 0.91   8.96  
N 4.43 3.10,2.76    9.53  
G 4.095 
3.675 
    8.65  
O 4.65 1.83 1.76 3.04  7.79 7.64 
K(Me)3 4.8 1.7 1.18 1.32 2.37 8.48 (CH3)3=2.49 
I 4.65 1.83 1.42,1.20,0.89 0.89  9.26  
L 4.14 1.39 0.92,0.86 0.44,0.17  8.43  
Q 4.33 2.01,1,86 2.26   8.70  
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
 101 
 
 
 
 
 
 
 
 
 
 
Figure 2.58. 1HNMR of Peptide WOrnL: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-Orn-
Ile-Leu-Gln-NH2  
 
 
Table 2.19. Proton Chemical Shift Assignments for Peptide WOrnL. 
 $ " ( & # Amide Amine 
R 4.34 1.65 1.51 3.13  8.08 6.63,7.12 
W 5.01 3.12 7.22,7.49 7.06,7.22 7.36 8.29 10.17 
V 4.39 2.02 0.86   8.76  
E 4.83 1.97 2.24   8.47  
V 4.19 1.96 0.91   8.74  
N 4.51 3.02,2.75    9.26  
G 4.06,3.77     8.59  
O 4.58 1.89 1.7 3.03  7.91 7.66 
O 4.73 1.72 1.60 2.67  8.55 7.66 
I 4.47 1.84 0.88,1.41,1.18 0.88  8.96  
L 4.12 1.39 1.11,0.86 0.55,0.41  8.33  
Q 4.33 2.04 2.27   8.59  
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.59. 1HNMR of Peptide WOrnMeL: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Orn(Me)-Ile-Leu-Gln-NH2  
 
 
Table 2.20. Proton Chemical Shift Assignments for Peptide WOrnMeL. 
 $ " ( & # Amide Amine 
R 4.32 1.70 1.50 3.12  8.07 6.63,7.11  
W 5.04 3.13    8.29 10.20 
V 4.38 2.03 0.91   8.77  
E 4.82 1.97 2.23   8.50  
V 4.18 1.94 0.91   8.72  
N 4.48 3.03,2.75     9.29  
G 4.03,3.72      8.60  
O 4.56 1.82 1.72 3.03  7.90 7.65 
O(Me)  4.74 1.72 1.60 2.61 CH3=2.43 8.56 8.16 
I 4.50 1.84 0.87,1.42 0.87  8.97  
L 4.10 1.39 1.15,0.90 0.54,0.38, 
0.90                  
 8.36  
Q 4.28 1.98 2.33   8.60  
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.60. 1HNMR of Peptide WOrnMe2L: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Orn(Me)2-Ile-Leu-Gln-NH2  
 
Table 2.21. Proton Chemical Shift Assignments for Peptide WOrnMe2L. 
 $ " ( & # Amide Amine 
R 4.33 1.61 1.52 3.12  8.07 6.61,7.10 
W 5.06 3.10    8.25 10.21 
V 4.40 2.02 0.86   8.82  
E 4.88 1.94 2.23   8.51  
V 4.20 1.92 0.89   8.73  
N 4.47 3.04,2.75     9.32  
G 4.06,3.74     8.59  
O 4.58 1.84 1.72 3.03  7.86 7.64 
O(Me)2   4.77 1.68 1.57 2.61 (CH3)2=2.54,2.50   8.57 8.16 
I 4.51 1.86 0.87,1.43,1.18 0.87  9.00  
L 4.14 1.4 1.14,0.92 0.56, 
0.38 
 8.38  
Q 4.32 2.05,1.87 2.28   8.59  
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.61. 1HNMR of Peptide WOrnMe3L: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Orn(Me)3-Ile-Leu-Gln-NH2  
 
Table 2.22. Proton Chemical Shift Assignments for Peptide WOrnMe3L. 
 $ " ( & # Amide Amine 
R 4.33 1.64 1.52 3.12    
W 5.07 3.10      
V 4.39 2.03 0.87     
E 4.92 1.96 2.24     
V 4.20 1.94 0.91     
N 4.47 3.01,2.76      
G 4.07,3.73       
O 4.60 1.83 1.75 3.02    
O(Me)3   4.81 1.69 1.60 2.71 (CH3)3=2.70    
I 4.51 1.85 0.89,1.43,1.2 0.89    
L 4.15 1.61 1.17,1.39,0.92 0.57,0.40,0.92     
Q 4.31 1.97 2.30     
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.62. 1HNMR of Peptide WDabL: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-Dab-
Ile-Leu-Gln-NH2  
 
Table 2.23. Proton Chemical Shift Assignments for Peptide WDabL. 
 $ " ( & # Amide Amine 
R 4.31 1.66 1.48 3.12  8.10 7.11,6.62 
W 4.90 3.16 7.23,7.49 7.07,7.23 7.43 8.29 10.17 
V 4.31 2.02 0.85   8.55  
E 4.72 2.00 2.29   8.38  
V 4.18 1.98 0.92   8.48  
N 4.56 2.97,2.76    9.05  
G 4.02,3.81     8.54  
O 4.52 1.83 1.76 3.02  8.01 7.66 
Dab 4.72 2.09 3.03   8.64 7.66 
I 4.4 1.85 0.87,1.42,1.17 0.87  8.76  
L 4.14 1.39 1.20,0.97 0.61,0.49  8.33  
Q 4.31 2.05,1.9 2.30   8.54  
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.63. 1HNMR of Peptide WDabMeL: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Dab(Me)-Ile-Leu-Gln-NH2  
 
Table 2.24. Proton Chemical Shift Assignments for Peptide WDabMeL. 
 $ " ( & # Amide Amine 
R 4.33 1.64 1.52 3.13  8.09 7.11, 
6.63 
W 4.97 3.14 7.62,7.39,7.23,7.23,7.06   8.30 10.16 
V 4.20 1.96 0.92   8.63  
E 4.82 1.98 2.29   8.42  
V 4.35 2.03 0.86   8.68  
N 4.53 3.02, 
2.76 
   9.17  
G 4.05, 
3.80 
    8.57  
O 4.56 1.81 1.81 3.02  7.98 7.65 
Dab(Me) 4.76 2.09 3.02 CH3=2.40  8.68 8.58 
I 4.46 1.86 1.43,1.16,0.87 0.87  8.89  
L 4.14 1.40 1.17,0.92 0.50  8.36  
Q 4.32 1.92 2.30   8.57  
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.64. 1HNMR of Peptide WDabMe2L: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Dab(Me)2-Ile-Leu-Gln-NH2  
 
Table 2.25. Proton Chemical Shift Assignments for Peptide WDabMe2L. 
 $ " ( & # Amide Amine 
R 4.33 1.63 1.51 3.12    
W 5.02 3.11      
V 4.38 2.04 0.85     
E 4.89 1.97 2.27     
V 4.20 1.95 0.90     
N 4.48 3.04,2.69      
G 4.047, 
3.750 
      
O 4.55 1.77 1.77 3.02    
Dab(Me)2  4.77 2.06 3.07 (CH3)2=2.457, 
2.542  
   
I 4.48 1.87 0.87,1.38,1.17 0.87    
L 4.13 1.38 1.13,0.90 0.45    
Q 4.30 1.96 2.27     
 
 
P P M
  6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.65. 1HNMR of Peptide WDabMe3L: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Dab(Me)3-Ile-Leu-Gln-NH2  
 
Table 2.26. Proton Chemical Shift Assignments for Peptide WDabMe3L. 
 $ " ( & # Amide Amine 
R 4.33 1.66 1.54 3.12    
W 5.07 3.13      
V 4.41 2.06 0.87     
E 4.96 1.98 2.30     
V 4.22 1.92 0.91     
N 4.48 3.06,2.73      
G 4.062,3.742        
O 4.59 1.79 1.79 3.03    
Dab(Me)3  4.79 2.11 3.24 (CH3)3= 
2.715  
   
I 4.51 1.88,1.51 0.88, 1.26  0.88    
L 4.16 1.40 0.95 0.46    
Q 4.31 1.93 2.27     
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.66. 1HNMR of Peptide WKT: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-Lys-Ile-
Thr-Gln-NH2  
 
Table 2.27. Proton Chemical Shift Assignments for Peptide WKT. 
 $ " ( & # Amide Amine 
R 4.20 1.58 1.50 3.08  8.13 7.07 
W 4.92 3.25,3.19    8.05 10.14 
V 4.17 2.01 0.92   8.47  
E 4.66 1.98 2.37   8.39  
V 4.18 2.00 0.87   8.18  
N 4.58 2.76,2.96    8.96  
G 4.00,3.86     8.49  
O 4.49 1.81 1.75 3.02  7.98 7.64 
K 4.45 1.69 1.25 1.37 2.68 8.39 7.35 
I 4.40 1.92 0.91 0.91  8.60  
T 4.42 4.11 1.15   8.30  
Q 4.34 1.95 2.33   8.39  
 
 
 
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4    
 110 
 
 
 
 
 
 
 
 
 
Figure 2.67. 1HNMR of Peptide WKMeT: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys(Me)-Ile-Thr-Gln-NH2  
 
Table 2.28. Proton Chemical Shift Assignments for Peptide WKMeT. 
 $ " ( & # Amide Amine 
R 4.21 1.61 1.45 3.08    
W 4.99 3.20    8.00  
V 4.23 1.99 0.86   8.38  
E 4.76 1.97 2.35     
V 4.17 1.98 0.92   8.60  
N 4.54 2.76,2.97      
G 4.02,3.80      8.55  
O 4.51 1.77 1.77 3.01    
K(Me) 4.47 1.65 1.17 1.33 2.50 
CH3=2.39 
  
I 4.44 1.94 0.91 0.91  8.77  
T 4.44 4.10 1.12     
Q 4.34 2.09,1.91 2.30     
 
 
 
P P M
  8.0     7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.68. 1HNMR of Peptide WKMe2T: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys(Me)2-Ile-Thr-Gln-NH2  
 
 
Table 2.29. Proton Chemical Shift Assignments for Peptide WKMe2T. 
 $ " ( & # Amide Amine 
R 4.23 1.62 1.46 3.09    
W 5.06 3.14    7.97  
V 4.27 2.01 0.87   8.53  
E 4.87 1.97 2.33     
V 4.19 1.96 0.92   8.69  
N 4.51 2.75,3.00      
G 4.04,3.76         
O 4.54 1.79 1.73 3.02    
K(Me)2 4.51 1.65 1.11 1.29 2.44 
(CH3)2=2.46, 
          2.44 
  
I 4.50 1.95 0.91 0.91  8.86  
T 4.38 4.19 1.18     
Q 4.33 1.95 2.30     
 
 
 
 
 
 
 
P P M
  8.4     8.0     7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.69. 1HNMR of Peptide WKMe3T: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys(Me)3-Ile-Thr-Gln-NH2  
 
Table 2.30. Proton Chemical Shift Assignments for Peptide WKMe3T. 
 $ " ( & # Amide Amine 
R 4.25 1.62 1.48 3.09    
W 5.12 3.14    7.95  
V 4.31 2.02 0.86   8.68  
E 4.96 1.97 2.33   8.55  
V 4.22 1.94 0.92   8.77  
N 4.49 2.75,3.04      
G 4.05,3.73       8.62  
O 4.57 1.81 1.71 3.02    
K(Me)3 4.57 1.67 1.11 1.28 2.52 
(CH3)2=2.61 
  
I 4.55 1.99 0.91 0.91  8.97  
T 4.49 4.09 1.11     
Q 4.36 1.88 2.28     
 
 
 
 
 
P P M
  8.4     8.0     7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4    
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Figure 2.70. 1HNMR of Peptide WKLcyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys-Ile-Leu-Gln-Cys-NH2  
 
Table 2.31. Proton Chemical Shift Assignments for Peptide WKLcyc. 
 $ " ( & # Amide Amine 
C 5.04 2.95    8.91  
R 4.61 1.80 1.66,1.51 3.18  8.71 7.11,6.67 
W 5.15 3.09,2.94 7.00,7.23,7.28,7.49   8.64  
V 4.58 2.05 0.87   9.54  
E 5.04 2.00,1.93 2.27   8.54  
V 4.24 1.92 0.89   9.09  
N 4.40 3.10,2.75    9.6  
G 4.115, 
3.675 
    8.68  
O 4.70 1.85 1.71 3.05  7.76 7.66 
K 4.93 1.72 1.29 1.38 2.53 8.52 7.21 
I 4.71 1.85 1.43,1.16,0.87 0.87  9.40  
L 3.90 1.29,0.76 0.37 0.07, 
-0.35 
 8.32  
Q 4.57 2.07,1.82 2.24,2.16   9.04  
C 5.22 3.00,2.40    8.36  
 
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    -1.0    
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Figure 2.71. 1HNMR of Peptide WKMeLcyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Lys(Me)-Ile-Leu-Gln-Cys-NH2 
 
Table 2.32. Proton Chemical Shift Assignments for Peptide WKMeLcyc. 
 $ " ( & # Amide Amine 
C 5.04 2.95      
R 4.59 1.73 1.50 3.16  8.72  
W 5.17 3.09,2.97    8.61  
V 4.58 2.07 0.87   9.53  
E 5.07 1.93 2.19   8.51  
V 4.23 1.91 0.89   9.05  
N 4.40 3.10,2.75      
G 4.115, 
3.668 
      
O 4.67 1.81 1.77 3.04  7.76 7.27 
K(Me) 4.92 1.71 1.33 1.33  2.36, 
2.24 
(CH3)=2.14 
I 4.72 1.86 1.41,1.17 0.87  9.40  
L 3.96 1.33 0.79,0.35 0.19,
-0.38 
 8.38  
Q 4.58 1.87 2.16   9.04  
C 5.21 2.97,2.41      
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   -0.4    
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Figure 2.72. 1HNMR of Peptide WKMe2Lcyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Lys(Me)2-Ile-Leu-Gln-Cys-NH2 
 
Table 2.33. Proton Chemical Shift Assignments for Peptide WKMe2Lcyc. 
 $ " ( & # Amide Amine 
C 5.04 2.92      
R 4.60 1.86 1.70 3.16    
W 5.12 3.03      
V 4.49 1.96 0.89     
E 5.11 1.93 2.28     
V 4.25 1.94 0.91     
N 4.40 3.04,2.75      
G 4.11,3.66       
O 4.75 1.79 1.79 3.00    
K(Me)2 4.90 1.72 1.31 1.31 2.25   (CH3)2= 
2.27, 2.23 
I 4.83 1.88 0.89 0.89    
L 4.01 1.34 0.81,0.41,0.31 -0.36    
Q 4.59 1.93 2.17     
C 5.22 3.05      
 
P P M
  6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   -0.4    
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Figure 2.73. 1HNMR of Peptide WKMe3Lcyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Lys(Me)3
'-Ile-Leu-Gln-Cys-NH2 
 
Table 2.34. Proton Chemical Shift Assignments for Peptide WKMe3Lcyc. 
 $ " ( & # Amide Amine 
C 5.04 2.92,3.10    8.92  
R 4.6 1.80 1.68,1.48 3.16  8.71 6.64,7.10 
W 5.14 2.96,3.11 7.02,7.25,7.28 7.50  8.64 10.17 
V 4.59 2.08 0.87   9.57  
E 5.11 1.93 2.29   8.50  
V 4.26 1.91 0.90   9.05  
N 4.40 3.09,2.75    9.61  
G 4.105, 
3.660 
    8.70  
O 4.68 1.84 1.74 3.03  7.76 7.65 
K(Me)3 4.89 1.77 1.22 1.35 2.36 8.48 (CH3)3=2.46,2.44 
I 4.74 1.87 1.17,1.42,0.88 0.88  9.42  
L 4.03 1.35,0.79 0.32 -
0.39 
 8.46  
Q 4.58 2.08,1.82 2.20   9.06  
C 5.21 2.96,3.11    8.59  
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 2.74. 1HNMR of Peptide WOrnLcyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Orn-Ile-Leu-Gln-Cys-NH2  
 
Table 2.35. Proton Chemical Shift Assignments for Peptide WOrnLcyc. 
 $ " ( & # Amide Amine 
C 5.04 2.91      
R 4.61 1.79 1.65,1.50 3.16  8.73  
W 5.12 3.09 7.00,7.23,7.27,7.49 6.99  8.67  
V 4.60 2.07 0.86   9.51  
E 5.09 1.97 2.17     
V 4.24 1.90 0.90   9.04  
N 4.40 3.09,2.75      
G 4.12,3.67       
O 4.69 1.83 1.83 3.04    
Orn 5.04 1.78 1.67 2.64    
I 4.69 1.83 1.39,1.16,0.87 0.87  9.40  
L 3.89 1.29 0.74,0.37 0.059, 
-0.33 
 8.35  
Q 4.56 2.05,1.82 2.18     
C 5.22 2.99,2.40      
 
 
 
P P M
  6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   -0.4    
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Figure 2.75. 1HNMR of Peptide WDabLcyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Dab-Ile-Leu-Gln-Cys-NH2  
 
Table 2.36. Proton Chemical Shift Assignments for Peptide WDabLcyc. 
 $ " ( & # Amide Amine 
C 5.04 2.94      
R 4.62 1.80 1.67,1.50 3.17  8.72  
W 5.07 3.05 7.00,7.23,7.27,7.49 6.96  8.68  
V 4.64 2.09 0.86   9.53  
E 5.19 1.97 2.21     
V 4.25 1.89 0.89   8.98  
N 4.41 3.11,2.74      
G 4.11,3.67       
O 4.69 1.88 1.75 3.04  7.82  
Dab 5.07 2.11 3.05     
I 4.68 1.83 1.37,1.15,0.84 0.84  9.35  
L 3.84 1.24 0.71,0.35 -0.09, 
-0.34 
 8.28  
Q 4.54 2.09,1.82 2.15   9.01  
C 5.22 2.99,2.39      
P P M
  8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
 119 
 
 
 
 
 
 
 
 
 
Figure 2.76. 1HNMR of Peptide WKTcyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys-Ile-Thr-Gln-Cys-NH2  
 
Table 2.37. Proton Chemical Shift Assignments for Peptide WKTcyc. 
 $ " ( & # Amide Amine 
C 5.00 2.95,2.62      
R 4.56 1.82 1.50 3.16    
W 5.30 3.08    8.33 10.10 
V 4.51 2.03 0.85   9.19  
E 5.06 1.97 2.25   8.59  
V 4.24 1.90 0.90   9.02  
N 4.41 3.10,2.76      
G 4.11,3.67       
O 4.66   3.03  7.77 7.66 
K 4.80 1.62 1.17 1.25 2.36   
I 4.77 1.99 0.92 0.92  9.25  
T 4.54 3.71 0.73   8.33  
Q 4.57 2.02,1.83 2.21   8.91  
C 4.98 3.08,2.96      
 
 
P P M
  8.4     8.0     7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4    
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Figure 2.77. 1HNMR of Peptide WKMeTcyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Lys(Me)-Ile-Thr-Gln-Cys-NH2 
 
Table 2.38. Proton Chemical Shift Assignments for Peptide WKMeTcyc.  
 $ " ( & # Amide Amine 
C 5.03 2.96,2.63      
R 4.55 1.82 1.51 3.16    
W 5.36 3.08      
V 4.51 2.03 0.85     
E 5.11 1.98 2.28     
V 4.25 1.90 0.91     
N 4.41 3.10,2.76      
G 4.10,3.67       
O 4.66 1.82 1.73 3.03    
K 4.80 1.64 1.19 1.21 2.13 CH3=
2.09 
 
I 4.80 2.00 0.92 0.92    
T 4.59 3.74 0.78     
Q 4.60 2.03,1.84 2.22     
C 4.98 3.09,2.97      
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Table 2.39. Proton Chemical Shift Assignments for Peptide KL7: Ac-Asn-Gly-Orn-Lys-
Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.67 2.82    8.44  
G 3.94     8.55  
O 4.35 1.88,1.78 1.7 3.01  8.13 7.64 
K 4.31 1.77 1.42 1.69 2.99 8.33 7.56 
I 4.14 1.85 1.48,1.20,0.89 0.89  8.25  
L 4.38 1.65 1.61 0.93,0.88  8.37  
Q 4.3 2.12,1.99 2.37   8.33  
 
 
Table 2.40. Proton Chemical Shift Assignments for Peptide KMeL7: Ac-Asn-Gly-Orn-
Lys(Me)-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.68 2.81    8.43  
G 3.94     8.56  
O 4.35 1.78 1.68 3.01  8.13 7.61 
K(Me) 4.30 1.75 1.40 1.68 3.02 
CH3=2.701 
8.33 8.05 
I 4.13 1.85 1.49,1.23,0.89 0.89  8.24  
L 4.38 1.63 1.63 0.86  8.36  
Q 4.3 2.10,1.96 2.37   8.32  
 
 
 
Table 2.41. Proton Chemical Shift Assignments for Peptide KMe2L7: Ac-Asn-Gly-Orn-
Lys(Me)2-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.7 2.81    8.54  
G 3.96     8.58  
O 4.36 1.75 1.75 3.02  8.12 7.60 
K(Me)2 4.30 1.95,1.79 1.40 1.69 3.12 
(CH3)2=2.87 
8.34 8.83 
I 4.14 1.84 0.89 0.89  8.28  
L 4.39 1.66 1.66 0.90  8.39  
Q 4.3 2.01 2.33   8.35  
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Table 2.42. Proton Chemical Shift Assignments for Peptide KMe3L7: Ac-Asn-Gly-Orn-
Lys(Me)3
'-Ile-Leu-Gln-NH2  
 $ " ( & # Amide Amine 
N 4.71 2.81    8.42  
G 3.94     8.55  
O 4.36 1.84 1.69 3.02  8.11 7.64 
K(Me)3 4.33 1.84,1.73 1.43 1.66 3.3 8.33 (CH3)3=3.1 
I 4.14 1.84 1.49,1.19,0.89 0.89  8.30  
L 4.39 1.7 1.61 0.92  8.37  
Q 4.31 2.04 2.36   8.33  
 
Table 2.43. Proton Chemical Shift Assignments for Peptide W7: Ac-Arg-Trp-Val-Glu-
Val-Asn-Gly-NH2  
 $ " ( & # Amide Amine 
R 4.18 1.60 1.48 3.08  8.14 6.63,7.12 
W 4.70 3.27    8.19 10.11 
V 4.02 1.96 0.85   7.75  
E 4.29 1.99 2.43   8.20  
V 4.10 2.07 0.94   8.22  
N 4.70 2.82    8.60  
G 3.91     8.38  
 
Table 2.44. Proton Chemical Shift Assignments for Peptide OrnL7: Ac-Asn-Gly-Orn-
Orn-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.69 2.80    8.41  
G 3.95     8.52  
O 4.35 1.85 1.72 3.02  8.15 7.6 
O 4.36 1.84 1.70 3.02  8.40 7.6 
I 4.15 1.85 1.35,1.14,0.90  0.90  8.25  
L 4.39 1.71 1.71 0.90  8.37  
Q 4.31 2.04 2.35   8.32  
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Table 2.45. Proton Chemical Shift Assignments for Peptide OrnMeL7: Ac-Asn-Gly-
Orn-Orn(Me)-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.69 2.80    8.45  
G 3.93     8.55  
O 4.35 1.84 1.76 3.04  8.16 7.6 
O(Me) 4.35 1.84 1.76 3.00 CH3=2.71 8.45 8.14 
I 4.13 1.83 1.48,1.13,0.89  0.89  8.31  
L 4.38 1.64 1.59,0.93,0.86 0.86  8.39  
Q 4.29 2.09,1.97  2.34   8.36  
 
 
Table 2.46 Proton Chemical Shift Assignments for Peptide OrnMe2L7: Ac-Asn-Gly-
Orn-Orn(Me)2-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.69 2.82    8.45  
G 3.94     8.56  
O 4.34 1.77 1.65 3.01  8.16 7.63 
O(Me)2 4.38 1.77 1.65 3.17 (CH3)2=2.88,2.87 8.44 8.16 
I 4.14 1.84 1.48,1.1,0.90  0.90  8.33  
L 4.38 1.63 1.63 0.90  8.40  
Q 4.31 2.10,1.98  2.36   8.36  
 
 
Table 2.47. Proton Chemical Shift Assignments for Peptide OrnMe3L7: Ac-Asn-Gly-
Orn-Orn(Me)3-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.67 2.80      
G 3.93       
O 4.33 1.79 1.65 3.01    
O(Me)3 4.38 1.81 1.69 3.34 (CH3)3=3.11   
I 4.13 1.84 1.48,1.1,0.88  0.88    
L 4.37 1.69 1.69 0.90    
Q 4.30 2.09,1.97  2.36     
 
Table 2.48. Proton Chemical Shift Assignments for Peptide DabL7: Ac-Asn-Gly-Orn-
Dab-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.69 2.81    8.41  
G 3.95     8.5  
O 4.35 1.85 1.69 3.01  8.17 7.6 
Dab 4.47 2.12 3.06   8.54 7.6 
I 4.14 1.81 1.37,1.1,0.90  0.90  8.29  
L 4.28 1.66 1.66 0.98,0.84   8.42  
Q 4.31 2.12,1.99  2.38   8.35  
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Table 2.49. Proton Chemical Shift Assignments for Peptide DabMeL7: Ac-Asn-Gly-
Orn-Dab(Me)-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.68 2.81      
G 3.95       
O 4.35 1.88 1.70 3.01    
Dab(Me)  4.47 2.11 3.09  CH3=2.73     
I 4.14 1.85 1.47,1.17,0.90 0.90    
L 4.39 1.63 0.91 0.91    
Q 4.31 1.99 2.37     
 
Table 2.50. Proton Chemical Shift Assignments for Peptide DabMe2L7: Ac-Asn-Gly-
Orn-Dab(Me)2-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.68 2.83      
G 3.95       
O 4.34 1.82 1.73 3.02    
Dab(Me)2 4.48 2.20 3.20  (CH3)2=2.901   
I 4.13 1.85 1.45,0.91  0.91    
L 4.40 1.65 0.92 0.92    
Q 4.305 2.03 2.35     
 
Table 2.51. Proton Chemical Shift Assignments for Peptide DabMe3L7: Ac-Asn-Gly-
Orn-Dab(Me)3-Ile-Leu-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.68 2.84      
G 3.94       
O 4.32 1.77 1.77 3.01    
Dab(Me)3 4.51 2.246 3.395  (CH3)3=3.142   
I 4.14 1.74 0.91 0.91    
L 4.39 1.644 1.644, 0.926 0.926    
Q 4.29 2.00 2.36     
 
Table 2.52. Proton Chemical Shift Assignments for Peptide KT7: Ac-Asn-Gly-Orn-Lys-
Ile-Thr-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.69 2.81    8.44  
G 3.94     8.55  
O 4.36 1.84 1.72 3.01  8.12 7.60 
K 4.34 1.87 1.43 1.70 3.01 8.37 7.53 
I 4.24 1.89 1.50,1.21,0.93   0.90  8.34  
T 4.36 4.19 1.20   8.26  
Q 4.34 2.14,2.00 2.37   8.40  
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Table 2.53. Proton Chemical Shift Assignments for Peptide KMeT7: Ac-Asn-Gly-Orn-
Lys(Me)-Ile-Thr-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.69 2.80      
G 3.94     8.55  
O 4.37 1.76 1.76 3.01  8.11  
K(Me) 4.34 1.75 1.42 1.70 3.01 
CH3=2.70  
  
I 4.24 1.89 1.49,1.22,0.91   0.91  8.33  
T 4.37 4.19 1.20   8.26  
Q 4.34 2.00 2.37   8.39  
 
Table 2.54. Proton Chemical Shift Assignments for Peptide KMe2T7: Ac-Asn-Gly-Orn-
Lys(Me)2-Ile-Thr-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.70 2.81    8.43  
G 3.94     8.55  
O 4.37 1.76 1.76 3.01  8.12  
K(Me)2 4.33 1.77 1.41 1.70 3.10 
CH3=2.87  
  
I 4.24 1.89 0.90 0.90  8.35  
T 4.37 4.19 1.20   8.25  
Q 4.33 2.00 2.37   8.40  
 
 
Table 2.55. Proton Chemical Shift Assignments for Peptide KMe3T7: Ac-Asn-Gly-Orn-
Lys(Me)3-Ile-Thr-Gln-NH2 
 $ " ( & # Amide Amine 
N 4.67 2.80    8.42  
G 3.94     8.55  
O 4.37 1.78 1.78 3.01    
K(Me)3 4.36 1.79 1.40 1.79 3.31 
CH3=3.10  
  
I 4.24 1.89 1.50,1.18,0.91  0.91  8.36  
T 4.37 4.19 1.19   8.24  
Q 4.33 2.09,2.00 2.37   8.39  
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Figure 2.78. 1HNMR of Peptide WDMAa: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Arg(Me)2-Ile-Leu-Gln-NH2  
 
Table 2.56. Proton Chemical Shift Assignments for Peptide WDMAa. 
 $ " ( & # Amide Amine 
R 4.44 1.66 1.53 3.14  8.03 7.12,6.74,6.60 
W 5.06 3.01,2.93    8.39 10.11 
V 4.54 2.05 0.84   9.22  
E 5.10 1.93 2.21   8.44  
V 4.22 1.91 0.88   8.90  
N 4.41 3.08,2.74    9.54  
G 4.10,3.69      8.69  
O 4.65 1.80 1.80 3.02  7.77 7.65 
R(Me)2 4.87 1.71 1.58 2.95 (CH3)2=2.356 8.52 6.26,6.21 
I 4.65 1.80 0.85 0.85  9.24  
L 3.91 1.21 0.79 0.37,0.25, 
-0.05 
 8.19  
Q 4.31 1.89 2.21   8.70  
 
 
 
 
P P M
  6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.79. 1HNMR of Peptide DMAa7: Ac-Asn-Gly-Orn-Arg(Me)2-Ile-Leu-Gln-NH2 
 
Table 2.57. Proton Chemical Shift Assignments for Peptide DMAa7. 
 $ " ( & # Amide Amine 
N 4.67 2.80    8.46  
G 3.93     8.58  
O 4.36 1.65 1.60 3.01  8.16 7.64 
R(Me)2 4.32 1.77 1.77 3.25 (CH3)2=3.002 8.36 6.79,6.76  
I 4.14 1.84 1.49,1.18, 
0.89 
0.89  8.30  
L 4.39 1.88 1.64 0.92,0.85  8.38  
Q 4.30 2.11,1.98  2.36   8.34  
 
 
 
 
 
 
 
 
 
P P M
  4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4    
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Figure 2.80. 1HNMR of Peptide WDMAaCyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Arg(Me)2-Ile-Leu-Gln-Cys-NH2 
 
Table 2.58. Proton Chemical Shift Assignments for Peptide WDMAaCyc. 
 $ " ( & # Amide Amine 
C 5.23 2.98, 
2.32 
     
R 4.61 1.79 1.66,1.51 3.16  8.73  
W 5.10 2.96 7.45,7.25 7.19,7.17 6.94 8.64  
V 4.61 2.07 0.86   9.54  
E 5.16 1.93 2.22   8.46  
V 4.26 1.91 0.90   9.05  
N 4.40 3.13, 
2.76 
     
G 4.115, 
3.672 
      
O 4.68 1.85 1.73 3.04  7.79  
R(Me)2 4.96 1.82 1.59 3.07,2.92 (CH3)2=2.27   
I 4.74 1.82 1.40,1.13 0.86  9.41  
L 3.86 1.24 0.7,0.35 -0.13,-0.4  8.24  
Q 4.54 1.80 2.15,2.09   9.02  
C 5.04 2.94    9.05  
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   -0.4    
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Figure 2.81. 1HNMR of Peptide WDMAs: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Arg(Me)2-Ile-Leu-Gln-NH2  
 
Table 2.59. Proton Chemical Shift Assignments for Peptide WDMAs. 
 $ " ( & # Amide Amine 
R 4.45 1.66 1.54 3.15  8.03 7.13,6.61 
W 5.09 3.02,2.93    8.38 10.07 
V 4.55 2.06 0.85   9.28  
E 5.10 1.94 2.23   8.48  
V 4.24 1.91 0.91   8.98  
N 4.42 3.09,2.77    9.57  
G 4.102,3.685      8.70  
O 4.66 1.84 1.73 3.04  7.77 7.66 
R(Me)2 4.88 1.766,1.68 1.52 2.96,2.83 (CH3)2=2.229 8.53 6.34,6.17 
I 4.69 1.85 1.39, 
1.14,0.88 
0.88  9.29  
L 3.92 1.22 0.79 0.35,0.016  8.20  
Q 4.32 2.01,1.84 2.23   8.73  
 
 
 
 
 
 
P P M
  8.8     8.4     8.0     7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4    0.0    
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Figure 2.82. 1HNMR of Peptide DMAs7: Ac-Asn-Gly-Orn-Arg(Me)2-Ile-Leu-Gln-NH2 
 
Table 2.60. Proton Chemical Shift Assignments for Peptide DMAs7. 
 $ " ( & # Amide Amine 
N 4.68 2.80    8.43  
G 3.94     8.56  
O 4.35 1.77 1.77 3.01  8.13 7.60 
R(Me)2 4.32 1.80 1.62 3.20 (CH3)2=2.812 8.32 6.81,6.75 
I 4.14 1.84 1.48,1.18, 
0.88 
1.00,0.89  8.27  
L 4.38 ---- 1.63 0.88  8.37 
 
 
Q 4.30 1.99 2.36   8.31  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P P M
  4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.83. 1HNMR of Peptide WDMAsCyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Arg(Me)2-Ile-Leu-Gln-Cys-NH2 
 
Table 2.61. Proton Chemical Shift Assignments for Peptide WDMAsCyc. 
 $ " ( & # Amide Amine 
C 5.23 2.95, 
2.38 
     
R 4.61 1.79 1.67,1.50 3.17  8.72  
W 5.11 3.00,2.89    8.60  
V 4.61 2.07 0.87   9.54  
E 5.15 1.93 2.23     
V 4.26 1.91 0.90   9.07  
N 4.40 3.11,2.77      
G 4.115, 
3.672 
      
O 4.68 1.85 1.73 3.04  7.79  
R(Me)2 4.96 1.82 1.68,1.56 2.996,2.879 (CH3)2=2.059   
I 4.77 1.84 1.40,1.13 0.88  9.41  
L 3.86 1.25 0.71,0.35 -0.07,-0.4  8.24  
Q 4.56 1.81 2.21,2.10   9.02  
C 5.04 3.03      
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 2.84. 1HNMR of Peptide VDMAs: Ac-Arg-Val-Val-Glu-Val-Asn-Gly-Orn-
Arg(Me)2-Ile-Leu-Gln-NH2  
 
Table 2.62. Proton Chemical Shift Assignments for Peptide VDMAs. 
 $ " ( & # Amide Amine 
R 4.32 1.74 1.63 3.19    
V 4.29 1.98 0.88     
V 4.23 2.02 0.88     
E 4.72 1.91 2.27     
V 4.15 1.96 0.90     
N 4.56 2.93,2.80      
G 4.006,3.812        
O 4.48 1.82 1.65 3.02    
R(Me)2 4.42 1.79 1.63 3.20 (CH3)2=2.802   
I 4.25 1.85 1.42,1.16,0.87 0.87    
L 4.48 1.66 0.87 0.87    
Q 4.33 2.06 2.34     
 
 
 
 
 
 
 
P P M
  4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.85. 1HNMR of Peptide VDMAsCyc: Ac-Cys-Arg-Val-Val-Glu-Val-Asn-Gly-
Orn-Arg(Me)2-Ile-Leu-Gln-Cys-NH2 
 
Table 2.63. Proton Chemical Shift Assignments for Peptide VDMAsCyc. 
 $ " ( & # Amide Amine 
C 5.24 3.16,2.61      
R 4.64 1.84 1.65 3.17  8.76  
V 4.64 1.87 0.79   8.52  
V 4.47 1.99 0.81   9.05  
E 5.09 1.88 2.14   8.43  
V 4.22 1.87 0.87   8.90  
N 4.52 2.90      
G 4.112, 
3.662 
      
O 4.65 1.82 1.71 3.02  7.78  
R(Me)2 4.44 1.82 1.64 3.17  (CH3)2=2.801  
I 4.49 1.86 1.12,0.83 0.83  9.14  
L 4.73 1.49 0.77 0.77  8.38  
Q 4.66 2.06 2.19   9.25  
C 5.09 3.06      
 
 
 
 
P P M
  8.8     8.4     8.0     7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4    0.0    
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Figure 2.86. 1HNMR of Peptide VDMAa: Ac-Arg-Val-Val-Glu-Val-Asn-Gly-Orn-
Arg(Me)2-Ile-Leu-Gln-NH2  
 
Table 2.64. Proton Chemical Shift Assignments for Peptide VDMAa. 
 $ " ( & # Amide Amine 
R 4.33 1.76 1.65 3.20    
V 4.27 1.96 0.89     
V 4.23 2.02 0.89     
E 4.70 1.92 2.28     
V 4.15 1.98 0.91     
N 4.58 2.96,2.79      
G 4.001,3.821        
O 4.48 1.80 1.65 3.02    
R(Me)2 4.43 1.78 1.62 3.24 (CH3)2=2.998   
I 4.25 1.86 1.43,1.17,0.87 0.87    
L 4.47 ----- 0.88 0.88    
Q 4.33 2.00 2.35     
 
 
 
 
 
P P M
  4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 2.87. 1HNMR of Peptide VDMAaCyc: Ac-Cys-Arg-Val-Val-Glu-Val-Asn-Gly-
Orn-Arg(Me)2-Ile-Leu-Gln-Cys-NH2 
 
Table 2.65. Proton Chemical Shift Assignments for Peptide VDMAaCyc. 
 $ " ( & # Amide Amine 
C 5.23 3.13,2.61      
R 4.61 1.76 1.76 3.26  8.79  
V 4.65 1.85 0.79   8.52  
V 4.48 1.98 0.81   9.05  
E 5.08 1.88 2.13   8.41  
V 4.21 1.86 0.87   8.91  
N 4.52 2.90      
G 4.113, 
3.663 
      
O 4.63 1.82 1.65 3.02  7.76  
R(Me)2 4.44 1.78 1.64 3.20  (CH3)2=2.997  
I 4.48 1.86 1.17,0.82 0.82  9.13  
L 4.72 1.50 0.79 0.79  8.38  
Q 4.64 2.08 2.27   9.24  
C 5.09 3.02      
 
P P M
  5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
CHAPTER III 
 
LYSINE ACYLATION AND AMIDE-! INTERACTIONS 
 
 
(Reproduced, in part, with permission from Hughes, R.M.; Waters, M.L. J. Am. Chem. 
Soc. 2006, 128, 13586 – 13591.) 
 
 
A. Background and significance. 
The acylation of lysine is a common post-translational modification of histone proteins. 
Lysine acylation can weaken the histone-DNA complex in chromatin by neutralizing the 
electrostatic interaction between unmodified lysine in histones and the negatively charged 
phosphate backbone of DNA, thereby activating transcription.1 Additionally, lysine 
acylation is commonly found in cells with DNA damage, where it is also thought to 
weaken the DNA-histone complex to make DNA accessible to repair enzymes,2 and can 
play a role in protein stability by preventing lysine ubiquitination, which tags proteins for 
proteolysis.3 The bromodomain, a protein domain with a specific affinity for acetylated 
lysine, is found in most acyltransferases and in many proteins associated with the 
                                                
1 Hong, L.; Schroth, G. P.; Matthews, H.; Yau, P.; Bradbury, E. M. J. Biol. Chem. 1993, 
268, 305-314. 
2 Masumoto, H.; Hawke, D.; Kobayashi, R.; Verreault, A.  Nature 2005, 436, 294. 
3 Caron, C.; Boyault, C.; Khochbin, S. BioEssays 2005, 27, 408-415. (b) Simonsson, M.; 
Heldin, C.; Ericsson, J.; Gronroos, E. J. Biol. Chem. 2005, 280, 21797-21803. 
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regulation of chromatin structure.4 The bromodomain binding pocket contains highly 
conserved aromatic residues that appear to interact with acetylated lysine through amide-
! interactions (Figure 3.1).5  
 
(a)     (b)  
Figure 3.1.  (a) Lys-Trp pair in typical cation-! geometry (PDB code: 1ONR). (b) KAc-Tyr pair in typical 
amide-! geometry (Bromodomain from GCN5 complexed with acetylated H4 peptide; PDB code: 1E6I). 
 
 
The importance of amide-! interactions in structural biology has been long established 
through data-mining studies of protein crystal structures, in which amide-containing 
sidechains (Gln, Asn) were found to have statistical preference for packing near the faces 
of aromatic rings.6 Additional investigations have identified numerous backbone amide-! 
                                                
4 Zeng, L.; Zhou, M. M. FEBS Letters 2002, 513, 124-128. 
5 (a) Dhalluin, C.; Carlson, J. E.; Zeng, L.; He, C.; Aggarwal, A.; Zhou, M. Nature 1999, 
399, 491-496. (b) Owen, D.J., Ornaghi, P., Yang, J.C., Lowe, N., Evans, P.R., Ballario, 
P., Neuhaus, D., Filetici, P., Travers, A.A. EMBO J.  2000, 19, 6141-6149.  
 
6 (a) Burley, S.K.; Petsko, G.A. FEBS Letters 1986, 203, 139-143. (b) Burley, S.K.; 
Petsko, G.A. Adv. Prot. Chem. 1988, 39, 125-189. (c) Singh, J.; Thornton, J. M. J. Mol. 
Biol. 1990, 211, 595-615. (d) Steiner, T.; Koellner, G. J. Mol. Biol. 2001, 305, 535 – 557. 
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interactions in protein and peptide structures,6
d,7 as well as a number of amide-! 
interactions that occur in the binding of ligands.8 For example, backbone amide-! 
interactions have been identified between Gly/Phe and Gly/Trp pairs in analyses of pair-
wise residue preferences in antiparallel "-sheets,9 and amide-! interactions have been 
identified in the binding of the drug bezafibrate by human deoxyhemoglobin.10 Amide-! 
interactions have also been utilized in the selective binding of guests by model systems in 
organic solution.11 Additional theoretical studies have been conducted to demonstrate 
both the orientation and magnitude of the amide-! interaction, using variously the 
formamide-benzene interaction12 and the ammonia-benzene interaction13 in the gas phase 
                                                
7 (a) van der Spoel, D.; van Buuren, A. R.; Tieleman, P.; Berendsen, H. J. C. J. Biomol. 
NMR 1996, 8, 229 – 238. (b) Honda, S.; Kobayashi, N.; Munekata, E. J. Mol. Biol. 2000, 
295, 269-278. (c) Duan, G.; Smith, V.H.; Weaver, D.F. Int. J. Quant. Chem. 2000, 80, 
44-60. (d) Toth, G.; Watts, C.R.; Murphy, R.F.; Lovas, S. Prot. Struct. Func. Gen. 2001, 
43, 373-381. (e) Toth, G.; Murphy, R.F.; Lovas, S. Prot. Eng. 2001, 14, 543-547. (f) 
Toth, G.; Murphy, R.F.; Lovas, S. J. Am. Chem. Soc. 2001, 123, 11782-11790. (g) Toth, 
G.; Kover, K.E.; Murphy, R.F.; Lovas, S. J. Phys. Chem. B. 2004, 108, 9287-9296. (h) 
Meyer, E.A.; Castellano, R.K.; Diederich, F. Angew. Chem. Int. Ed. 2003, 42, 1211-1250. 
(i) Sengupta, A.; Mahalakshmi, R.; Shamala, N.; Balaram, P. J. Pept. Res. 2005, 65, 113-
129. (j) Mahalakshmi, R.; Raghothama, S.; Balaram, P. J. Am. Chem. Soc. 2006, 128, 
1125-1138. 
8 Perutz, M.F. Phil. Trans. Phys. Sci. Eng. 1993, 345, 105-112. 
9 (a) Hutchinson, E. G.; Sessions, R. B.; Thornton, J. M.; Woolfson, D. N. Prot. Sci. 
1998, 7, 2287 – 2300. (b) Merkel, J. S.; Regan, L. Folding & Design 1998, 3, 449 - 455. 
10 Perutz, M. F.; Fermi, G.; Abraham, D. J.; Poyart, C.; Bursaux, E. J. Am. Chem. Soc. 
1986, 108, 1064-1078. 
11 (a) Bisson, A. P.; Lynch, V. M.; Monahan, M. C.; Anslyn, E. V. Angew. Chem. Int. Ed. 
1997, 36, 2340 – 2342. (b) Snowden, T. S.; Bisson, A. P.; Anslyn, E. V. J. Am. Chem. 
Soc. 1999, 121, 6324 – 6325. 
12 (a) Duan, G.; Smith, V.H.; Weaver, D.F. J. Phys. Chem. A 2000, 104, 4521-4532. (b) 
Duan, G.; Smith, V.H.; Weaver, D.F. Chem. Phys. Lett. 1999, 310, 323-332. 
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as models for the amide-! interaction in proteins. Notably, a recent study investigated 
both amide- and cation-! interactions using implicit solvent models and predicted the 
amide-! interaction of Asn and Gln sidechains with an adenine ring (Ade) to be 
intermediate in magnitude (-4 kcal/mol) between the cation-! interactions Arg-Ade (-7 
kcal/mol) and Lys-Ade (-2 kcal/mol).14 In addition, Burley and Pestko’s survey of 33 
protein crystal structures found higher fractions of polar amide residues interacting with 
aromatic sidechains (31% Asn, 40% Gln) than for Lys (26%), but lower than that of Arg 
(47%).6
a
 These findings suggest that the amide-! interaction may be more favorable than 
the cation-! interaction between lysine and an aromatic ring (Figure 3.1). 
To explore the efficacy of amide-! interactions, and in particular their role in the 
recognition of KAc, we have investigated the effects of acylation of lysine and its 
interaction with tryptophan within the context of a "-hairpin peptide (Figure 3.2). This is 
a useful model system to study non-covalent interactions in water within a biologically 
relevant context and has previously been used to study cation-! interactions.15 Two 
analogs of acyl lysine (KAc), formyl lysine (KFm) and trifluoroacetyl lysine (KFAc), 
were studied to explore the effects of changes in hydrophobic and electronic character of 
the acyl group. In our investigation, we find that the interaction between acylated lysine 
and tryptophan consists of a polar-! interaction that occurs primarily between the 
                                                                                                                                            
13 Tsuzuki, S.; Honda, K.; Uchimaru, T.; Mmikami, M.; Tanabe, K. J. Am. Chem. Soc. 
2000, 122, 11450-11458. 
14 Biot, C.; Buisine, E.; Rooman, M. J. Am. Chem. Soc. 2003, 125, 13988-13994. 
15 (a) Tatko, C.D.; Waters, M.L. Prot. Sci. 2003, 12, 2443-2452. (b) Tatko, C.D.; Waters, 
M.L. J. Am. Chem. Soc. 2004, 126, 2028-2034. (c) Hughes, R.M.; Waters, M.L. J. Am. 
Chem. Soc. 2005, 127, 6518-6519. 
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polarized amide of acyl lysine and the electron rich face of the tryptophan indole ring. 
Despite the loss of the positive charge upon N-acylation, the KAc···Trp interaction is as 
strong as the unmodified Lys···Trp interaction previously reported in the same model 
system.
15a,b 
This indicates that the polar-! interaction is energetically competitive with the 
cation-! interaction, likely due to a reduced desolvation penalty of interaction between 
lysine and tryptophan upon acylation of the lysine sidechain while maintaining the 
electrostatic and van der Waals components of the interaction via NH(#+)···!(#-) and !-
! stacking. 
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Figure 3.2. (a) "-hairpin peptide structure. (b) Amino acids at position X:  Lysine (Lys), Acyl Lysine 
(KAc), Formyl Lys (KFm), Trifluoroacetylated Lysine (KFAc), and Norleucine (Nle). 
 
B. Results and Discussion 
i. Design. The 12-residue "-hairpin sequence used in this study is based on a sequence 
that has been previously described (Figure 3.2).
15
 Key design features include a good 
turn-nucleating sequence (Val-Asn-Gly-Val) and a number of hydrophobic interactions to 
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stabilize the hairpin, including Val3, Val5, Ile10 on one face of the hairpin, and Trp2 and 
Leu11 on the opposite face of the hairpin.  The diagonal interaction between Trp2 and 
position 9 (residue X in Figure 3.2) is the site of interest for this study.  A Lys residue at 
position 9 has been previously been shown to interact favorably with Trp2 via a cation - ! 
interaction between the $-CH2 of Lys and the face of the aromatic ring.  To explore the 
relative favorability of an amide-! interaction, we investigated the effect of Lys 
acylation.   
ii. Characterization. As discussed in Chapter 1, the beta-hairpin structure and stability 
was characterized by a number of standard NMR techniques, including %-hydrogen (H%) 
chemical shifts, glycine splitting (&# Gly), and cross-strand NOEs.15,16 The degree of H% 
downfield shifting and Gly splitting relative to random coil values is used as an indicator 
of the degree of "-sheet structure at each position along the strand and in the turn, 
respectively.17 The fraction folded is calculated with the following equation: %folded = 
(dobs – dU)/(dF – dU), where the unfolded state (U) is represented by random coil control 
peptides and the fully folded state (F) by cyclic peptides (see Experimental). 
Furthermore, numerous NOEs between cross-strand pairs of sidechains were observed for 
all peptides, consistent with "-hairpin formation (see Experimental).  
iii. Effects of Lysine Acylation.  Acylation of lysine results in a modest 
enhancement in stability of the "-hairpin peptide. This is demonstrated by an increase in 
the %-hydrogen shifts relative to random coil, as shown in Figure 3.3a. Based on the 
                                                
16 Maynard, A. J.; Sharman, G. J.; Searle, M. S. J. Am. Chem. Soc. 1998, 120, 1996-
2007. 
17 Griffith-Jones, S. R.; Maynard, A. J.; Searle, M. S. J. Mol. Biol. 1999, 292, 1051-1069. 
 142 
glycine splitting, fraction folded of WKAc is 87% (± 1%) (Sidechain H%avg = 83 ± 
8%)18, versus 78% (± 1%) for the peptide WK at 298 K (Sidechain H%avg = 76 ± 7%),
18
 
indicating that acylation enhances hairpin stability (&&G = 0.38 kcal/mol, ± 0.05 
kcal/mol).  Because acylation of Lys may change its beta-sheet propensity, we performed 
a double mutant cycle to quantitatively asses the interaction energy between Trp and 
KAc. Val and Ser were used as controls for Trp and Lys, respectively.
15
 Double mutant 
cycles give the magnitude of the Trp···X sidechain-sidechain interaction for WK and 
WKAc to be -0.30 and -0.34 kcal/mol (± 0.1 kcal/mol), respectively. While the 
differences in the two interaction energies are within experimental error, this is 
significant in that acylation does not decrease the magnitude of the interaction with Trp, 
despite the loss of the positive charge. Rather, the conversion of the ammonium group to 
an amide provides an interaction with Trp of comparable magnitude.  
Although the interaction energies for Trp···KAc and Trp···Lys are similar, the upfield 
shifting patterns of the lysine and acyl lysine sidechains indicate a change in the 
interaction geometry with Trp for KAc relative to Lys (Figure 3.3b). While the 
unmodified lysine is most upfield shifted at the $-CH2 protons, KAc is most upfield 
shifted at its amide proton.  The $-CH2 of KAc exhibits some upfield shifting as well, 
wheareas the acetyl methyl group is less shifted. Thus, although it is difficult to 
determine if the amide group is stacked with the Trp or interacting via an NH···! 
interaction, it is clear that it interacts in a different geometry than Lys.  The preference for 
interaction at the amide NH in KAc versus the $-CH2 in Lys may arise from differences 
in the desolvation cost for an amide relative to an ammonium group.  If the amide in KAc 
                                                
18 Sidechain H%avg values were calculated excluding the terminal residues (Arg,Gln) and 
the turn residues (Asn,Gly). 
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is stacked with the Trp residue, the NH group may still be able to hydrogen bond with 
water, such that there is minimal desolvation penalty, as has been proposed for the 
interaction of Arg with Trp.19  In proteins, the stacked conformation for Asn and Gln 
sidechains with aromatic residues is favored by a factor of about 2.5.
 6d  Given that the 
Trp···KAc interaction is highly solvent exposed in this peptide model system, a stacked 
conformation is likely. 
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Figure 3.3.  (a) WK and WKAc %H shifts relative to random coil values. Glycine shifts reflect the 
splitting. (b) WK and WKAc sidechain upfield proton shifts relative to random coil values. Conditions: 
298K, 50 mM NaOAc-d3 in D2O, pH 4.0 (uncorrected), referenced to DSS. 
The thermodynamics of hairpin folding for WKAc are consistent with hairpin 
stabilization due to a polar-! interaction (Figure 3.4 and Table 3.1).20  The driving force 
for folding of WKAc is similar to WK, with an enthalpic driving force for the folding 
and an associated entropic cost, despite the difference in charge.  In contrast, comparison 
with a peptide containing a nonpolar alkyl sidechain, WNle, at position X shows that the 
                                                
19 (a) Mitchell, J. B. O.; Nandi, C. L.; McDonald, I. K.; Thornton, J. M. J. Mol. Biol. 
1994, 239, 315-331. (b) Gallivan, J. P., Dougherty, D. A. Proc. Natl. Acad. Sci. USA 
1999, 96, 9459-9464. 
20 Hughes, R. M.; Waters, M. L., J. Am. Chem. Soc., in press. 
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driving force folding of WKAc is much more enthalpically favorable than the nonpolar 
Nle sidechain.
15b
 This is consistent with significant interaction between the polarized 
amide NH and tryptophan in WKAc as seen in Figure 3.3b. 
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Figure 3.4. Thermal denaturation profiles of WK, WKAc, and WNle peptides as 
determined by NMR. The fraction folded was determined from the Gly splitting. Error is 
±0.5 K in temperature and ±1% in fraction folded. Conditions: 50 mM NaOAc-d3 buffer, 
pD 4.0 (uncorrected). 
 
Table 3.1. Thermodynamic Parameters
a
 for Folding at 298 K
10
 
Peptide &H° 
(kcal/mol) 
&S° 
(cal/mol K) 
&Cp° 
(cal/mol K) 
Reference 
WK -2.8 (0.03) -6.8 (0.1) -163 (3) 15a,b 
WKAc -2.91 (0.07) -6.1 (0.2) -250 (40) this work 
WNle -0.85 (0.07)  -0.7 (0.2) -170 (25) 15b 
a 
Determined from the temperature dependence of the Gly chemical shift from 0 to 60 °C. 
Errors (in parentheses) are determined from the fit. Error is ±0.5 K in temperature and 
±1% in fraction folded. Conditions: 50 mM NaOAc-d3 buffer, pD 4.0 (uncorrected). 
 
iv. Effects of Acyl Lysine Analogs. Acyl lysine analogs, formyl lysine (KFm) 
and trifluoroacetyl lysine KFAc), were used to further examine the effects of acylation. 
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KFm was investigated in order to determine the contribution of hydrophobic or van der 
Waals interactions, and KFAc was studied to examine electronic effects on the 
interaction with Trp interaction. With these analogs, subtle changes were detected in the 
geometry of the interaction, but there was little effect on stability and driving force for 
folding. WKAc and its analogs WKFm and WKFAc are approximately equistable at 
298K: 87, 86, and 87% folded (± 1%), respectively, based on the glycine splitting (83, 
82, and 83% ± 8% folded based on the average sidechain Ha fraction folded).
18
 This is 
supported by the consistency of the H% shifts relative to random coil (Figure 3.5a). While 
these hairpins are of similar stabilities, comparison of the sidechain upfield shifting 
profiles for KAc, FAc, and Fm indicates differences in the mode of interaction (Figure 
3.5b). The KFm sidechain has a similar profile to the KAc sidechain. Both are most 
upfield shifted at the amide NH position. However, the KFm has both polarized amide 
and aldehyde protons (Figure 3.6), both of which can interact favorably with the 
tryptophan ring. As a result, the upfield shifting is distributed more evenly over the two 
sites, while the KAc sidechain has a definite preference for interacting with tryptophan 
through the amide position. In contrast, the KFAc sidechain exhibits significant upfield 
shifting at the #- and $-CH2 groups and very little shifting of the amide nitrogen (Figure 
3.5b).  Indeed, it has an interaction profile more similar to lysine (Fig. 3.5c).  
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(a)  (b)  
 
(c)  
 
Figure 3.5.  (a) WKAc, WKFm, and WKFAc H% shifts relative to random coil values. 
Glycine shifts reflect the splitting. (b) KAc, Kfm, and KFAc sidechain upfield proton 
shifts relative to random coil values. (c) Lys and KFAc sidechain upfield proton shifts 
relative to random coil.  Conditions: 298K, 50 mM NaOAc-d3 buffer, pH 4.0 
(uncorrected), referenced to DSS. 
 
The differences in interaction geometries can be elucidated through a comparison 
of electrostatic potential maps of the three sidechains (KAc, KFm, and KFAc) as shown 
in Figure 3.6.  Clearly the amide proton is the most polarized site on each of the three 
sidechain analogs, with the carbonyl carbon on the KFAc analog also highly polarized 
due to the inductive effects of the fluorines. However, the fluorines in the KFAc analog 
may present both a steric and electronic barrier to interaction of the amide NH with the 
indole ring. The CF3 group in KFAc is the largest of the groups on the carbonyl, thus 
obscuring the amide proton. Additionally, CF···! interactions have been shown to have 
weak repulsive character in fluoromethane-benzene model systems, lending some 
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repulsive electronic character to the KFAc···Trp interaction.21 Due to long-range 
inductive effects of the fluorines, the # and $ positions of the KFAc sidechain are more 
polarized than the corresponding positions in the KAc and KFm sidechains (Figure 3.6). 
This, in combination with the electronic and steric repulsion of the trifluoro group, would 
explain the upfield shifting pattern seen in Figure 3.5c, where the most intense shifts are 
seen at the # and $ positions of the KFAc sidechain. 
 
 (a)  (b)   
 
(c)  
 
Figure 3.6. Electrostatic potential maps of amino acid sidechains: (a) KAc, (b) 
KFm, (c) KFAc. Electrostatic potential maps generated with MacSpartan (HF/6-31g*; 
Isodensity value = 0.02; range = -30 to 30 kcal/mol). 
 
The thermal denaturation for each of the three peptides WKAc, WKFm, and WKFAc 
were found to be close to or within error (Figure 3.7), resulting in very similar values for 
&H°, &S°, and &Cp° (Table 3.2). Thus, although changing the sterics and electronics of 
the amide group influences the geometry of the interaction, there is very little effect on its 
driving force.  This suggests a level of control of the interaction geometry that is not 
often achieved with noncovalent interactions.  Moreover, it provides insight into the 
                                                
21 Kawahara, S.; Tsuzuki, S.; Uchimaru, T. J. Phys. Chem. A. 2004, 108, 6744. 
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subtle factors that may influence the folding of a protein into a single, low energy 
structure. 
270 280 290 300 310 320 330
0.70
0.72
0.74
0.76
0.78
0.80
0.82
0.84
0.86
0.88
0.90
 WKAc
 WKFm
 WKFAc
F
ra
c
ti
o
n
 F
o
ld
e
d
Temperature (K)
 
 
Figure 3.7. Thermal denaturation profiles of WKAc, WKFm, and WKFAc peptides as 
determined by NMR. The fraction folded was determined from the Gly splitting. Error is 
±0.5 K in temperature and ±1% in fraction folded. Conditions: 50 mM NaOAc-d3 buffer, 
pD 4.0 (uncorrected). 
 
Table 3.2. Thermodynamic Parameters
a
 for Folding at 298 K 
Peptide &H° 
(kcal/mol) 
&S° 
(cal/mol K) 
&Cp° 
(cal/mol K) 
WKAc -2.91 (0.07) -6.1 (0.2) -250 (40) 
WKFm -3.06 (0.03) -6.7 (0.1) -195 (30) 
WKFAc -2.68 (0.07) -5.2 (0.2) -220 (30) 
a 
Determined from the temperature dependence of the Gly chemical shift from 0 to 60 
°C. Errors (in parentheses) are determined from the fit. 
 
C. Conclusion.  
We have utilized a "-hairpin model system to investigate the nature of an amide-! 
interaction between Trp and an acylated Lys residue and compared it to the interaction of 
Trp with the unmodified Lys.  Our system demonstrates both the geometric and energetic 
effects of acylation upon the Trp···Lys interaction. Surprisingly, while the geometry of 
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the interaction changes upon acylation, the magnitude of the interaction does not 
decrease, despite the loss of a positive charge.  NMR chemical shifts indicate that the 
amide NH is in close proximity to the face of the aromatic ring, rather than between the 
$-CH2 and Trp that is observed with the unmodified Lys.  The change in geometry is 
likely due to differences in desolvation costs for the Lys and KAc sidechains.  The 
thermodynamics for folding indicate that the amide-! interaction contains significant 
polar-! character. Acylated lysine analogs KFm and KFAc have further elucidated our 
understanding of this interaction through manipulation of both electronic and sterics of 
the Lys sidechain.  These changes in sterics and electronics result in subtle changes in the 
geometery of interaction, indicating the fine tuning that is possible in such noncovalent 
interactions.  These findings provide insight into the specific recognition of acylated 
lysine that plays a significant biological role in chromatin condensation via the “histone 
code” as well as the general role of amide-! interactions in protein structure and function.  
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D. Experimental Section 
 
i. Characterization of Structure. Methods used to indicate the formation of "-hairpin 
structure include the analysis of H% shifting relative to random coil, backbone amide 
shifts relative to random coil, and the identification of cross strand NOEs. The "-hairpin 
should have backbone hydrogen bonded amides between cross-strand residue pairs Arg-
Gln, Val-Ile, and Val-Orn in all hairpin peptides. The presence of these hydrogen bonds 
is readily demonstrated by downfield shifting of the amide hydrogens in these positions 
relative to random coil. As seen below, both peptides exhibit significant downfield 
shifting at key positions along the strand. As expected for "-hairpins, the termini are 
frayed and show little or no amide shifting.  The Asn amide shows significant downfield 
shifting as expected for a Type I’ turn. 
 
 
 
Figure 3.8. Backbone amide shifts for selected "-hairpin peptides. 
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Furthermore, analysis of the H% fraction folded plot for selected peptides WK, WKMe3, 
WKAc, WKFam, and WKTFAc, as calculated by equation [11], shows cooperative 
folding along the entire strand, with the exception of fraying at the termini.  
 
 
Figure 3.9. Fraction folded data for selected "-hairpin peptides. 
 
Finally, the identification of numerous cross-strand NOEs in all hairpin peptides indicates 
that all peptides have "-hairpin structure.  
 
Figure 3.10. WKAc Cross-strand NOEs: 
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Figure 3.11. WKAcCyc Cross-strand NOEs: 
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Figure 3.12. WKFmCyc Cross-strand NOEs: 
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Figure 3.13. WKFAcCyc Cross-strand NOEs: 
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Tables 3.3a-c. NOEs observed in peptides WKFAc, WKFAcCyc, WKFmCyc at 298 K 
(S=Strong; M=Medium; W=Weak) 
 
Table 3.3a. Peptide WKFAc: 
Ac-RWVEVNGO(KFAc)ILQ-NH 
    
Residue Proton Residue Proton Intensity 
Trp 2 Ar 4 Leu 11 #  W 
Trp 2 Ar 7 Leu 11 #  W 
Trp 2 Ar 7 KFAc 9 "  S 
Trp 2 Ar 7 KFAc 9 '  M 
Trp 2 Ar 7 KFAc 9 #  M 
Trp 2 Ar 7 Ile 10 % M 
Trp 2 Ar 7 Leu 11 % M 
Trp 2 Ar 7 Arg 1 % M 
Trp 2 Ar 7 Ile 10 % W 
Trp 2 Ar 7 Leu 11 % M 
Trp 2 Ar 6 KFAc 9 "  M 
Trp 2 Ar 6 KFAc 9 '  W 
Trp 2 Ar 6 KFAc 9 # W 
Trp 2 Ar 6 Leu 11 #  W 
Trp 2 Ar 5 KFAc 9 "  M 
Trp 2 Ar 5 Ile 10 %  M 
Trp 2 Ar 5 Leu 11 %  W 
Trp 2 Ar 5 Leu 11 " W 
Trp 2 Ar 5 Leu 11 '  M 
Trp 2 % Leu 11  % S 
 
 
Table 3.3b. Peptide WKFAcCyclic: 
Ac-CRWVEVNGO(KFAc)ILQC-NH2 
    
Residue Proton Residue Proton Intensity 
Trp 3 Ar 4 Leu 12 #  W 
Trp 3 Ar 4 Leu 12 '  W 
Trp 3 Ar 7 Leu 12 #  W 
Trp 3 Ar 6 KFAc10 "  S 
Trp 3 Ar 6 KFAc10 '  S 
Trp 3 Ar 6 Leu 12 %  M 
Trp 3 Ar 6 Leu 12 #  M 
Trp 3 Ar 6 Leu 12 '  W 
Trp 3 Ar 5 KFAc 10 "  W 
Trp 3 Ar 5 KFAc 10 '  W 
Trp 3 Ar 5 Leu 12 #  M 
Trp 3 % Leu 12  % S 
Trp 3 % Leu 12 #  S 
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Trp 3 NH Arg 2 % M 
Arg 2 NH Cys 1 % M 
Gln 13 NH Leu 12 % M 
Ile 11 NH KFAc 10 % M 
 
 
 
Table 3.3c. Peptide WKFmCyclic: 
Ac-CRWVEVNGO(KFm)ILQC-NH2 
    
Residue Proton Residue Proton Intensity 
Trp 3 Ar 4 Leu 12 #  W 
Trp 3 Ar 4 Leu 12 '  W 
Trp 3 Ar 7 Leu 12 #  M 
Trp 3 Ar 6 KFm 10 "  S 
Trp 3 Ar 6 KFm 10 '  S 
Trp 3 Ar 6 Leu 12 #  M 
Trp 3 Ar 6 Leu 12 '  W 
Trp 3 Ar 6 Leu 12 "   W 
Trp 3 Ar 5 Ile 11 %  M 
Trp 3 Ar 5 Leu 12  % M 
Trp 3 Ar 5 KFm 10 "  M 
Trp 3 Ar 5 KFm 10 '  M 
Trp 3 Ar 5 Leu 12 #  M 
Trp 3 % Leu 12  % S 
Trp 3 % Leu 12 #  S 
Glu 5 % KFm 10 '   W 
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Thermodynamic Analysis  
 
Peptides were analyzed assuming a two-state system.  The equilibrium constant was 
determined from the fraction folded (f) by K = f/(1-f).  The free energy was then 
calculated from !G° = - RTlnK.  In order to determine the thermodynamic parameters, 
!H°, !S°, and !Cp°, the temperature dependence of the Gly chemical shift difference 
was fit to the following equation:
22
  
 
Fraction Folded = [exp(x/RT)]/[1 + exp(x/RT)], where  
 
x = T(&Sº298 + a ln(T/298) + b (T – 298) – (c/2) (1/T
2
 – 1/298
2
)) – (&Hº298 + a (T – 298) + 
(b/2) (T
2
 – 298
2
) – c (1/T – 1/298))]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
22 Maynard, A.J. Sharman, G. J. and Searle, M. S. J. Am. Chem. Soc. 1998, 120, 1996-
2007. 
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Table 3.4. Temperature Dependence of the Fraction Folded from Glycine Chemical Shift 
Data for the peptides in this study:  
 
WK:        WKAc:             WKFm:   
Temp (K) fraction folded Temp (K) fraction folded Temp (K) fraction folded 
276 0.806 276 0.878 277 0.872 
281 0.806 280 0.879 281 0.874 
285 0.804 285 0.879 285 0.874 
289 0.801 289 0.879 290 0.87 
294 0.793 294 0.874 294 0.865 
298 0.783 298 0.866 298 0.858 
302 0.773 303 0.856 302 0.847 
307 0.754 307 0.843 307 0.834 
311 0.734 312 0.825 311 0.816 
316 0.709 316 0.800 315 0.797 
320 0.680 321 0.772 320 0.773 
324 0.650 325 0.744 324 0.744 
329 0.615 330 0.712 328 0.713 
  334 0.672   
  339 0.633   
  343 0.595   
  348 0.552   
 
 
 
WKFAc: 
   
Temp 
(K) 
fraction 
folded 
277 0.878 
281 0.882 
285 0.881 
290 0.881 
294 0.878 
298 0.873 
302 0.863 
307 0.851 
311 0.835 
315 0.816 
320 0.794 
324 0.764 
328 0.730 
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Figure 3.14. 
1
H NMR of Peptide WKAc: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys(Ac)-Ile-Leu-Gln-NH2  
 
 
Table 3.5. Proton Chemical Shift Assignments for Peptide WKAc. 
 % " ' # $ Amide Amine 
R 4.39 1.71 1.51,1.63 3.14  8.03 7.13,6.65 
W 5.08 3.07,3.03 7.46,7.29 7.195,7.20 7.03 8.32 10.13 
V 4.44 2.02 0.88   9.08  
E 4.92 2.01,1.89 2.23   8.56  
V 4.21 1.95 0.91   8.97  
N 4.44 3.07,2.75    9.47  
G 4.09,3.71      8.64  
O 4.65 1.80 1.72 3.04  7.79 7.65 
K(Ac) 4.76 1.65 1.18 1.29 2.82 
Ac=1.76 
8.47 Sidechain 
amide= 
7.40 
I 4.59 1.88 1.42,1.19,0.89 0.89  9.18  
L 4.02 1.31 0.98,0.64 0.46,0.21   8.26  
Q 4.32 2.03,1.85 2.24   8.69  
 
 
 
 
 
 
S p i n W o r k s  2 . 2 :   W L y s A c H P
P P M
  6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 3.15. 
1
H NMR of Peptide KAc7: Ac-Asn-Gly-Orn- Lys(Ac)-Ile-Leu-Gln-NH2 
 
 
Table 3.6. Proton Chemical Shift Assignments for Peptide KAc7. 
 % " ' # $ Amide Amine 
N 4.69 2.81    8.44  
G 3.94     8.57  
O 4.37 1.70 1.70 3.01  8.13 7.68 
K(Ac) 4.27 1.74 1.36,1.30 1.51 3.15 
Ac=1.96 
8.24 Sidechain 
amide= 
7.93 
I 4.13 1.84 1.49,1.19, 
0.89 
0.89  8.24  
L 4.38 1.88 1.62,1.59 0.92,0.85  8.33  
Q 4.30 2.09,1.98  2.37   8.33  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P P M
  4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 3.16. 
1
H NMR of Peptide WKFAc: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys(TFAc)-Ile-Leu-Gln-NH2  
 
 
Table 3.7. Proton Chemical Shift Assignments for Peptide WKFAc. 
 % " ' # $ Amide Amine 
R 4.38 1.66 1.55 3.13  8.05 7.12,6.64  
W 5.09 3.06    8.29 10.15 
V 4.45 2.02 0.86   8.88  
E 4.93 1.97 2.21   8.53  
V 4.20 1.92 0.90   8.82  
N 4.44 3.08,2.75    9.37  
G 4.08,3.71      8.73  
O 4.64 1.83 1.71 3.03  7.82 7.66 
K(FAc) 4.73 1.66 1.22 1.22 2.94 
 
8.50 Sidechain 
amide= 
9.13 
I 4.57 1.87 1.19,1.00,0.87  0.87  9.10  
L 4.06 1.32 0.99,0.69 0.46,0.22   8.31  
Q 4.31 1.89 2.24   8.63  
 
 
 
P P M
  6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4    
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Figure 3.17. 
1
H NMR of Peptide KFAc7: Ac-Asn-Gly-Orn- Lys(TFAc)-Ile-Leu-Gln-
NH2 
 
Table 3.8. Proton Chemical Shift Assignments for Peptide KFAc7. 
 % " ' # $ Amide Amine 
N 4.68 2.81    8.43  
G 3.94       
O 4.35 1.80 1.73 3.02  8,17  
K(FAc) 4.28 1.71 1.38 1.62 3.31 8.24 Sidechain 
amide= 
9.25 
I 4.14 1.85 1.52,1.24, 
0.88 
0.88  8.23  
L 4.38 1.66 1.28 0.91  8.33  
Q 4.29 2.00 2.37   8.33  
 
 
 
 
 
 
 
 
 
 
 
P P M
  4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 3.18. 
1
H NMR of Peptide WKFam: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Lys(Fam)-Ile-Leu-Gln-NH2  
 
 
Table 3.9. Proton Chemical Shift Assignments for Peptide WKFAm. 
 % " ' # $ Amide Amine 
R 4.39 1.68 1.52 3.13  8.05 7.12 
W 5.09 3.06,2.75 7.46,7.29 7.20,7.19 7.03 8.31 10.15 
V 4.46 2.01 0.88   8.94  
E 4.94 1.96 2.23   8.53  
V 4.20 1.95 0.91   8.86  
N 4.45 3.08,2.76     9.36  
G 4.09,3.72      8.66  
O 4.64 1.84 1.75 3.05  7.81 7.63 
K(Fam) 4.79 1.67 1.25 1.25 2.89 
 
8.46 
aldehyde=7.72 
Sidechain 
amide= 
7.60 
I 4.59 1.88 1.47,1.22,0.88  0.88  9.07  
L 4.04 1.32 1.01,0.67 0.56,0.23  8.28  
Q 4.32 1.90 2.26   8.64  
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 3.19. 
1
H NMR of Peptide KFam7: Ac-Asn-Gly-Orn-Lys(Fam)-Ile-Leu-Gln-NH2 
 
Table 3.10. Proton Chemical Shift Assignments for Peptide KFAm7. 
 % " ' # $ Amide Amine 
N 4.67 2.80    8.43  
G 3.94     8.56  
O 4.36 1.79 1.65 3.01  8.13 7.61 
K(Fam) 4.27 1.75 1.36 1.52 3.22 8.24 
aldehyde=8.00 
Sidechain 
amide= 
7.98 
I 4.13 1.84 1.49,1.17, 
0.87 
0.87  8.24  
L 4.37 1.65 0.89 0.89  8.34  
Q 4.30 1.99 2.36   8.34  
 
 
 
 
 
 
 
 
P P M
  7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 3.20. 
1
H NMR of Peptide WKAcCyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Lys(Ac)-Ile-Leu-Gln-Cys-NH2 
 
Table 3.11. Proton Chemical Shift Assignments for Peptide WKAcCyc. 
 % " ' # $ Amide Amine 
C 5.22 2.98,2.39      
R 4.60 1.79 1.49 3.16  8.70  
W 5.12 3.03    8.59  
V 4.55 1.82 0.86   9.48  
E 4.97 2.00 2.21   8.59  
V 4.22 1.91 0.895   9.10  
N 4.39 3.09,2.75      
G 4.11,3.67       
O 4.71 1.80 1.75 3.04  7.73  
K(Ac) 4.92 1.69 1.27 1.30 2.83 
Ac=
1.72 
  
I 4.72 1.85 1.42,1.17,0.88 0.88  9.39  
L 3.89 1.29 0.75,0.36 0.06, 
-0.34 
 8.26  
Q 4.55 2.06 2.17   9.03  
C 5.04 2.90      
S p i n W o r k s  2 . 2 :   W L y s A c _ C y c l i c
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 3.21. 
1
H NMR of Peptide WKFamCyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Lys(Fam)-Ile-Leu-Gln-Cys-NH2 
 
Table 3.12. Proton Chemical Shift Assignments for Peptide WKFamCyc. 
 % " ' # $ Amide Amine 
C 5.22 2.98,2.40      
R 4.59 1.79 1.66,1.50 3.16    
W 5.13 3.05,2.91      
V 4.56 2.06 0.87   9.50  
E 4.98 2.01,1.88 2.21     
V 4.22 1.91 0.90     
N 4.39 3.09,2.75      
G 4.11,3.67       
O 4.69 1.84 1.76 3.04    
K(Fam) 4.93 1.70 1.26 1.26 2.90 Aldehyde=7.61  
I 4.72 1.87 1.42,1.18,0.89 0.89  9.41  
L 3.90 1.29 0.76,0.36 0.07, 
-0.35 
   
Q 4.56 1.82 2.16     
C 5.04 3.04,2.91      
 
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 3.22. 
1
H NMR of Peptide WKFAcCyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-Lys(TFac)-Ile-Leu-Gln-Cys-NH2 
 
 
Table 3.13. Proton Chemical Shift Assignments for Peptide WKFacCyc. 
 % " ' # $ Amide Amine 
C 5.21 2.97,2.38      
R 4.59 1.79 1.48,1.64 3.16    
W 5.12 3.04,2.99      
V 4.54 2.03 0.86   9.43  
E 5.01 1.99 2.18     
V 4.21 1.90 0.89     
N 4.39 3.10,2.74      
G 4.11,3.66       
O 4.68 1.83 1.77 3.04    
K(TFAc) 4.93 1.70 1.25 1.25 2.95   
I 4.68 1.86 1.41,1.16,0.88 0.88  9.43  
L 3.92 1.30 0.75,0.35 0.11, 
-0.35 
   
Q 4.54 1.81 2.16     
C 5.04 3.02,2.91      
 
P P M
  8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 3.23. 
1
H NMR of Peptide VKAc: 
 
 
 
Figure 3.24. 
1
H NMR of Peptide VKAcCyc: 
 
 
 
 
 
 
 
 
 
P P M
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Figure 3.25. 
1
H NMR of Peptide VKFac: 
 
 
 
Figure 3.26. 
1
H NMR of Peptide VKFacCyc: 
 
 
P P M
  4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
P P M
  4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
CHAPTER IV 
ALKYL-! INTERACTIONS 
(Reproduced, in part, with permission from Hughes, R.M.; Wiggins, Kimberly R.; 
Khorasanizadeh, Sepideh; Waters, M. L. submitted for publication.) 
 
A. Tert-butyl norleucine and an alkyl-!  interaction. 
i. Background and significance. 
With rapid advancements in genomics, epigenetics has become the next major 
challenge in understanding how genetic information is controlled.
1
  It is becoming clear 
that post-translational modifications of proteins are a key component in controlling gene 
expression.  These modifications include a number of subtle structural changes, including 
Lys and Arg methylation, Lys acylation, and Ser/Thr/Tyr phosphorylation, which act as 
chemical switches to induce or repress protein-protein interactions. Among all histone 
modifications, lysine methylation is especially important for chromatin function due to its 
stability and direct contribution to heritable patterns of gene expression.
2
 To understand 
how such modest structural modifications can control biomolecular recognition events, it 
is critical to understand the underlying noncovalent interactions involved. 
                                                
1
 Khorasanizadeh, S. CELL 116, 259-272. 
 
2
 Martin, C.; Zhang, Y. Nat Rev Mol Cell Biol 2005, 6, 838-49. 
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Methylation of Lys induces a protein-protein interaction through the binding of methyl 
lysine (KMen, n = 1-3) in an aromatic cage.  This interaction was first described for the 
binding of methylated Histone 3 (H3) tail to the HP1 chromodomain (Figure 4.1).3,4  HP1 
and methylated H3 interact specifically whether lysine 9 is mono, di or trimethylated.  
However, the binding is most effective when methyllysine is trimethylated.5  In addition, 
more recent findings have shown that phosphorylation of serine 10 prevents interaction of 
HP1 with methylated H3.6 Therefore, a binary switch mechanism has been proposed for 
the recognition of methllysine containing peptides by chromodomains.  Interestingly, 
binding of a methylated lysine in an aromatic cage is not exclusive to chromodomains.  
PHD fingers and Tudor domains also assemble three aromatic residues around 
methyllysine of the H3 tail.7,8 
Recognition of methylated lysine by an aromatic cage appears to be mediated by 
cation-! interactions between the methylated ammonium group and the side chains of 
three aromatic residues.  The cation-! interaction is defined by the attractive interaction 
between a positively charged moiety (simple cations, ammonium groups, etc.) and the 
                                                
3 Jacobs, S. A.; Khorasanizadeh, S. Science 2002, 295, 2080-2083. 
 
4 Nielsen, P. R.; Nietlispach, D.; Mott, H. R.; Callaghan, J.; Bannister, A.; Kouzarides, 
T.; Murzin, A. G.; Murzina, N. V.; Laue, E. D. Nature 2002, 416, 103-7. 
 
5 Fischle, W.; Wang, Y. M.; Jacobs, S. A.; Kim, Y. C.; Allis, C. D.; Khorasanizadeh, S. 
Genes & Development 2003, 17, 1870-1881. 
 
6 Eissenberg, J. C.; Elgin, S. C. R. Nature 2005, 438, 1090-1091. 
 
7 Mellor, J. Cell 2006, 126, 22-4. 
 
8 Sims, R. J., III; Reinberg, D. Genes Dev 2006, 20, 2779-86. 
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quadrupole moment of an aromatic ring.9 The magnitude of the cation-! interaction in 
proteins is dependent on a number of factors, including the electronic density of the 
aromatic ring (Phe vs Trp, for example), the distribution of positive charge across the 
cationic moiety, and the degree of solvent exposure of the interaction, as well as the 
contribution of other forces, such as van der Waals interactions and the hydrophobic 
effect.9 Numerous examples of functional cation-! interactions exist in structural biology, 
and they have been demonstrated to be important to protein structure and stability and the 
functioning of enzymes and ion-channels.9 
Due to the potential importance of cation-! interactions in the recognition of the post-
translationally modified amino acids KMen (n = 1-3) and the still growing body of 
theoretical and experimental knowledge concerning the various energetic components of 
the interaction, a number of questions remain that need to be addressed experimentally 
regarding the interplay between electrostatics, van der Waals interactions, and the 
hydrophobic effect.10,11,12,13,14,15,16 Moreover, in the context of chromodomain, it is not 
                                                
9 Ma, J. C.; Dougherty, D. A. Chemical Reviews 1997, 97, 1303-1324. 
 
10 Eriksson, M. A. L.; Morgantini, P. Y.; Kollman, P. A. J. Phys. Chem. B 1999, 103, 
4474-4480. 
 
11 Hunter, C. A.; Low, C. M. R.; Rotger, C.; Vinter, J. G.; Zonta, C. Proc. Nat. Acad. Sci. 
USA 2002, 99, 4873-4876. 
 
12 Mo, Y. R.; Subramanian, G.; Gao, J. L.; Ferguson, D. M. J. Am. Chem. Soc. 2002, 124, 
4832-4837. 
 
13 Ruan, C. H.; Rodgers, M. T. J. Am. Chem. Soc. 2004, 126, 14600-14610. 
 
14 Costanzo, F.; Della Valle, R. G.; Barone, V. J. Phys. Chem. B 2005, 109, 23016-23023. 
 
15 Reddy, A. S.; Sastry, G. N. J. Phys. Chem. A 2005, 109, 8893-8903. 
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clear to what degree a charge-quadrupole interaction imbues specificity to a biologically 
significant ligand-receptor interaction or if the interaction is primarily due to hydrophobic 
and/or van der Waals interactions between the methyl groups and the aromatic pocket.  
To this end, we have synthesized the neutral analog of KMe3, tert-butyl norleucine 
(tBuNle; 2-amino-7,7-dimethyloctanoic acid), and investigated its interaction with Trp in 
a "-hairpin model system and then compared these results to in vitro binding assays with 
the HP1 chromodomain.  This hairpin model system has been previously used to 
investigate the cation-! interaction between KMe3 and Trp.17 In this model system, we 
find striking contrasts between the behaviour of the two sidechains with Trp that provide 
insight into the role of hydrophobicity and the importance of the charge-quadrupole 
component of the Trp-KMe3 interaction. Furthermore, in vitro binding studies of the 
neutral tBuNle analog of the H3 tail peptide demonstrate that the positive charge is 
required to give a selective, high affinity interaction between the histone tail and the HP1 
chromodomain protein. 
 
                                                                                                                                            
16 Xu, Y. C.; Shen, J. H.; Zhu, W. L.; Luo, X. M.; Chen, K. X.; Jiang, H. L. J. Phys. 
Chem. B 2005, 109, 5945-5949. 
 
17 Hughes, R. M.; Waters, M. L. J. Am. Chem. Soc. 2005, 127, 6518 - 6519. 
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Figure 4.1. A) crystal structure of the HP1 chromodomain (yellow surface) in complex 
with lysine 9-trimethylated histone H3 tail residues 5 through 10 (grey stick). B) 
Aromatic cage (green) formed by two tryrosines and one tryptophan captures the 
methyllysine (grey). 
ii. Results and Discussion. 
In our previous study of peptides WK and WKMe3 (Figure 4.2), we found that 
methylation of Lys enhanced its interaction with Trp significantly, but that the driving 
force became more hydrophobic in nature, and the enthalpic component, attributed to the 
charge-quadrupole interaction, decreased relative to unmodified Lys.17 This leads to the 
question as to whether the positive charge is indeed necessary for interaction with an 
aromatic residue or an aromatic pocket in aqueous solution, or whether hydrophobic and 
van der Waals interactions alone will suffice.  We chose to investigate the interaction of 
Trp with tBuNle because the size and shape of KMe3 and tBuNle are virtually identical 
(see Figure 4.3), as are the polarizabilities (11.3 vs 12.0 Å3) (see Experimental Section), 
but the charge, and hence ability to participate in a cation-! interaction, differs 
significantly.  Hence, if hydrophobicity and van der Waals interactions are the primary 
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driving force for interaction with Trp, the two sidechains should interact in the same 
manner with Trp, but not if the charge-quadrupole component is important.   
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Figure 4.2. "-Hairpin peptide containing KMe3 or tBuNle.  Peptides are referred to by 
the residues at positions 2 (Trp) and 9 (X) in the text. 
A   B  
Figure 4.3.  Electrostatic potential maps of the (a) KMe3 sidechain and (b) tBuNle 
sidechain. Electrostatic potential maps were generated with MacSpartan: HF/6-31g*; 
Isodensity value = 0.02; range = -75 (red, electron rich) to +125 kcal/mol (blue, electron 
poor). 
The unnatural amino acid, tBuNle, was synthesized from pseudo-ephedrine 
glycinamide and 1-bromo-5,5-dimethylhexane1, 2,18 via the method of Myers, et al.19 and 
incorporated into the peptide via standard solid phase peptide synthesis to give the 
                                                
18 Rybczynski, P. J.; Zeck, R. E.; Dudash, J., Jr.; Combs, D. W.; Burris, T. P.; Yang, M.; 
Osborne, M. C.; Chen, X.; Demarest, K. T. J. Med. Chem. 2004, 47, 196-209. 
 
19 Myers, A. G.; Schnider, P.; Kwon, S.; Kung, D. W. J. Org. Chem. 1999, 64, 3322-
3327. 
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peptide WtBuNle (see Experimental Section).  The sidechain-sidechain interaction, as 
well as its impact on hairpin stability, was investigated by NMR and compared to 
WKMe3.  The interaction between residue 9 (X) and Trp can be characterized by the 
extent of upfield shifting of the X sidechain (Figure 4.4).  Greater upfield shifting 
indicates closer proximity to the face of the Trp indole ring.  We have previously shown 
that KMe3 exhibits enhanced interaction with Trp relative to the unmethylated Lys, 
particularly at the #-CH2 and the methyl positions (Figure 4.4a).  Surprisingly, tBuNle 
exhibits little upfield shifting; the #-CH2 and methyl groups are less shifted even than 
unmodified Lys.  This indicates that tBuNle has no preference for interaction with the 
face of Trp, despite its large hydrophobic surface area. This clearly demonstrates the 
importance of the electrostatic component of the cation-! interaction. Without 
polarization of the methyl groups, there is no specific interaction between the sidechain 
and the aromatic ring. This is similar to the preference observed for binding of a 
trimethylammonium group with Dougherty’s cyclic aromatic host relative to a tert-butyl 
group in an early study of cation$! interactions in water.20 Despite this lack of interaction 
between Trp and tBuNle, WtBuNle is as well folded as WKMe3, as determined from the 
similarity of the downfield shifting of the H% protons of the two peptides relative to 
random coil values (Figure 4.4b). Quantification of the fraction folded indicates that 
WtBuNle is a very well folded hairpin (96±1% based on Gly splitting; 90±7% based on 
H% chemical shifts), as is WKMe3 (93±1% based on Gly splitting; 91±15% based on H% 
                                                
20 Petti, M. A.; Shepodd, T. J.; Barrans, J. R. E.; Dougherty, D. A. J. Am. Chem. Soc. 
1998, 110, 6825 - 6840. 
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chemical shifts).21 This indicates that the tBuNle provides stability to the hairpin through 
means other than specific interaction with the face of the indole ring of Trp.  This is 
likely due to non-specific hydrophobic interactions between tBuNle and other sites on the 
face of the "-hairpin. 
A  
B  
Figure 4.4.  (A) tBuNle and KMe3 sidechain upfield shifts relative to random coil 
values. (B) H% shifts relative to random coil values. Glycine shifts reflect the splitting.  
                                                
21 Maynard, A. J.; Sharman, G. J.; Searle, M. S. J. Am. Chem. Soc. 1998, 120, 1996-2007. 
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Double mutant cycles were performed in which the interacting residues at positions 2 
and 9 were mutated to non-interacting residues Ser and Val to determine the magnitude 
of the isolated sidechain-sidechain interaction.3-5,22  These experiments give a value of -
1.0 (± 0.1) kcal/mol for the Trp-KMe3 interaction and a value of -0.6 (± 0.1) kcal/mol for 
the Trp-tBuNle interaction. This data demonstrates the larger magnitude of the cation-! 
interaction versus the alkyl-Trp interaction and provides an approximation of the 
magnitude of the simple hydrophobic interaction between the alkyl sidechain and the 
aromatic ring.  This value can be compared to the interaction energy of –0.3 kcal/mol for 
Trp with Nle.22 
Both WKMe3 and WtBuNle exhibit high thermal stability, as determined by NMR 
(Figure 4.5). Fitting of the thermal denaturation data with a modified Van’t Hoff 
equation23,24 reveals that WKMe3 exhibits a favorable entropy of folding and a slightly 
unfavorable enthalpy of folding, indicative of multiple sites of favorable interaction with 
the Trp ring and a favorable hydrophobic component to folding (Table 4.1).  By 
comparison, the WtBuNle shows an extremely favorable folding entropy and a 
significantly unfavorable enthalpy of folding, as well as a larger &Cp value. The 
considerable increase in folding entropy upon going from the trimethyl Lys to the tbutyl 
sidechain, and the corresponding decrease in enthalpic favorability, is consistent with a 
greater hydrophobic driving force for folding of WtBuNle as well as elimination of the 
favorable electrostatic interaction between Trp and KMe3.  Comparison of the 
                                                
22 Tatko, C. D.; Waters, M. L. J. Am. Chem. Soc. 2004, 126, 2028-2034. 
 
23 Griffith-Jones, S. R.; Maynard, A. J.; Searle, M. S. J. Mol. Biol. 1999, 292, 1051-1069. 
 
24 Hughes, R. M.; Waters, M. L. J. Am. Chem. Soc. 2006, 128, 12735-42. 
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thermodynamic parameters for WKMe3, WtBuNle, and WK indicates that the attraction 
between KMe3 and Trp has a significant hydrophobic component, but the specificity of 
the interaction is not due to a simple hydrophobic effect, as is the case for WtBuNle. 
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Figure 4.5. Thermal denaturation profiles of WKMe3, and WtBuNle peptides as 
determined by NMR. The fraction folded was determined from the Gly splitting. Error is 
±0.5 K in temperature and ±1% in fraction folded. Conditions: 50 mM NaOAc-d4 buffer, 
pD 4.0 (uncorrected). 
Table 4.1. Thermodynamic Parametersa for WKMe3 and WtBuNle at 298 K2 
Peptide &H° 
(kcal/mol) 
&S° 
(cal/mol K) 
&Cp° 
(cal/mol K) 
WK -2.6 (0.1) -6.2 (0.2) -182 (27) 
WKMe3L -0.1 (0.1) +4.5 (0.3) -243 (36) 
WtBuNle +2.0 (0.4) +12.9 (1.4) -330 (50) 
(a) Determined from the temperature dependence of the Gly chemical shift from 0 to 80 
°C. Units are: &H°: kcal/mol; &S°: cal/mol K; &Cp°: cal/mol K. Errors (in parentheses) 
are determined from the fit. Error for &Cp° values estimated at 15%. 
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Although there is no specific interaction between tBuNle and Trp in our "-hairpin 
model system, it was not clear that the same effect would be observed in the binding of 
the Histone 3 peptide to the HP1 chromodomain: the aromatic pocket made up of a Trp, 
and two Tyr residues is designed to perfectly accommodate a group with the same size 
and shape as either a trimethylammonium or a tert-butyl group (Figure 4.1B).  Given the 
hydrophobicity of the tBuNle sidehain and the similar polarizability of tBuNle and 
KMe3, as well as the exposure of the aromatic pocket to solvent on the surface of the 
protein, it seemed likely that a mutant Histone 3 peptide containing the tBuNle sidechain 
at position 9 would bind to chromodomain as strongly as the Histone peptide containing 
KMe3, despite the lack of a positive charge.  Hence, we synthesized the modified H3 
peptide (NH2-ARTKQTAR(tBuNle)STGGKAY-COOH; H3-tBuNle9), and compared it 
to the native sequence containing KMe3 (NH2-ARTKQTAR(KMe3)STGGKAY-COOH; 
H3-K9Me3) as a positive control, the partially methylated variants KMe2 (NH2-
ARTKQTAR(KMe2)STGGKAY-COOH; H3-K9Me2) and KMe (NH2-
ARTKQTAR(KMe)STGGKAY-COOH; H3-K9Me), as well as Lys (NH2-
ARTKQTARKSTGGKAY-COOH; H3-K9) as a negative control. Specific binding  was 
found for the trimethylated peptide, with a Kd of 10 uM, with concomitantly weaker 
binding for H3-K9Me2 and H3-K9Me, and virtually no binding for H3-K9 (Figure 4.6).  
We then tested the binding of the neutral analog, H3-tBuNle9, and found it is nearly as 
poor as the unmethylated peptide H3-K9 for binding to the HP1 chromodomain (Figure 
4.6).  This observation was surprising given the similarity in size and shape, as well as 
the greater hydrophobicity of the tert-butyl group relative to the trimethylammonium 
group of KMe3. Indeed, H3-K9Me and H3-K9Me2 bind more strongly than does H3-
 179 
tBuNle9, despite the fact that they do not fill the binding pocket of HP1 chromodomain.5  
This clearly demonstrates the essential nature of the cation-! component to binding of the 
lysine-methylated H3 tail to chromodomains.   
 
 
Figure 4.6.  Binding of H3-K9Me3, H3-K9Me2, H3-K9Me, H3-tBuNle9, and H3-K9 
to the HP1 chromodomain as determined by fluorescence polarization assay.  Drosophila 
HP1 chromodomain was purified and used in binding studies with fluoresceinated 
peptides as previously described.5 Binding assays were performed at 15 degree celcius in 
phosphate buffer pH 7.5 and containing 25 mM NaCl and 1 mM DTT.  
iii. Conclusions 
In conclusion, this study provides substantial insight into why lysine methylation is 
successful in making critical interactions that are required for controlling gene 
expression.  We have demonstrated the essential nature of the cation-! component to the 
interaction of the H3 peptide tail and the HP1 chromodomain. This data enhances our 
fundamental understanding of how the methylation of lysine functions cooperatively 
within the broad spectrum of post-translational modifications. For example, the cation-! 
component for docking of a chromodomain on a lysine-methylated histone tail is 
especially useful for controlling epigenetic signaling via a phosphorylation switch. 
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Recent studied have shown that phosphorylation of the residue adjacent to the 
methyllysine reduces the affinity of the chromodomain for the histone tail by 100-fold 
and effectively blocks recognition of the methyllysine signal.25,26  Therefore, the presence 
of a phosphate group immediately adjacent to the methyllysine dramatically reduces the 
stability of the cation-! bond between the methyllysine and the aromatic cage.  Among 
well-known post-translational modifications that contribute to biomolecular signaling, 
lysine methylation of histone tails is a stable modification during the cell cycle which is 
inherited during cell division.2 Although recent studies have identified bona fide 
nucleosome-specific lysine-demethylases, it appears these contribute to the resetting of a 
fraction of methyllysine signals by mechanisms that are poorly understood.   Therefore, 
the reversible phosphorylation of the residue adjacent to the methyllysine is a novel 
biomolecular feature for on-off switching of the lysine methylation signal.  
Phosphorylation blocks the docking of proteins to methyllysines, thus chromatin can 
undergo maximal compaction in preparation of the metaphase chromosomes.26,27  
Subsequent events that reverse the phosphorylation allow reestablishing functional 
chromatin boundaries by recruiting specific methyllysine-docking factors.  This is 
consistent with a histone code that suggests distinct histone modifications act sequentially 
or in combination to bring about important events for eukaryotic gene regulation.28  
                                                
25 Fischle, W.; Tseng, B. S.; Dormann, H. L.; Ueberheide, B. M.; Garcia, B. A.; 
Shabanowitz, J.; Hunt, D. F.; Funabiki, H.; Allis, C. D. Nature 2005, 438, 1116-22. 
 
26 Flanagan, J. F.; Mi, L. Z.; Chruszcz, M.; Cymborowski, M.; Clines, K. L.; Kim, Y. C.; 
Minor, W.; Rastinejad, F.; Khorasanizadeh, S. Nature 2005, 438, 1181-1185. 
 
27 Hirota, T.; Lipp, J. J.; Toh, B. H.; Peters, J. M. Nature 2005, 438, 1176-1180. 
 
28 Strahl, B. D.; Allis, C. D. Nature 2000, 403, 41-45. 
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Additionally, these results recall prescient studies by Dougherty and co-workers, who 
showed binding discrimination between interaction of an aromatic host with a trimethyl 
ammonium group and a tert-butyl group in a small molecule model system in borate 
buffer.20 Likewise, the data from our "-hairpin model system predicts the in vitro 
behaviour of the H3 peptide-chromodomain binding. Valuable mechanistic information is 
readily obtained from the model system which is not directly available from the protein-
peptide interaction, giving a fuller understanding of the forces underlying the preference 
for KMe3 recognition and firmly establishing the importance of the charge-quadropole 
interaction to binding and specificity.  Finally, this study provides insight into the subtle 
features of noncovalent interactions that contribute to biomolecular recognition, and 
indicates that the simple separation of interactions into polar and hydrophobic can be too 
simplistic to fully understand or control biomolecular recognition. 
 
B. Trifluoro homonorleucine and an alkyl-! interaction. 
i. Background and significance. 
Halogenation is commonly carried out in the pharmaceutical industry in order to 
enhance the binding affinities and/or metabolic activities of various drug candidate 
molecules. Fluorination, chlorination, and bromination are commonly used to enhance 
the hydrophobicity of compounds, which is thought to increase their affinity for binding 
sites, without adding a great deal of steric bulk to the molecule.29 However, there are a 
number of non-covalent interactions involving the halogens that may not be fully 
                                                                                                                                            
 
29 Bohm, H. J.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Muller, K.; Obst-Sander, 
U.; Stahl, M.; Chembiochem 2004, 5, (5), 637-643. 
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appreciated by the pharmaceutical industry, leading to unanticipated interactions with 
halogenated drugs in protein binding sites. These interactions include fluorine—carbonyl 
interactions (orthogonal multipolar interactions) that are moderately favorable in solution 
that have been shown to exist in protein crystal structures and quantified using model 
systems.30 Additionally, iodination of aromatic rings has been shown to enhance the 
magnitude of aromatic-aromatic interaction within a designed "-hairpin peptide via direct 
halogen-! interaction.31 Within the context of our "-hairpin model system, we have 
investigated the effects of fluorination of an alkyl sidechain on its interaction with the 
aromatic amino acid tryptophan (Trp). Our results indicate that, in the proximity of 
aromatic residues, repulsive electronic effects due to a fluorine-! interaction can 
counterbalance increases in hydrophobicity due to fluorination, leading to lower 
interaction energies with Trp. These results indicate that while the fluorination of 
medicinal compounds may increase their hydrophobicity, the drug target site must be 
well defined in order to achieve the anticipated enhancement in binding affinity.  
 
 
                                                
30 (a) Schweizer, E.; Hoffmann-Roder, A.; Olsen, J. A.; Seiler, P.; Obst-Sander, U.; 
Wagner, B.; Kansy, M.; Banner, D. W.; Diederich, F. Organic & Biomolecular 
Chemistry 2006, 4, (12), 2364-2375. (b) Hof, F.; Scofield, D. M.; Schweizer, W. B.; 
Diederich, F. Angew. Chem. Int. Ed. 2004, 43, (38), 5056-5059. (c) Olsen, J.; Seiler, P.; 
Wagner, B.; Fischer, H.; Tschopp, T.; Obst-Sander, U.; Banner, D. W.; Kansy, M.; 
Muller, K.; Diederich, F. Organic & Biomolecular Chemistry 2004, 2, (9), 1339-1352. 
(d) Olsen, J. A.; Banner, D. W.; Seiler, P.; Wagner, B.; Tschopp, T.; Obst-Sander, U.; 
Kansy, M.; Muller, K.; Diederich, F. Chembiochem 2004, 5, (5), 666-675. (e) Olsen, J. 
A.; Banner, D. W.; Seiler, P.; Sander, U. O.; D'Arcy, A.; Stihle, M.; Muller, K.; 
Diederich, F. Angew. Chem. Int. Ed. 2003, 42, (22), 2507-2511. 
 
31 Tatko, C. D.; Waters, M. L. Organic Letters 2004, 6, (22), 3969-3972. 
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ii. Design and Synthesis. 
The peptides investigated in this study (Figure 4.7) were designed, synthesized, 
and characterized using methods previously discussed in this chapter. The sidechain tert-
Butyl Norleucine (tBuNle) should make a useful comparison to tFhNle due to its 
identical length and anticipated similarity in hydrophobicity. Calculated LogP values, or 
the partition coefficient between octanol and water, suggest that the hydrophobicities of 
the two sidechains are similar (Figure 4.8).  
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Figure 4.7. (a) "-hairpin peptide containing tFhNle or tBuNle.  Peptides are referred to 
by the residues at positions 2 (Trp) and 9 (X) in the text. 
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a)  b)   c)  
 
Figure 4.8. Calculated logP values for sidechains of a) tFhNle and b) tBuNle. c) Pentane 
is shown for comparison (MacSpartan 2004: HF/6-31g**; Ghose-Crippen method). 
  
iii. Results and Discussion. 
The peptides WtFhNle and WtBuNle are both well folded "-hairpins with similar 
stabilities, as demonstrated by H% chemical shifts (Figure 4.8a).  Fraction folded based on 
the Gly splitting gives a population of 92% for WtFhNle and 96% for WtBuNle. 
Presumably, based on the discussion of tBuNle undertaken earlier in this chapter, both 
hairpins are stabilized by significant non-specific, hydrophobic interactions, particularly 
in regard to their interactions with Trp. Comparison of the upfield shifts of the tFhNle 
and tBuNle sidechains, however, begins to paint more subtle picture of the interactions 
that are stabilizing the hydrophobic cluster of the "-hairpin (Figure 4.9). While the 
terminal portions of the tBuNle sidechain are most upfield shifted, indicating that they are 
interaction more with the face of the Trp ring than the rest of the sidechain, the tFhNle 
ligand is most upfield shifted at the ' position, and even slightly downfield shifted, 
relative to random coil, at the # postion. This is a significant effect given the identical 
length and similarly patterned functionality of the two ligands. The proposed difference 
in the two interactions is due to the electron density around the electronegative fluorines 
logP= 
2.88 
logP= 
3.80 
logP= 
2.58 
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at the termini of the tFhNle sidechain. These fluorines do not interact favorably with the 
similarly electron-rich face of the Trp ring. In contrast, the tBuNle ligand can interact 
with the face of the ring via van der Waals interactions, particularly at its bulky termini, 
where hydrophobic and van der Waals forces combine make it the most favorable site of 
interaction with the ring. Data taken from double mutant cycles supports this idea, giving 
interaction energies of -0.42 kcal/mol for the tFhNle-Trp interaction and -0.58 kcal/mol 
for the tBuNle-Trp interaction.  This is consistent with the upfield shifting profiles, which 
indicate more contact (on average) for the tBuNle sidechain with the Trp ring. 
 
  
Figure 4.9. (a) H% chemical shifts for WtBuNle and WtFhNle. (b) Upfield shifts of 
tBuNle and tFhNle sidechains.  
 Another valuable comparison is to work discussed earlier in this thesis (Chapter 
3), concerning the interaction of a variety of acylated Lys residues with Trp. The 
interaction of trifluoroacetylated lysine (FAc) with Trp gives a very similar upfield 
shifting profile to that of tFhNle, in that fluorination moves the bulk of the upfield 
shifting away from the amide NH, supporting the general notion of the repulsive effect of 
fluorination in proximity to aromatic rings (Figure 4.10).  
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Figure 4.10. (a) Upfield shifts of sidechains tBuNle and tFhNle. (b) Diagram of  amino 
acid sidechains tFhNle and Fac. 
 Thermodynamic analysis of WtBuNle and WtFhNle by NMR indicates that both 
have a significant entropic driving force for folding (Figure 4.11; Table 4.2). This is 
expected, given the generally non-specific, hydrophobic nature of both interactions. 
However, the entropic component of folding for WtbutylNle is much greater than that of 
WtFhNle, as is the heat capacity, indicative of a stronger hydrophobic clustering in the 
peptide. 
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 Figure 4.11. Thermal denaturation profiles of WtFhNle, and WtBuNle peptides by 
NMR. The fraction folded was determined from the Gly splitting. Error is ±0.5 K in 
temperature and ±1% in fraction folded. Conditions: 50 mM NaOAc-d4 buffer, pD 4.0 
(uncorrected). 
Table 4.2. Thermodynamic Parametersa for WtFhNle and WtbutylNle at 298 K10 
Peptide &H° 
(kcal/mol) 
&S° 
(cal/mol K) 
&Cp° 
(cal/mol K) 
WtFhNle -0.8 (0.1) +2.1 (0.5) -246 (37) 
WtBuNle +2.0 (0.4) +12.9 (1.4) -334 (50) 
[a] Determined from the temperature dependence of the Gly chemical shift from 0 to 80 
°C. Units are: &H°: kcal/mol; &S°: cal/mol K; &Cp°: cal/mol K. Errors (in parentheses) 
are determined from the fit. Error for &Cp° values estimated at 15%. 
iv.  Conclusion 
In conclusion, the comparison of the interactions of two hydrophobic amino acid 
sidechains with Trp indicates that the two have surprisingly different modes of interaction 
with the aromatic ring. While both sidechains create highly stable "-hairpin peptides, 
there are distinct differences in sidechain upfield shifting profiles and folding 
thermodynamics that show the effects of “hydrophobic” fluorines are more complex than 
generally anticipated. Specifically, a fluorinated group can control interaction geometry 
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through repulsive interactions with electron rich groups such as aromatic rings. Thus, the 
role of fluorination is more complex than simply increasing hydrophobicity. This finding 
has implications for drug design and molecular recognition in general, as this data 
indicates that fluorination could be used to orient ligands within binding pockets via 
either attractive (multipolar & hydrophobic) or repulsive (F-!) interactions.  
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C. Experimental Section 
 
i. Small molecule synthesis 
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Scheme 4.1. Synthesis of Fmoc-L-tButylNle-OH 
 
Synthesis of 1,1-dimethyl hexane trimethylsilyl ether 1 (Scheme 4.1).32 0.030 g CuCN 
was added to a dry 3-neck flask fitted with a reflux condenser under argon. 25 mL of 1M 
t-butyl MgCl in THF was added via syringe, followed by the slow addition (dropwise; 12 
minutes) of trimethyl chlorosilane (3.10 mL). Reaction was refluxed for 2 hours. After 
cooling to room temperature, 5 mL of water was carefully added to the reaction, and the 
resulting mixture was filtered through a Buchner funnel. The resulting filtrate was dried 
with sodium sulfate and the solvent was removed in vacuo. The resulting oil was 
chromatographed on silica gel (1:1 Hexanes:EtOAc), giving 3.37 g of a light yellow oil 
(16.7 mmol; 67% yield). ESI-MS: calculated = 202.18; actual = 202.2 NMR (600 
                                                
32 Shirahata, A. Tet. Lett. 1989, 30, 6393 – 6394. 
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MHz,CDCl3): 3.575 (t, 2H), 1.482 (q, 2H), 1.263 (m, 2H), 1.142 (m, 2H), 0.824 (s, 9H), 
0.013 (s, 9H). 
Synthesis of 1-bromo, 5,5-dimethyl hexane 2 (Scheme 4.1).33 Product 1 was 
dissolved in methanolic citric acid (1g citric acid in 20 mL methanol) and allowed to stir 
for 30 minutes at room temperature. The solvent was removed in vacuo and the resulting 
oil was taken up into EtOAc and washed with water (2 X 25 mL). The organic layer was 
then dried with sodium sulfate and the solvent removed in vacuo. The resulting oil was 
then taken up in 25 mL 48% HBr and allowed to reflux for 3 hours. The resulting 
solution was cooled to room temperature and extracted with 1:1 CH2Cl2:Et2O (2 X 25 
mL). The organic layer was combined and washed with NaHCO3 (2 X 25 mL) and brine 
(1 X 25 mL), dried with sodium sulfate, and the solvent removed in vacuo. Resulting oil 
was purifined via silica gel flash chromatography (4:1 EtOAc:Hexanes), giving 2.98 g of 
a slightly yellow oil (15.4 mmol, 92% yield). APCI-MS: calculated = 192.1; actual = 
192.2 NMR (400 MHz,CDCl3): 3.565 (t, 2H), 1.974 (m, 2H), 1.337 (m, 2H), 1.024 (s, 
9H). 
Synthesis of (R,R)-(-)-pseudoephedrine glycinamide hydrate 3 (Scheme 4.1). 
A 250 mL round bottom flask is charged with (R,R)-(-)pseudoephedrine (10 g; 60.5 
mmol) and glycine methyl ester (9.88g; 78.7 mmol) in 50 mL THF, followed by 15 
minutes of stirring at room temperature under argon. Lithium tert-butoxide powder 
(6.78g; 84.7 mmol) was added in one portion. The reaction was then stirred for 2 hours, 
followed by the addition of water (75 mL), and the resulting mixture was concentrated in 
vacuo. The resulting oil is taken up in hot THF (50 mL) and water (2 mL) was added to 
                                                
33 Rybczynski, P. J., et al. J. Med Chem. 2004, 47, 196 – 209. 
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the hot solution. Crystallization occurred upon cooling to room temperature. Allowed 
solution to sit at -20 deg C overnight. Crystals collected by filtration and dried after 
washing with diethyl ether. After leaving under vacuum overnight, the white crystalline 
powder weighed 9.66 g (40.4 mmol; 67% yield). ESI-MS: calculated = 239; actual = 
239.1 Spectroscopic data matched published data. NMR (400 MHz,CDCl3): 7.27-7.38 
(m, 5H), 4.50-4.60 (m, 1.5H), 3.81 (m, 0.5H), 3.681 (d, 0.5H), 3.388 (d, 1H), 3.313 (d, 
0.5H), 2.934 (s, 1.5H), 2.774 (s, 1.5H), 2.420 (s(br), 3H), 1.029 (d, 1.5H), 0.951 (d, 
1.5H).  
Alkylation of (R,R)-(-)-pseudoephedrine glycinamide hydrate 3 (Scheme 4.1). An 
oven dried 3-neck round bottom flask was charged with dry LiCl (0.606g; 14.4 mmol) 
and allowed to cool to room temperature under vacuum. The flask was then flushed with 
argon, and THF was added (20 mL). The resulting suspension was allowed to stir for 20 
minutes at room temperature. Solid PSE glycinamide 3 (0.862 g; 3.6 mmol) was then 
added in one portion, and the solution immersed in an isopropanol bath maintained at 0 
deg C with a Neslab Cryotrol cold finger and allowed to stir for 30 minutes. Next, 
LiHMDS is added via dry syringe dropwise (14 mL of a 1M solution in THF), followed 
by 20 minutes of stirring. Finally, product 2 (0.802 g; 4.2 mmol) is added slowly over 10 
minutes via syringe to the enolate solution. The reaction mixture was then allowed to stir 
for 23 hours at 0 deg C. The reaction was quenched with the addition of 10 mL H2O and 
acidified to near pH 0 with 6M HCl. The resulting acidic solution was extracted with 
ethyl acetate (3 X 50 mL), dried with sodium sulfate, and rotovapped to dryness. The 
resulting oil was then purified via silica gel flash chromatography via gradient elution 
(column washed with 100 mL CH2Cl2, followed by washes of 20:1 CH2Cl2:MeOH (400 
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mL), 10:1 CH2Cl2:MeOH (220 mL), and 5:1 CH2Cl2:MeOH (200 mL). (Yield: 0.770g, 
2.3 mmol, 64% yield). NMR (600 MHz, CDCl3): 8.194, (br, 2H), 7.24-7.41 (m, 5H), 
4.909 (s, 1H), 4.473 (d, 1H), 4.270 (t, 1H), 2.868 (s, 3H), 2.799 (br, 3H), 1.765 (m, 2H), 
1.04-1.35 (m, 6H), 0.811 (s, 9H). ESI-MS: calculated = 334.26 actual = 334.3. 
Synthesis of Fmoc-L-tbutylNle-OH 6 (Scheme 4.1). Product 5 was taken up in 4.6 mL 
of 1N NaOH and 20 mL of H2O. The resulting mixture was refluxed for 5.5 hours, 
allowed to cool to room temperature, and filtered through a Buchner funnel. The filtered 
solution was washed with ethyl acetate (1 X 25 mL), frozen, and lyophilized to dryness. 
The resulting oil was dissolved in 25 mL of H2O with stirring. 0.387 g of sodium 
bicarbonate was added, followed by 25 mL of dioxane. The resulting solution was cooled 
in an ice bath for 30 minutes. Fmoc-OSu (0.935 g; 2.8 mmol) was dissolved in 10 mL 
dioxane and added to the chilled solution dropwise via pipette. The reaction was stirred 
for 1 hour at ice temperature and 3 hours at room temperature. Reaction followed by TLC 
(10:1 CH2Cl2: MeOH). Water was then added (30 mL) and the resulting solution was 
extracted with 75 mL 1:1 EtOAc/Ether. The organic layer was separated and back 
extracted with 2% sodium bicarbonated (2 X 25 mL). The aqueous layers were combined 
and acidified to pH 1, followed by extraction with EtOAc (2 X 50 mL). The organic layer 
was dried with sodium sulfate and the solvent removed in vacuo, giving product 6 as a 
clear oil (0.454 g; 48% overall yield for two steps). NMR (600 MHz, CDCl3): 7.7465 (d, 
2H), 7.582 (d, 2H), 7.383 (t, 2H), 7.297 (t, 2H), 5.2355 (d, 1H), 4.397 (m, 2H), 4.215 (t, 
1H), 1.898 (m, 1H), 1.708 (m, 1H), 1.4 – 1.5 (m, 6H), 0.842 (s, 9H). ESI-MS: calculated 
= 409.23 actual = 409.3. 
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Scheme 4.2. Synthesis of Fmoc-L-tFhNle-OH 
 
Synthesis of 7 (Scheme 4.2). Identical procedure followed as reported for the synthesis 
of compound 5. 5-Iodo-1,1,1-trifluoropentane (1.11 g; 4.41 mmol) obtained from Matrix 
Scientific, Inc. was used as the alkyl halide. (Yield: 1.036g, 2.99 mmol, 71% yield). 
NMR (300 MHz, CDCl3): 8.230 (br, 2H), 7.24-7.40 (m, 5H), 4.879 (m, 1H), 4.464 (d, 
1H), 4.431 (d, 1H), 4.256 (t, 1H), 2.868 (s, 3H), 2.505 (br, 3H), 1.924 (m, 1H), 1.736 (m, 
1H), 1.410 (m, 4H), 0.790 (m, 2H).  ESI-MS: calculated = 346.187 actual = 346.2. 
Synthesis of Fmoc-L-tFhNle-OH 8 (Scheme 4.2). Identical procedure followed as 
reported in synthesis of compound 6, giving product 8 as a clear oil (0.454 g; 48% overall 
yield for two steps). NMR (300 MHz, CDCl3): 7.75 (d, 2H), 7.56 (d, 2H), 7.387 (t, 2H), 
7.297 (t, 2H), 5.20 (d, 1H), 4.417 (m, 2H), 4.205 (t, 1H), 1.4 – 2.1 (m, 8H). ESI-MS: 
calculated = 421.15 actual = 421.2. 
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ii. Concentration Study.  
The hairpin WtBuNle exhibits aggregation behaviour in the 1 mM and above 
concentration range. In order to determine the most suitable concentrations for NMR 
analysis, a concentration study was performed by CD (10 mM sodium phosphate buffer, 
pH 6.4, 298K). The peptide was found to be monomeric near and below approximately 
0.5 mM concentration. As a result, the NMR studies of the WtbutylNle hairpin were 
carried out at concentrations of 0.5 mM or less. The thermal denaturation, for example, 
was executed at 0.316 mM.  
 
Figure 4.12. Concentration study by CD of the peptide WtBuNle. 
 
iii. Quantification of Folding  
To determine the chemical shifts of the fully folded state, 14-residue disulfide-linked 
analogs of peptides were synthesized with the sequence of Ac-CRWVEVNGOXILQC-
NH2, where X = KMe3 or tbutylNle. The disulfide bond between Cys1 and Cys14 
constrains the peptide to a "-hairpin. To determine the unfolded chemical shifts, 7-mers 
 195 
were synthesized with sequences Ac-RWVEVNG-NH2 and Ac-NGOXILQ-NH2, where 
X = KMe3 or tbutylNle. The chemical shifts for residues in the strand and one turn 
residue were obtained from each 7-mer peptide.  The fraction folded was determined 
from equation 1.  
 
Fraction Folded = ['obs – '0]/[ '100 – '0]  (eqn 1) 
 
&G = =-0.001987*298*ln(ff/(1-ff)) (eqn 2) 
 
iv. Characterization of Structure 
 
Methods used to indicate the formation of "-hairpin structure include the analysis of H% 
shifting relative to random coil, backbone amide shifts relative to random coil, and the 
identification of cross strand NOEs. The "-hairpin should have backbone hydrogen 
bonded amides between cross-strand residue pairs Arg-Gln, Val-Ile, and Val-Orn in all 
hairpin peptides. The presence of these hydrogen bonds is readily demonstrated by 
downfield shifting of the amide hydrogens in these positions relative to random coil. As 
seen below, both peptides exhibit significant downfield shifting at key positions along the 
strand. As expected for "-hairpins, the termini are frayed and show little or no amide 
shifting.  The Asn amide shows significant downfield shifting as expected for a Type I’ 
turn. 
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Figure 4.13. Backbone amide shifts of peptides WKMe3 and WtBuNle. 
 
 
Finally, the identification of numerous cross-strand NOEs in all hairpin peptides indicates 
that all peptides have "-hairpin structure.  
 
Figure 4.14. WtBuNleCyc Cross-strand NOEs: 
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Table 4.3. NOEs observed at 298 K (S=Strong; M=Medium; W=Weak) for peptide 
WtBuNleCyc (Ac-RWVEVNGO(tBuNle)ILQ-NH2): 
    
Residue Proton Residue Proton Intensity 
Trp 3 Ar 4 Leu 12 '  W 
Trp 3 Ar 4 Leu 12 (  W 
Trp 3 Ar 4 Tbutyl10 (CH3)3 W 
Trp 3 Ar 7 Leu 12 '  W 
Trp 3 Ar 7 Tbutyl10 (CH3)3 W 
Trp 3 Ar 7 Tbutyl10 ' W 
Trp 3 Ar 7 Tbutyl10 # W 
Trp 3 Ar 7 Tbutyl10 " M 
Trp 3 Ar 6 Leu 12 '  W 
Trp 3 Ar 6 Leu 12 (  W 
Trp 3 Ar 6 Tbutyl10 (CH3)3 W 
Trp 3 Ar 5 Ile 11 %  M 
Trp 3 Ar 5 Tbutyl10 " M 
Trp 3 Ar 5 Tbutyl10 # W 
Trp 3 Ar 5 Tbutyl10 (CH3)3 W 
Trp 3 Ar 5 Leu 12 '  W 
Trp 3 Ar 5 Leu 12  " W 
Trp 3 % Leu 12 %  S 
Trp 3 NH Arg 2 % S 
Arg 2 NH Cys 1 % S 
Gln 13 NH Leu 12 % S 
Val 6 NH Glu 5 % S 
Val 4 NH Trp 3 % S 
 
v. Thermodynamic Analysis  
 
Peptides were analyzed assuming a two-state system.  The equilibrium constant was 
determined from the fraction folded (f) by K = f/(1-f).  The free energy was then 
calculated from !G° = - RTlnK.  In order to determine the thermodynamic parameters, 
!H°, !S°, and !Cp°, the temperature dependence of the Gly chemical shift difference 
was fit to the following equation:34  
 
Fraction Folded = [exp(x/RT)]/[1 + exp(x/RT)], where  
 
x = T(&Sº298 + a ln(T/298) + b (T – 298) – (c/2) (1/T
2 – 1/2982)) – (&Hº298 + a (T – 298) + 
(b/2) (T2 – 2982) – c (1/T – 1/298))]. 
 
 
 
 
 
 
                                                
34 Maynard, A.J. Sharman, G. J. and Searle, M. S. J. Am. Chem. Soc. 1998, 120, 1996-
2007. 
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Temperature Dependence of the Fraction Folded from Glycine Chemical Shift Data for 
the peptides in this study:  
 
Table 4.4. Thermal Denaturation data for WtBuNle and WtFhNle: 
 
WtBuNle:   WtFhNle: 
 
Temp (K) fraction folded Temp (K) fraction folded 
271.33 0.921 275.45 0.893 
276.60 0.932 279.81 0.899 
281.63 0.943 284.16 0.903 
286.61 0.953 288.52 0.908 
291.80 0.959 292.87 0.912 
296.63 0.964 297.23 0.912 
302.00 0.968 301.58 0.913 
306.64 0.970 305.94 0.908 
311.62 0.966 310.29 0.895 
316.66 0.960 314.64 0.888 
319.38 0.954 319.00 0.877 
325.60 0.932 323.35 0.860 
330.33 0.917 327.71 0.838 
  332.06 0.809 
  336.42 0.778 
  340.77 0.741 
  345.13 0.698 
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Figure 4.15. 1HNMR of Peptide WtBuNle: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
tbutylNle-Ile-Leu-Gln-NH2  
 
Table 4.5. Proton Chemical Shift Assignments for Peptide WtBuNle. 
 % " ( ' # Amide Amine 
R 4.49 1.68 1.57 3.15  8.03 7.13,6.63 
W 5.12 3.08 7.451,7.287 7.210,7.193 6.986 8.30 10.11 
V 4.49 2.02 0.86   9.20  
E 5.05 2.00 2.20   8.30  
V 4.21 1.93 0.90   9.03  
N 4.41 3.04,2.73    9.52  
G 4.1055, 
3.692  
    8.64  
O 4.67 1.77 1.77 3.04  7.72 7.64 
tBuNle 4.78 1.68 1.20 1.02 0.91 
(CH3)3=0.639 
8.42  
I 4.63 1.85 1.42,1.17,0.87 0.87  9.31  
L 3.95 1.25 0.92 0.38,0.095   8.19  
Q 4.31 2.01 2.26   8.70  
 
 
 
 
 
 
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 4.16. 1HNMR of Peptide tBuNle7: Ac-Asn-Gly-Orn-tbutylNle-Ile-Leu-Gln-NH2 
 
Table 4.6. Proton Chemical Shift Assignments for Peptide tBuNle7. 
 % " ( ' # Amide Amine 
N 4.68 2.84      
G 3.94       
O 4.38 1.82 1.67 3.02    
tBuNle 4.27 1.75 1.26 1.15 1.15 
(CH3)3=0.843 
  
I 4.14 1.79 1.39, 
0.89 
0.89    
L 4.38 ----- ------ 0.90    
Q 4.31 2.02 2.34     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P P M
  4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 4.17. 1HNMR of Peptide WtbuNleCyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-
Orn-tbutylNle-Ile-Leu-Gln-Cys-NH2 
 
Table 4.7. Proton Chemical Shift Assignments for Peptide WtBuNleCyc. 
 % " ( ' # Amide 
C 5.23 2.999,2.374     
R 4.615 1.80 1.51 3.16  8.725 
W 5.13 3.06    8.56 
V 4.53 2.02 0.874   9.49 
E 5.07 1.99 2.186   8.60 
V 4.233 1.912 0.897   9.13 
N 4.397 3.085,2.74     
G 4.108,3.686      
O 4.702 1.78 1.78 3.046  7.75 
tBuNle 4.92 1.717 1.241 0.928 0.928 
(CH3)3=0.655 
 
I 4.702 ----- 1.40,1.16,0.866 0.866  9.49 
L 3.866 1.257 0.350 -.072, 
-0.361 
 8.233 
Q 4.545 1.83 2.14   8.999 
C 5.053 2.936     
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 4.18. 1HNMR of Peptide WtFhNle: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
TFhNle-Ile-Leu-Gln-NH2  
 
Table 4.8. Proton Chemical Shift Assignments for Peptide WtFhNle. 
 % " ( ' # Amide Amine 
R 4.42 1.66 1.53 3.14  8.05 7.12,6.67 
W 5.11 3.07    8.33 10.15 
V 4.22 1.92 0.90   9.02  
E 4.99 2.02,1.88 2.22   8.57  
V 4.50 2.03 0.87   9.14  
N 4.42 3.08,2.75    9.49  
G 4.096, 
3.70 
    8.63  
O 4.66 1.83 1.75 3.04  7.78 7.64 
TFhNle 4.84 1.69 1.30 1.30 1.87 8.48  
I 4.62 1.86 1.41,1.19, 
0.88 
0.88  9.28  
L 3.98 1.27 0.47 0.13,0.395  8.21  
Q 4.32 2.01,1.86 2.24   8.70  
 
 
 
 
 
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 4.19. 
1HNMR of Peptide tFhNle7: Ac-Asn-Gly-Orn-TFhNle-Ile-Leu-Gln-NH2 
 
Table 4.9. Proton Chemical Shift Assignments for Peptide tFhNle7. 
 % " ( ' # Amide Amine 
N 4.69 2.80    8.43  
G 3.95     8.48  
O 4.40 1.88 1.74 3.01  8.25 7.63 
TFhNle 4.29 1.70 1.56 1.43 1.81 8.24  
I 4.16 1.86 1.49,1.18, 
0.89 
0.89  8.28  
L 4.37 1.88 1.65 0.90  8.34  
Q 4.29 1.97,2.08 2.36   8.32  
 
 
 
 
 
 
 
 
 
 
P P M
  4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
 204 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.10. Proton Chemical Shift Assignments for Peptide WTFhNlecyc: Ac-Cys-Arg-
Trp-Val-Glu-Val-Asn-Gly-Orn-TFhNle-Ile-Leu-Gln-Cys-NH2 
 % " ( ' # Amide Amine 
C 5.05 2.96      
R 4.61 1.80 1.67,1.52 3.16  8.70  
W 5.12 3.04    8.58  
V 4.57 1.85 0.87   9.47  
E 5.02 2.03,1.88 2.17     
V 4.23 1.92 0.91   9.13  
N 4.41 3.05, 
2.76 
     
G 4.109, 
3.679 
      
O 4.70 1.80 1.80 3.05    
TFhNle 4.96 1.74 1.38 1.38 1.93   
I 4.70   0.89   9.48 
L 3.88 1.26 0.36 -0.04, 
-0.35 
  8.24 
Q 4.54 2.08,1.84 2.21    9.01 
C 5.23 3.00,2.40      
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Figure 4.20. 1HNMR of Peptide VtFhNle: Ac-Arg-Val-Val-Glu-Val-Asn-Gly-Orn-
tFhNle-Ile-Leu-Gln-NH2 
 
 
 
P P M
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CHAPTER V 
 
INVESTIGATION OF A CITRULLINE-! INTERACTION 
 
 
A. Background and significance. 
Citrullination of proteins (via the deiminiation of arginine) is a post-translational 
modification that is over-abundant in sufferers of rheumatoid arthritis (RA) (Figure 
5.1).
1,2
 This transformation is carried out by the enzyme protein arginine deiminase 4 
(PAD4), whose activity appears to be under-regulated in the RA disease state. It is 
proposed that the increase in citrullinated proteins eventually results in the targeting of 
normal tissue by the immune system.
3
 As a result, PAD4 is a target for drug discovery. 
Small molecule inhibitors of this enzyme could potentially slow the progression of RA or 
reduce the severity of its symptoms.  
 
 
                                                
1
 Luo, Y.; Arita, K.; Bhatia, M.; Knuckley, B.; Lee, Y.; Stallcup, M. R.; Sato, M.; 
Thompson, P. R. Biochem. 2006, ASAP. 
 
2
 Thompson, P. R.; Fast, W. ACS Chem. Biol.2006, 1, 433-441. 
 
3
 Utz, P. J.; Genovese, M. C.; Robinson, W. H. Ann. Rheum. Dis. 2004, 63, 330-332. 
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Figure 5.1 (adapted from reference 2) a) Cit, Arg, and methylated Arg sidechains. (b) 
Proposed mechanism for the deimination of Arg by PAD4. 
 
Under normal physiological circumstances, PAD4 functions as a modifier of 
histone tails. The modification of arginine and methylated arginine to citrulline in histone 
tails is a novel and potentially critical portion of the histone code whose significance is 
still being determined.
4
 For instance, it is known that the methylation of arginine in 
histone tails can lead to transcriptional activiation. While there is no known arginine 
demethylase, it is possible that citrullination might serve the same purpose, by turning off 
the methylated arginine signal.
2
 Given our recent work in the area of methylated arginine 
and the cation-! interaction, a logical extension of this work is to examine the interaction 
between a citrulline residue and a !-system.5 It is possible the loss of a cation-! 
                                                
4
 Arita, K.; Shimizu, T.; Hashimoto, H.; Hidaka, Y.; Yamada, M.; Sato, M. Proc. Nat. 
Acad. Sci. 2006, 103, 5291-5296. 
 
5
 Hughes, R. M.; Waters, M. L., J. Am. Chem. Soc. 2006, 128, 12735 – 12742. 
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interaction between arginine and a binding site lined with aromatic residues, such as the 
chromodomain, via citrullination may be a key factor in its influence on biological 
activity. The diminished affinity of citrulline for aromatic groups, in comparison to 
methylated arginines, would indicate that PAD4 is indeed functioning as a surrogate 
arginine demethylase. 
B. Results and Discussion.  
For the sake of comparison, we used the same twelve residue "-hairpin peptide used in 
our investigation of the Trp-Arg and Trp-DMA interactions discussed in Chapter 2 
(Figure 5.2). Substitution of citrulline (Cit) into the same position used for Arg and DMA 
results in a hairpin that is slightly less well-folded than the peptide WR (80% versus 84%, 
based on the Gly splitting) (Figure 5.3). As the both peptides are similarly well-folded, 
they should provide an excellent framework for comparison of the Trp-Arg and Trp-Cit 
interactions. Furthermore, analysis of the sidechain upfield shifting profile is a key piece 
of data, since it indicates both proximity and orientation about the aromatic ring (Figure 
5.4). One key difference between the Arg and Cit sidechains is the upfield shift of the 
terminal NH2 group, indicating a change in geometry. The Arg sidechain is shifted 
upfield consistently at each position on the guanidinium group, while the Cit sidechain is 
shifted upfield significantly at the # and internal NH positions, but not at the terminal 
NH2. This is suggestive of a stacking interaction between Arg and Trp, and a non-
stacking interaction between Cit and Trp. The precise orientation of this interaction is 
difficult to determine from our NMR data, but ab initio calculations give some insight 
into what might be occurring. 
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Figure 5.2. "-hairpin peptides used in this investigation. 
 
a) b)  
Figure 5.3. a) H$ shifts for WCit and WR peptides (Gly shifts based on the 
splitting). b) Fraction folded data for WCit and WR "-hairpin peptides. 
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Figure 5.4. a) Sidechain upfield shifts for Arg and Cit residues relative to random 
coil. b) Labeled Arg and Cit sidechains. 
 
 Starting from stacked conformations, geometry optimizations were undertaken for 
truncated Trp-Arg and Trp-Cit complexes in the gas phase and in water (implicit solvent; 
IEFPCM model).
6
 The purpose of this experiment is two-fold: 1) to assist in the 
interpretation of our NMR data, and 2) to highlight the differences between preferred 
geometries in the gas phase and the aqueous phase.  
As seen in figure 5.5b and 5.5c, the Trp-Arg and Trp-Cit complexes do not remain 
stacked in the gas phase, instead preferring T-shaped (Trp-Arg) or V-shaped (Trp-Cit) 
orientations that maximize the electrostatic interactions (note the NH-O hydrogen bond 
between the indole NH and the citrulline carbonyl). In the presence of implicit solvent, 
however, the ligands are expected to balance the solvation effects with orientations that 
still enable favorable electrostatic contact with the Trp ring and hydrogen-bonding 
interactions with water. The results of our calculations are shown in figure 5.5d and 5.5e, 
and are consistent with the upfield shifting profiles seen in our NMR data in aqueous 
solution: the Arg remains stacked with Trp in order to maintain the cation-! interaction 
and hydrogen-bond with solvent, while the Cit is optimized to a conformation that 
                                                
6
 Gaussian 03 (B04). Frisch, M. J., et al. 
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enables a polar-! interaction with the face of the indole ring while solvating the carbonyl 
and the terminal NH2 group. Further calculation of the interaction energies between the 
complexes at the MP2/6-31g** level shows that the Arg-Trp  stacked interaction (-2.95 
kcal/mol) in implicit water is worth more than the Cit-Trp V-shaped interaction (-0.55 
kcal/mol) (see Experimental section for details). Perhaps most importantly, the Cit-Trp 
stacking interaction in implicit water is repulsive (+2.88 kcal/mol), which suggests that 
the Cit-Trp orientation shown in 5.5c is a likely preferred orientation for the two 
sidechains within the folded "-hairpin. 
a)   
b)   
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c)   
d)   
e)   
Figure 5.5. (a) Starting orientations for geometry optimizations of Trp-Arg and Trp-Cit 
complexes. (b) Results for gas phase optimization of Trp-Arg. (c) Results for gas phase 
opitimization of Trp-Cit. (d) Results for aqueous phase optimization of Trp-Arg. (e) 
Results for aqueous phase optimization of Trp-Cit. (Gaussian 03; HF/6-31g**; CPCM 
Implicit solvation model). Space filling models are shown to demonstrate proximity via 
Van der Waals contacts. 
 
Comparison of the upfield shift profiles of Cit and methylated arginines DMAa 
and DMAs further demonstrates the difference between the interaction of the deiminated 
ligand with Trp (Figure 5.6). While the methyl groups of DMA are significantly upfield 
shifted, indicating stacking with the aromatic ring, the upfield shifting profile of Cit 
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shows more upfield shifting at the internal amide proton, indicating that it is likely not  in 
a stacked orientation with the aromatic ring. Based on this data, it is clear that 
deimination of either DMAa or DMAs in vivo would eliminate the favorable stacking 
interaction with aromatic groups by substituting it with a lower affinity interaction (such 
as an amide-! interaction). To support this hypothesis, double mutant cycles were 
conducted in order to quantify the Trp-Cit interaction. This gave a value of -0.21 
kcal/mol for the interaction. This is in contrast to a value of -0.5 kcal/mol for the Arg-Trp 
interaction and -1.0 kcal/mol for the DMA-Trp interactions (see Chapter 2). Based on this 
data, it is certainly possible that citrullination modulates transcription by weakening the 
interaction between histone tails and transcriptional cofactors such as chromodomains, 
which bind DMA via cation-! interactions. 
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Figure 5.6. a) Comparison of upfield shifts for Cit, DMAa, and DMAs. b) Labeled Cit, 
DMAa, and DMAs sidechains. 
 
Additionally, the thermodynamics of "-hairpin folding were investigated with 
VT-NMR (Figure 5.7; Table 5.1). Based on our thermal denturation data, it appears that, 
while there are small differences in the thermodynamics of folding between WCit and 
WR, that the values for entropy, enthalpy and heat capacity are within error. The primary 
differences occur when comparing the folding dynamics of WCit and the DMA-
 214 
containing peptides, where a more favorable entropy and heat capacity of folding are the 
primary differences upon going from Cit to the DMA ligands. These changes are 
consistent with the deimination of DMA resulting in a diminished interaction with Trp. 
Again, it might be gathered from this data that the deimination of methylated Arg to Cit 
in histone tails is a key signal for transcriptional deactivation via the decreased binding 
affinity of Cit with aromatic rings. 
 
Figure 5.7 Thermal denaturation profile for peptide WCit. 
 
Table 5.1. Thermodynamic Parameters
a
 for Hairpin Folding at 298 K. 
Peptide %H° %S° %Cp° 
WCit -3.6 (0.1) -9.5 (0.2) -176 (26) 
WR -3.7 (0.1) -9.1 (0.2) -193 (29) 
WDMAs -2.4 (0.2) -2.6 (0.8) -409 (61) 
WDMAa -2.3 (0.1) -2.1 (0.4) -355 (53) 
(a)
 
Determined from the temperature dependence of the Gly chemical shift from 0 to 80 °C. Units are: 
DH°: kcal/mol; DS°: cal/mol K; DCp°: cal/mol K. Errors (in parentheses) are determined from the fit. Error 
for DCp° values from equation 9 estimated at 15%. 
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C. Conclusion.  
The interaction between Cit and Trp has been compared to the interaction 
between Arg and Trp. These sidechains are related through the enzyme PAD4 and their 
proposed roles in the histone-mediated transcription of DNA. While subtle differences 
exist between the interaction of Arg and Cit with aromatic rings, it appears that the Cit-
Trp interaction falls into the camp of polar-! interactions, such as those observed 
between acylated Lys and Trp, while the Arg-Trp interaction has definite cation-! 
character. It is apparent that both sidechains, in addition to undergoing favorable 
interactions with !-systems, can undergo numerous H-bonding interactions with other 
sidechains or with solvent molecules. This can be a complicating factor when analyzing 
their individual effects on the folding of our "-hairpin model system. Nonetheless, it is 
clear that the Trp-Arg interaction is slightly more favorable than the Trp-Cit interaction. 
Since the citrullination of methylated Args is also possible, the most important 
differences may be between the Trp-DMA and Trp-Cit interactions, since the Trp-DMA 
interactions are clearly more favorable. This lends credibility to the idea that PAD4 may 
function as a substitute arginine demethylase. Overall, analysis of the Trp-Cit interaction 
enables us to better place studies of the Arg-! interaction within the grand and complex 
context of the “histone code.” 
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D. Experimental. 
 
Table 5.2. Thermal denaturation data for peptide WCit. 
 
Temperature (K) Fraction Folded 
273.12 0.829 
278.51 0.828 
282.95 0.823 
287.51 0.818 
292.41 0.806 
296.51 0.796 
301.83 0.779 
305.51 0.759 
310.47 0.736 
311.16 0.729 
314.51 0.707 
319.15 0.677 
323.51 0.642 
327.74 0.602 
328.18 0.599 
332.51 0.564 
336.42 0.525 
 
Calculation of Interaction Energies. 
 
The complexes shown in Figure 5.5 were optimized at the HF/6-31g** level in Gaussian 
03 (B04). Interaction energies were determined via single point calculations at the 
MP2/6-31g** level (SCRF=IEFPCM; SOLVENT=WATER; SCF=TIGHT) using the 
equation below: 
%EMP2 = EA-B - EA - EB 
 
Where EA-B is the MP2 energy of the optimized complex, EB is the MP2 energy of 
optimized monomer B, and EA is the MP2 energy of optimized monomer A. 
 
Table 5.3. Values used to calculate interaction energies for complexes in Figure 5.5. 
 Warg_Stack  Wcit_Stack  Wcit_V 
Complex -646.36  -665.73  -665.73 
Arg -244.45     
Cit   -263.83  -263.83 
Trp -401.90  -401.90  -401.90 
%E (hartrees) -0.0047  0.0046  -0.0009 
%E (kcal/mol) -2.95  2.88  -0.56 
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Figure 5.8. 
1
HNMR of Peptide WCit: Ac-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-Cit-Ile-
Leu-Gln-NH2  
 
Table 5.4. Proton Chemical Shift Assignments of Peptide WCit. 
 $ " & # ' Amide Amine 
R 4.37 1.62 1.54 3.13  8.05 6.65,7.12 
W 5.04 3.10 7.311,7.466 7.043,7.209 7.199 8.32 10.12 
V 4.42 1.98 0.85   8.95  
E 4.86 2.00 2.23   8.49  
V 4.19 1.97 0.90   8.88  
N 4.45 2.98,2.68    9.365  
G 4.076,3.7235     8.607  
O 4.61 1.80 1.77 3.01  7.83 7.65 
Cit 4.75 1.61 1.51 2.79  8.482 5.80 
I 4.54 1.88 1.30,0.87 0.87  9.07  
L 4.07 1.28 ------ 0.485,0.260  8.27  
Q 4.31 1.90 2.24   8.646  
 
 
 
 
 
 
 
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 5.9. 
1
HNMR of Peptide WCitCyc: Ac-Cys-Arg-Trp-Val-Glu-Val-Asn-Gly-Orn-
Cit-Ile-Leu-Gln-Cys-NH2  
 
Table 5.5. Proton Chemical Shift Assignments of Peptide WCitCyc. 
 $ " & # ' Amide Amine 
C 5.048 3.00      
R 4.60 1.806 1.66,1.502 3.166  8.712  
W 5.126 3.033    8.618  
V 4.580 2.06 0.869   9.517  
E 5.009 1.947 2.228   8.54  
V 4.235 1.931 0.908   9.111  
N 4.399 3.12,2.759      
G 4.114,3.6725       
O 4.697 1.77 1.77 3.05  7.759  
Cit 4.939 1.689 1.470 2.814    
I 4.736 1.86 1.416,1.18,0.884 0.884  9.415  
L 3.8921 1.291 0.742,0.369 0.0406, 
-0.342 
 8.275  
Q 4.57 1.82 2.142   9.048  
C 5.23 2.96,2.39      
 
 
  
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 5.10. 
1
HNMR of Peptide Cit7mer: Ac-Asn-Gly-Orn-Cit-Ile-Leu-Gln-NH2  
 
Table 5.6. Proton Chemical Shift Assignments of Peptide Cit7mer. 
 $ " & # ' Amide Amine 
N 4.68 2.84    8.428  
G 3.942     8.561  
O 4.37 1.76 1.76 3.01  8.138 7.64 
Cit 4.32 1.62 1.57 3.10  8.29 6.29 
I 4.13 1.83 1.37 0.91  8.248  
L 4.40 1.68 0.914 0.914  8.342  
Q 4.31 2.00 2.37   8.342  
 
P P M
  4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
  
 
 
 
CHAPTER VI 
 
EXPERIMENTAL AND COMPUTATIONAL INVESTIGATION OF A !-HAIRPIN 
RECEPTOR FOR ATP 
 
 
A.  Background and significance. 
Protein-nucleotide interactions have been studied for quite some time, as 
indicated by the presence of nearly 6,000 structures of protein-DNA complexes in the 
Protein Data Bank (http://www.pdb.org). A more recent challenge that has been 
undertaken by a number of researchers is the design of peptidic and peptidomimetic 
receptors for individual nucleotides (ATP, GTP, TTP, CTP), and single and double 
stranded DNA.
1
 Particularly challenging is the development of receptors with both high 
affinity and selectivity between different nucleotides. This is an important goal that has 
potential applications in the study of DNA base-repair enzymes, assays for use in 
                                                
1
 a) Cooper, W. J.; Waters, M. L. Curr. Op. Chem. Biol. 2005, 9, (6), 627-631. b) 
Imanishi, M.; Yan, W.; Morisaki, T.; Sugiura, Y. Biochem. Biophys. Res. Comm. 2005, 
333, (1), 167-173. c) Hirata, A.; Ueno, M.; Aizawa, Y.; Ohkubo, K.; Morii, T.; 
Yoshikawa, S. Bioorg. Med. Chem. 2005, 13, (9), 3107-3116. d) Butterfield, S. M.; 
Sweeney, M. M.; Waters, M. L. J. Org. Chem. 2005, 70, (4), 1105-1114. e) Luedtke, N. 
W.; Liu, Q.; Tor, Y. Biochemistry 2003, 42, (39), 11391-11403. f) Hastings, C. A.; 
Barton, J. K. Biochemistry 1999, 38, (31), 10042-10051.g) Aizawa, Y.; Sugiura, Y.; 
Ueno, M.; Mori, Y.; Imoto, K.; Makino, K.; Morii, T. Biochemistry 1999, 38, (13), 4008-
4017. h) Aizawa, Y.; Sugiura, Y.; Morii, T. Biochemistry 1999, 38, (5), 1626-1632. i) 
Okahata, Y.; Niikura, K.; Sugiura, Y.; Sawada, M.; Morii, T. Biochemistry 1998, 37, 
(16), 5666-5672. j) Lescrinier, T.; Hendrix, C.; Kerremans, L.; Rozenski, J.; Link, A.; 
Samyn, P.; Van Aerschot, A.; Lescrinier, E.; Eritja, R.; Van Beeumen, J.; Herdewijn, P. 
Chemistry-a European Journal 1998, 4, (3), 425-433. k) Nolte, A.; Klussmann, S.; Bald, 
R.; Erdmann, V. A.; Furste, J. P. Nature Biotechnology 1996, 14, (9), 1116-1119. l) 
Cheng, X.; Kay, B. K.; Juliano, R. L. Gene 1996, 171, (1), 1-8. m) Sardesai, N. Y.; 
Zimmermann, K.; Barton, J. K. J. Am. Chem. Soc. 1994, 116, (17), 7502-7508. 
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chemical biology, and the development of peptide-based therapeutics for gene therapy. 
One exciting development in this field has been the development of a !-hairpin receptor 
for various nucleotides (ATP, GTP, TTP, CTP) and single stranded DNA.
2
  This water-
soluble, monomeric !-hairpin has been shown to bind ssDNA with an affinity rivaling 
that of proteins (Figure 6.1).  
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Figure 6.1 (a) Schematic of !-hairpin nucleotide binding interaction. (b) Structure of 
WKWK, a receptor for ATP. (c) Structures of various nucleotides. 
 
Efforts to make this receptor highly selective for ATP over various other 
nucleotides have been met with varying degrees of success,
2
 perhaps due to a limited 
body of knowledge regarding the finer structural details of the !-hairpin receptor itself. In 
                                                
2
 Butterfield, S. M.; Sweeney, M. M.; Waters, M. L., Journal of Organic Chemistry 2005, 
70, (4), 1105-1114. 
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this study, we set out to further characterize the hairpin structure through a series of 
computational and experimental efforts designed to give insight into the mechanism of 
ATP binding (based on computationally determined !-hairpin structure) and the potential 
for enhancing the selectivity of the receptor based on the acquired structural knowledge. 
Earlier studies conducted by Butterfield and Waters showed the fundamental 
importance of the Trp and Lys residues to the binding of ATP. Mutation of the Trp 
residues to smaller aromatics significantly decreased the affinity of the receptor for ATP. 
Based on the degree of upfield shifting (observed by NMR) of the adenine ring in the 
presence of the !-hairpin, as well as the quenching of Trp fluorescence in the presence of 
ATP, it is inferred that "-" stacking interactions between the Trp ring and the adenine 
ring are important to the binding of ATP. Also important are electrostatic interactions 
between the negatively charged phosphate tail of ATP and the positively charged residues 
Lys residues on the !-hairpin. This was demonstrated by the mutation of Lys residues to 
neutral Thr, which decreased the binding affinity for ATP by a factor of 20, indicating 
that each Lys-phosphate interaction is worth about -1.5 kcal/mol per Lys.
2
 Comparison of 
the ATP binding affinity to ADP and AMP gave similar results. Overall, this data 
corresponds well to what has been observed in data mining surveys of ATP-binding 
proteins: hydrogen bonding, "-" stacking, and cation-" interactions all contribute to ATP 
binding. One survey of 68 high-resolution crystal structures of ATP-binding proteins 
found, on average, 2.7 hydrogen bonds, 1.0 "-" stacking interactions, and 0.8 cation-" 
interactions per ATP-protein complex.
3
 
 
                                                
3
 Mao, L.; Wang, Y.; Liu, Y.; Hu, X. J. Mol. Biol. 2004, 336, 787-807. 
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B. Results and Discussion. 
Determination of WKWK NMR Structure. Initial efforts at predicting the 
structure of WKWK were based on an existing !-hairpin NMR structure of a trpzip 
peptide available from the PDB (PDB ID:1LE1). This structure was taken from the PDB, 
and its residues modified using Sybyl to match the sequence WKWK. The sequence was 
subsequently minimized and subjected to MD simulation in explicit water using the 
molecular dynamics (MD) program GROMACs.
4
 MD simulations were carried out using 
this equilibrated structure in the presence of ATP and AMP. These studies indicated the 
potential importance of electrostatic contacts between other positively charged residues in 
the !-hairpin (Orn8 and Arg1, Fig 6.1b), in addition to the already characterized Lys 
residues. While simulations using this model structure were initially useful, it was 
important to have a structure determined from our NMR data for the sake of accuracy, 
and to insure that our initial assumptions regarding the structure of WKWK were correct.  
 Using the program CNS_Solve,
5
 and all available NMR data (NOEs, 
1
H 
chemical shifts, J
3
 coupling constants), the experimentally determined structure of 
WKWK matched well with our initial computationally determined structure (Figure 
6.2a). We used this NMR structure for all future simulation work. Both  our “hacked” 
structure and our NMR structure revealed that the orientation of the Trps in our ATP 
receptor were different than those in the trpzip peptide (Figure 6.2b). In fact, the Trps are 
                                                
4
 Lindahl. E.; Hess, B.; van der Spoel, D. J. Mol. Mod. 2001, 7, 306-317. 
 
5
 Brunger, A.T.; Adams, P.D.; Clore, G.M.; Delano, W.L.; Gros, P.; Grosse-Kunstleve, 
R.W.; Jiang, J.-S.; Kuszewski, J.; Nilges, N.; Pannu, N.S.; Read, R.J.; Rice, L.M.; 
Simondson, T.; Warren, G.L. ACTA CRYST. 1998, D54, 905-921. 
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not unlike those of the aromatic groups found in !-sheets in WW domain proteins, which 
contain two highly conserved Trp residues (Fig. 6.2c).
 
Initial assessment of this structure 
indicated that it presents a large recognition surface for the adenine moiety of ATP with a 
number of potential points for electrostatic contacts with the triphosphate tail (Lys, Orn, 
Arg). 
 
 
a) b)  
c)  
Figure 6.2. (a) Average NMR structure of WKWK. (b) NMR structure of trpzip peptide 
(1LE1). (c) Aromatic group orientation in WW domain (1K94). 
 
WKWK Mutations. A series of mutations to WKWK were chosen based on the 
initial MD simulations and the experimentally determined structure of the !-hairpin. 
Manual docking of ATP with the hairpin in Sybyl (manual rotation and translation of 
ATP within the binding pocket of the NMR structure) shows a variety of potential 
orientations during which the ATP can simultaneously obtain "-" stacking interactions 
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with the Trp rings and maintain electrostatic contact with a positively charged residue 
(Figure 6.3a). Mutations were chosen to test the effect of neutralizing these residues to 
determine if indeed they were equally important to the binding of ATP, regardless of 
their location within the hairpin structure (Table 6.1; Figure 6.4).  
 
a)  b)  
c)  d)  
Figure 6.3 (a-d). Possible orientations of ATP in WKWK binding pocket.  
 
Table 6.1. Selected mutations for peptide WKWK. 
Name Sequence Position of Mutation 
WKWK Ac-R-W-V-K-V-N-G-O-W-I-K-Q-NH2 ----- 
O8Q   Ac-R-W-V-K-V-N-G-Q-W-I-K-Q-NH2 8 
O8T  Ac-R-W-V-K-V-N-G-T-W-I-K-Q-NH2 8 
O8Dab      Ac-R-W-V-K-V-N-G-Dab-W-I-K-Q-NH2 8 
O8K   Ac-R-W-V-K-V-N-G-K-W-I-K-Q-NH2 8 
R1Cit     Ac-Cit-W-V-K-V-N-G-O-W-I-K-Q-NH2 1 
K4Q  Ac-R-W-V-Q-V-N-G-O-W-I-K-Q-NH2 4 
K11Q  Ac-R-W-V-K-V-N-G-O-W-I-Q-Q-NH2 4 
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Figure 6.4. Positions of mutant sites in WKWK hairpin. 
 
Each selected mutation requires some degree of explanation. The Orn residue at 
position 8 in the turn of the !-hairpin is not on the binding face of the receptor (Fig. 6.4). 
Therefore, it was not initially thought to be important to binding. However, initial manual 
docking studies and MD simulations suggested otherwise. For this reason, Orn was 
mutated to the neutral residue Gln, and was tested for potential distance dependence of 
the interaction via the residues Lys (one methylene longer) and Dab (one methylene 
shorter). For the sake of consistency, the mutation O8T was studied, since Thr was used 
original mutation selected for the Lys residues in the initial studies.
2
 To investigate the 
electrostatic contribution of Arg to binding, Citrulline was selected as the most logical 
mutation for Arg, since they are structurally similar, enabling Cit to be a neutral 
replacement for Arg (See Chapter 5). Furthermore, the mutants K4Q and K11Q were 
chosen for comparison to the original mutants of Butterfield and Waters K4T and K11T, 
since more recent studies suggested that Thr might be a poor choice for as mutation for 
Lys because of its lower !-sheet propensity.6   
                                                
6
 (a) Cochran, A.G.; Tong, R. T.; Starovasnik, M. A.; Park, E. J.; McDowell, R. S.; 
Theaker, J. E.; Skelton, N. J. J. Am. Chem. Soc. 2001, 123, 625 – 632. (b) Russell, S. J.; 
Blandl, T.; Skelton, N.; Cochran, A. G. J. Am. Chem. Soc. 2003, 125, 388 – 395. 
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Binding studies for WKWK and mutants. Binding studies were conducted for 
WKWK and the mutant hairpins with both AMP and ATP. The binding of AMP was 
measured by NMR due to the weaker AMP binding constants, which required higher 
concentrations of receptor and nucleotide. The binding of ATP was measured by the 
change in fluorescence of the Trp residues, which allowed for the use of lower 
concentrations of both receptor and nucleotide. Binding of AMP to the mutant hairpins 
indicated, not surprisingly, that the binding affinity of the receptor was diminished for the 
neutralized mutants R1Cit and O8Q. Interestingly, the mutation of Orn to Lys or Dab 
also diminished binding to AMP relative to the parent sequence WKWK. This effect 
may be due to conformational effects due to replacing Orn in the turn of the hairpin, and 
will be addressed later in this chapter.  
 
Table 6.2. Binding affinities for AMP (determined by NMR titration) 
Peptide Kd (M
-1
) ##G (kcal/mol) 
WKWK* 6.90 ± 0.1 (-2.95) 
O8Dab 12.8 ± 0.1 +0.37 
O8K 11.9 ± 0.1 +0.33 
O8Q 15.6 ± 0.2 +0.49 
R1Cit 18.2 ± 0.1 +0.58 
 
 
ATP binding studies with the WKWK mutants show similar trends in the data, 
although binding of the triphosphate shows clearer differences between closely related 
*matches S.B. value 
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mutant sequences. Some trends from the AMP binding studies remain the same (O8Dab 
and O8K bind ATP more poorly than WKWK), while others show intriguing 
differences. While the O8Q mutant decreases binding affinity for ATP by 0.73 kcal/mol, 
the R1Cit mutant only decreases binding by 0.27 kcal/mol. One might expect this ATP-
hairpin interaction to be subject to the polyelectrolyte effect, in which change in the 
charge state of the receptor will decrease binding affinity by approximately the same 
amount.
7
 However, it appears that structure, rather than the charge state of the receptor 
alone, is playing a key role in determining the important electrostatic contacts between 
the peptide and ATP. As a result, the unstructured N-terminus of the hairpin (R1) plays 
less of a role in binding than do charged residues in the structured regions of the hairpin 
(K4, O8, K11). This is supported by our NMR data, which shows little hairpin structure 
at the terminal residues (discussed in next section). Additionally, our set of Thr mutants 
(O8T, K4T, K11T) display lower binding affinities than their corresponding Gln mutants 
(O8Q, K4Q, K11Q). Again, this may be related to structure changes of the receptor due 
to the lower !-sheet propensity of Thr. These differences in binding affinities are of some 
significance. The Lys to Gln mutants predict an average value of 0.94 kcal/mol for each 
Lys-ATP interaction, while the Lys to Thr mutants predict an average value of 1.43 
kcal/mol for each Lys-ATP interaction. Butterfield and Waters estimated the contribution 
of the Trp-Adenine aromatic interaction to be 1.8 (± 0.2) kcal/mol based on salt studies 
with ATP and AMP. By comparison, assuming that the interaction energy is divided 
equally among the two Trp(s) in the receptor, a single Trp-Adenine interaction appears to 
                                                
7
 Zhang, W.; Bond, J. P.; Anderson, C. F.; Lohman, T. M.; Record, M. T. Proc. Nat. 
Acad. Sci. USA 1996, 93, (6), 2511-2516. 
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be nearly equal in magnitude to a phosphate-Lys interaction (both are approximately 0.9 
kcal/mol). This establishes a benchmark for the enhancement of nucleotide affinity. Since 
all the interactions are approximately equal, the path to selectivity may wind through the 
enhancement of one interaction over the other. Since the electrostatic interaction between 
the positively charged residues and the phosphate tail is largely non-specific, the most 
promising option for selectivity may be enhancement of the electrostatic complimentarity 
between Trp (likely via a non-natural surrogate) and aromatic functionality of the 
nucleotide. 
 
Table 6.3. Binding affinities for ATP (determined by fluorescence titration) 
Peptide Kd (µM) ##G (kcal/mol) 
WKWK* 303 ± 22 (-3.38) 
O8Dab 387 ± 28 +0.14 
O8K 384 ± 40 +0.14 
O8Q 1047 ± 56  +0.73 
O8T 1765 ± 103 +1.04 
R1Cit 479 ± 75 +0.27 
WQWK 1655 ± 140 +1.01 
WKWQ 1294 ± 105 +0.86 
WTWK
†
 3789 ± 344 +1.50 
WKWT
†
 3014 ± 184 +1.36 
*Differs from initial Kd determined for WKWK (170 uM). 
†
Kd determined by S. B. 
 230 
NMR characterization of WKWK mutants. One and two-dimensional NMR 
techniques were used to characterize the structure of the WKWK mutants. As seen 
below, the H$ shifts of the mutant hairpins compare well with those of the parent 
sequence WKWK, indicating that all mutant sequences still retain !-hairpin structure 
(Figure 6.5). However, some of the hairpins (O8T, for instance) show less H$ shifting 
than the native sequence indicating a lower !-hairpin population. Table 6.4 shows that 
the hairpins are all equally well folded based on the Gly splitting (within experimental 
error), with the exception of O8T, which is slightly less well folded (90%). 
 
Figure 6.5. H$ shifts for WKWK and selected mutant peptides. 
Table 6.4 Fraction folded (taken from Gly splitting) 
Peptide Fraction Folded 
WKWK 0.96 
O8K 0.96 
O8Dab 0.94 
O8Q 0.93 
O8T 0.90 
R2Cit 0.95 
K11Q 0.96 
K4Q 0.94 
          Error in fraction folded is ± 1%. 
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It is clear that the presence of Thr in the !-hairpin is slightly more destabilizing to 
the hairpin than Gln as a substitution for a positively charged residue (Lys or Orn). It is 
proposed that these changes are due to subtle conformational differences in the !-hairpin, 
which may include a change in the Trp binding pocket relative to the parent peptide 
WKWK. We attempt to address these questions, among others, via the computational 
methods discussed in the subsequent section. 
Molecular dynamics simulations of WKWK  and selected mutants. Molecular 
dynamics simulations were carried out for the peptide WKWK in complex with ATP. 
Four different simulations, each with different orientations of ATP in the binding pocket 
of the receptor were undertaken in order to examine possible binding orientations of 
ATP. Additionally, simulations of WKWK mutants were undertaken in order to examine 
how various mutations might perturb the ATP binding interface of the parent sequence 
WKWK.  
In our simulations of ATP in complex with WKWK, ATP was placed in the 
WKWK “binding pocket” in four different starting orientations, each orientation 
containing a different stacking orientation of the adenine ring with respect to the Trps 
(see Figure 6.3). This enables the adenine ring to interact with the Trps while the 
phosphate tail is free to seek out different favorable electrostatic contacts during the 
simulation. The simulations were carried out in explicit water at 300 K and 1 atm 
pressure (Amber 8-p148). Special parameters were used for the simulation of ATP that 
were developed specifically for use with the Amber force field.
8
 The most stable binding 
orientation of ATP was evaluated by monitoring the average potential energy during the 
                                                
8
 Meagher, K. L.; Redman, L. T.; Carlson, H. A. J. Comput. Chem. 2003, 24, 1016-1025. 
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simulation (Figure 6.6). Of the four peptide-ATP complexes, orientation 1 (satp1, Fig. 
6.3a) was clearly the most stable, indicating that it is a likely orientation for ATP.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6. Plots of potential energy taken from the simulations of WKWK and 
ATP. 
Table 6.5 Average potential energy from ATP-hairpin simulations. 
Complex Average Potential Energy (kcal/mol) 
satp1 -27508.1 
satp2 -25435.7 
satp3 -25823.5 
satp4 -25405.8 
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Snapshots taken from the trajectory for complex satp1 reveal the critical contacts 
occurring between the peptide-ATP complex. Figure 6.7(a) shows the complex near the 
beginning of the simulation, while 6.7(b) and 6.7(c) are taken from near the middle and 
the end of the simulation.  
 
 
 
 
 
 
Figure 6.7. Snapshots taken from the simulation of ATP with WKWK (satp1). a) 
near beginning of simulation. b) near middle of simulation. c) near end of simulation. 
 
By the end of the simulation, a well-defined H-bond occurs between K11 and the 
phosphate tail of ATP, while the adenosine ring is clearly interacting with the Trp rings. 
The ribose ring, which has been shown experimentally to interact with the Trp rings via 
NMR, is also in contact with the Trp rings as the simulation progresses.  While it is 
important to acknowledge that the brevity of the simulations precludes complete 
exploration of the phase space of the binding interaction, the contacts observed here are 
consistent with our experimental data and may serve as a guide for design of future 
receptors. Furthermore, these simulations highlight the origin of our poor selectivity 
among various nucleotides: there is no narrow binding pocket, but rather a fairly shallow 
concave binding face established by the Trp rings that allows for numerous possible 
a) b) c) 
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stacking orientations while the phosphate tail is free to contact a number of positively 
charged residues located elsewhere in the hairpin.  
Additional simulations of the mutant peptides K4T and K4Q were undertaken in 
order to analyze potential structural differences caused by the two mutations. These 
simulations were initiated by taking the average NMR structure of WKWK and mutating 
the appropriate Lys residue to either Thr or Gln using the program Sybyl. The mutant 
structures were then loaded into Amber 8, solvated with TIP3P explicit water, 
neutralized, and minimized. The resulting minimized structures were gradually heated 
from 0 to 300 K before being subjected to 2 ns of MD simulation using Amber ff99. The 
lowest energy structures were extracted from each simulation and are shown in Figure 6.8 
below. While no differences in the structures are immediately obvious (other than the 
orientations of the two mutant sidechains), backbone superposition of the two structures 
shows that the orientation of the Trps are only slightly perturbed. While it is difficult to 
relate this directly to our binding data, this small perturbation of the binding pocket 
indicates that electrostatic differences between the interaction of the ATP phosphate tail 
with Gln and Thr are the most likely source for the observed differences in binding 
affinities. 
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a) b)  
c)  
Figure 6.8. a) K4T low energy structure b) K4Q low energy structure c) 
superimposed K4T (green) and K4Q (blue). 
 
C. Conclusions.  
In this chapter we have investigated a number of critical contacts involved in the 
binding of ATP by a !-hairpin peptide. Various contributing factors, such as 
electrostatics and hairpin stabilities have been evaluated. Both experimental and 
computational efforts have converged to give a more detailed picture of the binding 
interactions involved in our receptor. Since nucleotide selectivity is our ultimate goal, this 
work suggests a number of potential avenues by which selectivity may be achieved. One 
such way is through the use of Trp analogues designed to better complement the 
electrostatic potential surface (for example, halogenated indole rings) of a particular 
nucleotide ring (adenine, guanine, etc.). Another method is to develop ways to restrict 
access to our “open-faced” binding pocked. This could occur through the addition of a 
third !-strand or an $-helix designed to orient residues above and around the Trp-
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nucleotide interface. Clearly, more work is required in order to design selectivity into our 
receptor. However, this work provides a good starting point for such a discussion. 
 
D. Experimental 
i. Job plots and concentration studies of WKWK mutants. Job plots of 
WKWK constructed by Butterfield indicated that the hairpin binds to ATP with a 1:1 
stoichiometry. We constructed our own Job plots to assure that our mutations to the 
parent peptide did not disturb this binding stoichiometry (Figure 6.9). A series of 
solutions were prepared in which the total peptide + ATP concentration was held constant 
at 3 mM, but mole fraction of the peptide was varied. Plots were constructed with NMR, 
with solutions made up in 10 mM d3-acetate buffer, pH 5.0 (uncorrected). The 
concentration of the peptide-nucleotide complex is determined by the equation below, 
where # is the change in the peptide chemical shift relative to the free peptide, #o is the 
change in chemical shift as determined by fitting of the NMR titration data to an equation 
[2], and [Ro] is the total peptide concentration. A plot of [complex] versus mole fraction 
of peptide was constructed as shown below (equation [1]). 
[complex] = (# / #o) X [Ro]  [1] 
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a) b)  
c)  
Figure 6.9. a) R1Cit Job Plot b) K4Q Job Plot c) O8Q Job Plot 
 
ii. Concentration studies. Additionally, concentration studies of the peptides 
were conducted by CD, and indicate that the +3 charged mutant hairpins exhibit some 
aggregation at or above 500 µM in concentration. This could affect the results of our 
AMP titrations, which were conducted using receptor concentrations in the range of 1 – 2 
mM. However, this is not a concern with our ATP concentrations, in which the receptor 
concentration was well below 100 µM for all of our studies. 
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a)  
b)  
c)  
d)  
e)  
Figure 6.10. Concentration studies of peptides a) K4Q b) O8K c) O8Q d) R1Cit 
e) O8Dab. (298K, 20 mM sodium phosphate buffer, pH 6.0). 
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iii. NMR Titrations. Peptides were dissolved in 10 mM d3-acetate buffer, pH 5.0 
(uncorrected), using DSS as an internal standard. The concentration of peptide was held 
constant between 1-4 mM for titrations with AMP. AMP was added to the peptide 
solutions from a 0.6 M stock in D2O in 1 – 6 µL increments. A 1D proton spectrum was 
then acquired, using 8 – 64 scans with water presaturation. Binding was measured by 
fitting the upfield shifting of the tryptophan H-5 protons to the following equation for 1:1 
binding in Kaleidagraph, where !obs is the observed chemical shift of a tryptophan proton, 
!R  is the chemical shift of the tryptophan proton in the absence of nucleotide, "o is the 
maximum change in chemical shift at 100% complexation, [Ro] is the concentration of 
the receptor, [So] is the concentration of the nucleotide, and K is the binding constant: 
 
!obs = !R + "o/2[Ro]{[Ro] + [So] + 1/K - sqrt(([Ro] + [So] + 1/K) 2 - 4[Ro][So])}  [2] 
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Table 6.6. NMR Titration Data for WKWK + AMP ([WKWK = 1.3 mM]) 
Trp H-5 Shift (ppm) [AMP] mM 
7.090 0 
7.069 1.43 
7.048 2.94 
7.033 4.44 
7.017 6.19 
6.996 9.76 
6.983 12.79 
6.975 16.83 
6.969 20.11 
6.964 26.04 
6.961 31.65 
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Table 6.7. NMR Titration Data for O8K + AMP ([O8K = 2.08 mM]) 
Trp H-5 Shift (ppm) [AMP] mM 
7.099 0 
7.079 2.23 
7.056 4.48 
7.034 6.45 
7.018 8.54 
6.994 12.37 
6.981 16.47 
6.973 20.20 
6.966 24.84 
6.962 30.13 
6.959 38.25 
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Table. 6.8. NMR Titration Data for O8Dab + AMP ([O8Dab = 1.54 mM]) 
Trp H-5 Shift (ppm) [AMP] mM 
7.089 0 
7.070 2.445 
7.047 4.65 
7.026 6.40 
7.005 8.10 
6.982 11.54 
6.970 15.17 
6.963 18.76 
6.956 24.58 
6.949 30.01 
6.947 36.33 
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Table 6.9. NMR Titration Data for O8Q + AMP ([O8Q = 1.52 mM]) 
Trp H-5 Shift (ppm) [AMP] mM 
7.087 0 
7.068 1.57 
7.048 3.07 
7.039 4.78 
7.024 5.995 
7.004 11.28 
6.990 15.39 
6.982 19.26 
6.974 21.65 
6.968 28.94 
6.965 33.59 
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Table 6.10. NMR Titration Data for R1Cit + AMP ([R1Cit] = 3.42 mM) 
Trp H-5 Shift (ppm) [AMP] mM 
7.133 0 
7.118 1.405 
7.093 3.83 
7.079 6.50 
7.060 7.45 
7.031 12.0 
7.016 16.21 
7.006 20.31 
6.996 24.13 
6.985 29.51 
6.979 36.57 
6.975 40.04 
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iv. Fluoresence Titrations. Peptide samples were prepared in 10 mM acetate 
buffer, pH 5.0. Peptide concentrations were determined in 6M GdnHCl, using the 
absorbance of Trp residues at 280 nm (e = 5690 M-1 cm -1). ATP stock solutions were 
prepared in 10 mM sodium acetate buffer, pH 5.0, and concentrations were determined 
by UV/Vis spectroscopy. Fluoresence scans were obtained at 25 C, using an excitation 
wavelength of 297 for Trp, and monitoring the emission at 348 nm. Fluoresence titrations 
were fit to the following equation for 1:1 binding in KaleidaGraph, where I is the 
observed fluorescence intensity, Io is the initial fluorescence intensity of the peptide, I# is 
the fluorescence intensity at binding saturation, [L] is the concentration of the added 
nucleotide, and Kd is the dissociation constant: 
I – [Io + I#([L]/Kd]/[1 + ([L]/Kd)]   [3] 
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Figure 6.11. Fluorescence titration of WKWK with ATP. 
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Figure 6.12. Fluorescence titration of O8T with ATP. 
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Figure 6.13. Fluorescence titration of O8K with ATP. 
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Figure 6.14. Fluorescence titration of O8Dab with ATP. 
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Figure 6.15. Fluorescence titration of R1Cit with ATP. 
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Figure 6.16. Fluorescence titration of K4Q with ATP. 
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Figure 6.17. Fluorescence titration of O8Q with ATP. 
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Figure 6.18. Fluorescence titration of K11Q with ATP. 
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Figure 6.19. 
1
HNMR of Peptide R1Cit: Ac-Cit-Trp-Val-Lys-Val-Asn-Gly-Orn-Trp-Ile-
Lys-Gln-NH2  
 
Table 6.11 Proton Chemical Shift Assignments for Peptide R1Cit. 
 $ ! % & ' Amide Amine 
Cit 4.47 1.76 1.53 3.14    
W 5.29 3.08,3.31      
V 4.18 1.89 0.91     
K 4.39 1.17,0.00 0.50 2.77    
V 4.73 2.05 0.94     
N 4.39 3.12,2.77      
G 4.18,3.45        
O 4.73 1.91 1.79 3.10    
W 5.10 3.12      
I 4.78 1.97 0.97     
K 4.06 1.27 0.39 0.67 2.63   
Q 4.35 1.99 2.32     
 
Table 6.12. Proton Chemical Shift Assignments for Peptide R1Cit7: Ac-Cit-Trp-Val-
Lys-Val-Asn-Gly-NH2 
 $ ! % & ' Amide Amine 
Cit 4.26 1.71 1.39 2.97    
W 4.73 3.28      
V 3.98 1.95 0.85     
K 4.13 1.57 1.33 1.33 3.01   
V 4.09 2.07 0.94     
N 4.69 2.78      
G 3.90       
 
 
 
 
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 6.20. 
1
HNMR of Peptide R1CitCyc: Ac-Cys-Cit-Trp-Val-Lys-Val-Asn-Gly-Orn-
Trp-Ile-Lys-Gln-Cys-NH2  
 
Table 6.13. Proton Chemical Shift Assignments for Peptide R1CitCyc. 
 $ ! % & ' Amide Amine 
C 5.11 3.11      
Cit 4.73 n.d. n.d. 3.13    
W 5.39 3.24,3.04      
V 4.18 1.88 0.90     
K 4.38 1.13,-0.1     0.45 2.36    
V 4.79 2.03 0.93     
N 4.38 3.11,2.77      
G 4.19,3.42         
O 4.73 n.d. n.d. 2.94    
W 5.11 3.11      
I 4.84 1.97 0.96     
K 4.12 1.27 0.29 0.64 2.63   
Q 4.63 1.91 2.24     
C 5.25 3.04,2.42      
 
 
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 6.21. 
1
HNMR of Peptide O2Q: Ac-Arg-Trp-Val-Lys-Val-Asn-Gly-Gln-Trp-Ile-
Lys-Gln-NH2  
 
Table 6.14. Proton Chemical Shift Assignments for Peptide O2Q. 
 $ ! % & ' Amide Amine 
R 4.55 1.81 1.67 3.26    
W 5.29 3.10,3.31      
V 4.19 1.94 0.93     
K 4.47 1.25,0.07 0.55 1.23 2.40   
V 4.74 2.08 0.96     
N 4.43 3.12,2.83      
G 4.20,3.49        
Q 4.72 2.24,2.03 2.43     
W 5.11 3.22,3.12      
I 4.78 1.98 1.51,1.29, 
0.99 
0.99    
K 4.07 1.31,0.36 0.48 0.68 2.65   
Q 4.40 2.10,1.97 2.34     
 
Table 6.15. Proton Chemical Shift Assignments for Peptide O2Q7: Ac-Asn-Gly-Gln-
Trp-Ile-Lys-Gln-NH2 
 $ ! % & ' Amide Amine 
N 4.66 2.76      
G 3.84       
Q 4.23 1.86 2.12     
W 4.70 3.31,3.23      
I 4.02 1.71 0.80 0.80    
K 4.17 1.70 1.39 1.70 2.95   
Q 4.27 1.99 2.35     
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 6.22. 
1
HNMR of Peptide O2QCyc: Ac-Cys-Arg-Trp-Val-Lys-Val-Asn-Gly-Gln-
Trp-Ile-Lys-Gln-Cys-NH2  
 
Table 6.16. Proton Chemical Shift Assignments for Peptide O2Qcyc. 
 $ ! % & ' Amide Amine 
C 5.10 3.08      
R 4.75 1.90 1.76 3.25    
W 5.38 3.25,3.04      
V 4.17 1.88 0.89     
K 4.43 1.14, 
-0.07     
0.45 2.32    
V 4.75 2.06 0.94     
N 4.36 3.12,2.79      
G 4.17,3.41          
Q 4.71 1.97 2.40     
W 5.10 3.08      
I 4.84 1.97 0.95 0.95    
K 4.09 1.28 0.25 0.64 2.63   
Q 4.61 1.89 2.23     
C 5.24 3.02,2.38      
 
 
 
 
 
 
 
 
 
 
 
 
 
P P M
  10.0     9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    -1.0    
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Figure 6.23. 
1
HNMR of Peptide O2K: Ac-Arg-Trp-Val-Lys-Val-Asn-Gly-Lys-Trp-Ile-
Lys-Gln-NH2  
 
Table 6.17. Proton Chemical Shift Assignments for Peptide O2K. 
 $ ! % & ' Amide Amine 
R 4.53 1.75 1.75 3.25  8.16 7.23 
W 5.29 3.32,3.08    8.62 10.15 
V 4.16 1.90 0.90   9.00  
K 4.43 1.17,0.00 0.50 n.d. 2.39 8.37  
V 4.73 2.06 0.95   9.54  
N 4.39 3.12,2.78    9.50  
G 4.17,3.44     8.55  
K 4.68 1.78 n.d. 1.48 3.09 7.70  
W 5.10 3.13    8.69 10.15 
I 4.78 1.96 1.25,0.97 0.97  9.71  
K 4.06 1.26 0.38 0.63 2.62 8.36  
Q 4.38 1.95 2.32   8.73  
 
Table 6.18. Proton Chemical Shift Assignments for Peptide O2K7: Ac-Asn-Gly-Lys-
Trp-Ile-Lys-Gln-NH2 
 $ ! % & ' Amide Amine 
N 4.66 2.77      
G 3.85       
K 4.23 1.61 n.d. 1.22 2.88   
W 4,71 3.26      
I 4.06 1.73 1.07,0.83 0.83    
K 4.15 1.71 n.d. 1.40 2.97   
Q 4.28 1.99 2.36     
 
 
 
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 6.24. 
1
HNMR of Peptide O2Dab: Ac-Arg-Trp-Val-Lys-Val-Asn-Gly-Dab-Trp-
Ile-Lys-Gln-NH2  
 
Table 6.19. Proton Chemical Shift Assignments for Peptide O2Dab. 
 $ ! % & ' Amide Amine 
R 4.53 1.78 1.65 3.25  8.16  
W 5.29 3.31,3.08    8.62 10.15 
V 4.17 1.90 0.92   8.83  
K 4.37 1.23,0.00 0.51 1.12 2.36 8.43  
V 4.73 2.07 0.94   9.53  
N 4.40 3.10,2.77      
G 4.15,3.48     8.63  
Dab 4.84 2.15 3.11   7.75  
W 5.11 3.27,3.13    8.88  
I 4.79 1.97 1.49,1.26,0.98 0.98  9.75  
K 4.07 1.26,0.33 0.45 0.65 2.62 8.36  
Q 4.38 2.07,1.94 2.31   8.74  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 6.25. 
1
HNMR of Peptide O2DabCyc: Ac-Cys-Arg-Trp-Val-Lys-Val-Asn-Gly-
Dab-Trp-Ile-Lys-Gln-Cys-NH2  
 
Table 6.20. Proton Chemical Shift Assignments for Peptide O2DabCyc. 
 $ ! % & ' Amide Amine 
C 5.078 3.055      
R 4.718 1.867 1.578 3.22  8.726  
W 5.367 3.016    8.742  
V 4.729 1.995 0.901   9.635  
K 4.31 1.133 0.43 -0.125 2.289 8.414  
V 4.148 1.859 0.867   8.828  
N 4.344 3.03,2.75      
G 4.125,3.409       
Dab 4.88 2.172 3.06   7.71  
W 5.07 3.055      
I 4.776 1.956 1.237,0.924 0.924  9.86  
K 4.086 1.234 0.617 0.274 2.586 8.336  
Q 4.59 1.88 2.21   9.078  
C 5.219 2.91,2.398      
 
 
 
 
 
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Table 6.21. Proton Chemical Shift Assignments for Peptide O2Dab7: Ac-Asn-Gly-Dab-
Trp-Ile-Lys-Gln-NH2 
 $ ! % & ' Amide Amine 
N 4.66 2.77      
G 3.84       
Dab 4.40 1.99 2.94     
W 4.70 3.25      
I 4.06 1.72 1.36,1.07,0.83   0.83    
K 4.14 1.71 n.d. 1.39 2.97   
Q 4.28 1.99 2.36     
 
 
 
Table 6.22. Proton Chemical Shift Assignments for Peptide K11Q: Ac-Arg-Trp-Val-
Lys-Val-Asn-Gly-Orn-Trp-Ile-Gln-Gln-NH2  
 $ ! % & ' Amide Amine 
R 4.45 1.78 1.68 3.23    
W 5.25 3.30,3.08      
V 4.72 2.02 0.93     
K 4.39 1.16, 
-0.02  
0.48 n.d. 2.36   
V 4.17 1.88 0.90     
N  3.08,2.77      
G 4.18,3.45     8.55  
O 4.72 1.78 1.78 3.10    
W 5.10 3.23,3.13      
I  1.96 1.44,1.25,0.97 0.97    
Q 4.20 0.99,0.85 1.49,1.25     
Q 4.35 1.91 2.30     
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Figure 6.26. 
1
HNMR of Peptide K11QCyc: Ac-Cys-Arg-Trp-Val-Lys-Val-Asn-Gly-
Orn-Trp-Ile-Gln-Gln-Cys-NH2  
 
Table 6.23. Proton Chemical Shift Assignments of Peptide K11QCyc. 
 $ ! % & ' Amide Amine 
C 5.014 2.92      
R 4.655 ------ ------ 3.186  8.553  
W 5.279 3.05      
V 4.702 2.014 0.858   9.655  
K 4.33 1.069, 
-0.173  
0.428 n.d. 2.257 8.31  
V 4.116 1.88 0.827   8.936  
N 4.31 2.82,2.70      
G 4.1455,3.815       
O 4.709 1.78 1.78 3.038  7.616  
W 5.061 3.10      
I 4.796 1.999 0.928 0.928  9.80  
Q 4.264 0.866 1.38   8.35  
Q 4.546 1.93 2.12   9.006  
C 5.10 2.87,2.28      
 
 
 
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 6.27. 
1
HNMR of Peptide K4Q: Ac-Arg-Trp-Val-Gln-Val-Asn-Gly-Orn-Trp-Ile-
Lys-Gln-NH2  
 
Table 6.24. Proton Chemical Shift Assignments of Peptide K4Q. 
 $ ! % & ' Amide Amine 
R 4.508 1.766 1.633 3.219    
W 5.25 3.30,3.09    8.60  
V 4.688 2.039 0.899     
Q 4.438 0.727,0.383 1.368,1.055   8.352  
V 4.125 1.859 0.867   8.89  
N 4.367 3.06,2.78      
G 4.093,3.493       
O 4.696 1.78 1.78 3.07    
W 5.055 3.10    8.789  
I 4.719 1.899 1.45,1.20,0.92 0.92  9.656  
K 4.036 1.243 0.359 0.618 2.59 8.31  
Q 4.344 1.922 2.27     
 
 
 
 
 
 
 
 
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 6.28. 
1
HNMR of Peptide WQWKCyc: Ac-Cys-Arg-Trp-Val-Gln-Val-Asn-Gly-
Orn-Trp-Ile-Lys-Gln-Cys-NH2  
 
Table 6.25. Proton Chemical Shift Assignments for Peptide K4QCyc. 
 $ ! % & ' Amide Amine 
C 5.068 3.13,3.06      
R 4.147 0.865 ----- 2.73    
W 5.358 3.123      
V 4.764 2.092 0.874   9.60  
Q 4.413 0.342 1.678   8.374  
V 4.116 1.749 0.842   8.905  
N 4.326 3.06,2.76      
G 4.095,3.456       
O 4.74 1.81 1.81 3.06    
W 5.068 3.13,3.06      
I 4.741 1.952 0.905 0.905  9.811  
K 4.077 1.248 0.483 ------ 2.66 8.30  
Q 4.59 1.95 2.19   9.069  
C 5.217 2.97,2.27      
 
 
 
 
 
 
 
 
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
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Figure 6.29. 
1
HNMR of Peptide O8T: Ac-Arg-Trp-Val-Lys-Val-Asn-Gly-Thr-Trp-Ile-
Lys-Gln-NH2  
 
Table 6.26. Proton Chemical Shift Assignments for Peptide O8T. 
 $ ! % & ' Amide Amine 
R 4.48 1.72 1.63 3.21    
W 5.23 3.06      
V 4.64 2.00 0.90   9.43  
K 4.247 -0.01 0.521 1.16 2.41 8.35  
V 4.122 1.88 0.872   8.80  
N 4.36 3.08.2.79      
G 4.153,3.471       
T 4.57 4.04 1.27     
W 5.04 3.12      
I 4.68 1.90 1.45,1.21, 
0.92 
0.92    
K 4.013 1.25 0.40 0.67 2.60 8.33  
Q 4.33 1.98 2.28     
 
 
 
 
 
 
 
 
P P M
  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0    
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Figure 6.30. 
1
HNMR of Peptide O8TCyc: Ac-Cys-Arg-Trp-Val-Lys-Val-Asn-Gly-Thr-
Trp-Ile-Lys-Gln-Cys-NH2  
 
Table 6.27. Proton Chemical Shift Assignments for Peptide O8TCyc. 
 $ ! % & ' Amide Amine 
C 4.89 2.83      
R 4.523 1.66 1.66 3.016  8.539  
W 5.187 2.852    8.547  
V 4.508 1.836 0.703   9.469  
K 4.04 0.914 -0.383 0.227 2.156 8.19  
V 3.93 1.64 0.66   8.64  
N 4.125 3.234,3.992      
G 3.992,3.234       
T 4.39 3.87 1.09   7.51  
W 4.867 2.98    8.492  
I 4.55 1.74 1.20,0.74 0.74  9.625  
K 3.867 1.039 0.039 0.453 2.391 8.133  
Q 4.391 1.83 2.01   8.875  
C 5.023 2.82,2.18      
 
Table 6.28. Proton Chemical Shift Assignments for Peptide K7: Ac-Asn-Gly-Orn-Trp-
Ile-Lys-Gln-NH2 
 $ ! % & ' Amide Amine 
N 4.657 2.79      
G 3.845       
O 4.275 1.71 1.65 2.954    
W 4.697 3.275      
I 4.048 1.603 0.853 0.853    
K 4.165 1.74 1.55 ----- 2.95   
Q 4.275 1.82 2.30     
 
P P M
  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0    
  
 
CHAPTER VII 
CATION-! INTERACTIONS IN A SMALL MOLECULE MODEL SYSTEM 
 
A. Background and significance. 
The cation-! interaction is known to be an important interaction in protein stability, 
molecular recognition, and enzymatic catalysis.1 In recent years, this interaction has been 
increasingly utilized in the field of organic chemistry by catalytic and asymmetric 
induction systems.2 However, it has been suggested that in certain supramolecular 
systems studied in organic solution, the interaction between a charged !-system and an 
aromatic ring has less influence on conformational stability than other competing non-
covalent interactions, including CH—O and NH—O interactions.3 In this study, we use 
                                                
1 (a) Ma. J. C.; Dougherty, D. A. Chem. Rev. 1997, 97, 1303-1324. (b) Castellano, R. K. 
Diederich, F.; Meyer, E. A. Angew. Chem. Int. Ed. 2003, 42, 1210-1250. (c) Gallivan, J. 
P.; Dougherty, D. A. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 9459-9464. (d) Zacharias, 
N.; Dougherty, D.A. Trends Pharmacol. Sci. 2002, 23, 281-287. (e) Munoz-Caro, C.; 
Nino, A. Biophys. Chem. 2002, 96, 1-14. (f) Quiocho, F. A.; Hu, G.; Gershon, P.D.; Curr. 
Opin. Struct. Biol. 2000, 10, 78-86. (g) Yamamoto-Katayama, S.; Ariyoshi, M.; Ishihara, 
K.; Hirano, T.; Jingami, H.; Morikawa, K. J. Mol. Biol. 2002, 316, 711-723. (h) Lee, S.; 
Lin, X.; McMurray, J.; Sun, G. Biochemistry 2002, 41, 12107-12114. (i) Eichman, B. F.; 
O’Rourke, E. J.; Radicella, J. P.; Ellenberger, T. Embo. J. 2003, 22, 4898-4909. 
2 (a) Yamada, S.; Morita, C. J. Am. Chem. Soc. 2002, 124, 8184-8185. (b) Acharya, P.; 
Plashkevych, O.; Morita, C.; Yamada, S.; Chattopadhyaya, S. J. Org. Chem. 2003, 68, 
1529-1538. 
 
3 (a) Raymo, F.; Bartberger, M.; Houk, K.; Stoddart, F. J. Am. Chem. Soc. 2001, 123, 
9264-9267. (b) Houk, K.; Menzer, S.; Newton, S.; Raymo, F.; Stoddart, F.; Williams, D. 
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designed model systems to investigate the orientation effects of a cation-! interaction 
versus competing CH— and NH—O interactions in organic solution. We find that in 
organic solution, within the context of our model systems, the cation-! interaction 
predominates over other possible non-covalent interactions. This effect is complex and 
due to favorable energies for the cation-! interaction in chloroform biased towards the 
stacked orientation by energetic and entropic effects, including the presence of an 
unexpected oxygen-arene interaction within the designed system.  
B. Design 
Model systems 1 and 2 (Figure 7.1) are based on a previously reported system designed 
to examine offset stacked aromatic interactions.4 The orientation dependence of model 
system 1 on the cation-! interaction has been previously investigated in aqueous 
solution.4b Model system 2 was designed as a control for monitoring the influence of the 
methoxy group present in model system 1 on the stacking interaction in organic solvents. 
Comparison of the preference for stacking interactions between the two sets of molecules 
should indicate what role, if any, that the methoxy group is playing in the dominant 
conformations of model system 1 molecules in different solvents.  
 
                                                                                                                                            
J. Am. Chem. Soc. 1999, 121, 1479-1487. (c) Raymo, F.; Houk, K.; Stoddart, F. J. Org. 
Chem. 1998, 63, 6523-6528. 
 
4 (a) Rashkin, M. J.; Waters, M. L. J. Am. Chem. Soc. 2002, 124, 1860-1861. (b) Rashkin, 
M. J.; Hughes, R. M.; Calloway, N. T.; Waters, M. L. J. Am. Chem. Soc. 2004, 126, 
13320-13325. (c) Martin, C. B.; Mulla, H. R.; Willis, P. G.; Cammers-Goodwin, R. J. 
Org. Chem. 1999, 64, 7802-7806. 
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Figure 7.1. Designed model systems 1 and 2 
In our initial investigation in water, it was shown that the stacking interaction is highly 
favored over potential interactions between polarized hydrogens on the pyridinium ring 
and the methoxy group.4b However, in a different solvent environment, the stacking 
interaction (cation-!) might not be more favorable than other possible non-covalent 
interactions, which could result in a solvent-induced conformational switch in our model 
system. For example, NH—O and CH—O hydrogen bonds are predicted to be more 
favorable in organic solvent than in water.5 This is readily demonstrated by Hunter’s 
simplified electrostatic model, in which electrostatic interactions are treated as pair-wise 
hydrogen bonds, and their free energies of interaction in a wide variety of solvents 
calculated from AM1 electrostatic potentials.6 However, predicting the magnitude of 
CH—O and NH—O interactions relative to a competing cation-! interaction is a 
challenging problem that requires high-level computational treatment.7 Accordingly, 
                                                
5 Houk, K. N.; Menzer, S.; Newton, S. P.; Raymo, F. M.; Stoddart, J. F.; Williams, D. J. 
J. Am. Chem. Soc. 1999, 121, (7), 1479-1487. 
6 Hunter, C. A. Angew. Chem. Int. Ed. 2004, 43, 5310-5324.  
 
7 Gallivan, J. P.; Dougherty, D. A. J. Am. Chem. Soc. 2000, 122, 870-874. 
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high-level (MP2/6-31g**) ab initio calculations have been performed to predict the 
relative magnitudes of cation-! and CH-- and NH—O interactions in chloroform. 
 
C.  Results and Discussion 
Synthesis. The synthesis of model system 1 (compounds 1a – 1d) has been described 
previously.4b The synthesis of model system 2 (compounds 2a – 2d) is shown in Scheme 
7.1. Compound 2a was synthesized starting with the reduction of 2-bromobenzaldehyde 
with sodium cyanoborohydride to compound 3. Compound 3 was brominated with 
phosphorous tribromide, followed by reaction with pyridine. Suzuki coupling of the 
cationic species 4a with phenyl boronic acid gave compound 2a. Compounds 2b – 2d 
were synthesized starting with the reaction of 2-bromobenzaldehyde with the appropriate 
pyridyl Grignard reagent.8 The resulting compounds were acylated with acetic anhydride, 
followed by deoxygenation with samarium iodide.9 Suzuki coupling with phenyl boronic 
acid, followed by protonation with HBF4, yielded compounds 2b – 2d. 
 
 
 
 
 
                                                
8 Trecourt, F.; Breton, G.; Bonnet, V.; Mongin, f.; Marsais, F.; Queguiner, G. Tet. Lett. 
1999, 40, 4339-4342. 
9 Kato, Y.; Mase, T. Tet. Lett. 1999, 40, 8823-8826. 
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Scheme 7.1. Synthesis of model system 2 compounds 2a – 2d. 
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Investigation of Conformational Preferences. We investigated the tendency of the 
pyridinium ring C to stack with the anisole ring A in both model systems (Figures 7.1 and 
7.2) in chloroform. The magnitude of the stacking interaction is described qualitatively 
by the upfield shifting of the pyridine ring protons relative to control compounds 4a - d. 
As seen in our earlier studies in water,4b the magnitude of the upfield shifting varies 
according to the position of the cation, with the ipso compound exhibiting the most 
upfield shifting due to its proximity to the A ring (Figure 7.3). 
N
MeO O
CH3
N
H
NH···O
interaction
···H
?
pyridinium-! 
stacking 1b
O
CH3
NHC
H
CH···O
interaction
···
N
MeO
H
?
pyridinium-! 
stacking 1c  
Figure 7.2. Possible interaction geometries of model system 1.
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Figure 7.3. Upfield shifting of the pyridinium rings in chloroform of (a) compounds 1a 
and 2a; (b) compounds 1b and 2b; (c) compounds 1c and 2c; (d) compounds 1d and 2d. 
Compounds and pyridinium protons are labeled as shown in Scheme 7.1. 
As shown in Figures 7.3c and 7.3d, both the meta and para-substituted 
compounds from model systems 1 and 2 show similar magnitudes of upfield shifting at 
all pyridinium ring protons, with differences between systems 1 and 2 of " 0.1 ppm. 
Since compounds 2c and 2d do not contain a methoxy group, this indicates that the 
stacking interaction in 1c and 1d occurs with little interference from C-H---O or N-H---O 
interactions in chloroform. This is not surprising for the para-substituted compound 1d, in 
which the NH is not able to access a hydrogen bond with the oxygen on the A ring. 
However, some interaction between the methoxy group and the pyridinium ring might be 
a) b) 
c) d) 
 269 
anticipated for compound 1c, in particular a C-H—O interaction (see examples in Figure 
7.2).  
Analysis of the ipso and ortho-substituted compounds 1a and 1b is slightly more 
ambiguous (Fig. 7.3a and 7.3b). While both sets of compounds exhibit similar 
magnitudes of upfield shifting at most positions, the amine of 1b is signficantly less 
upfield shifted than the amine of 2b, suggesting the presence of a potential NH—O bond 
in 1b. Additionally, in the case of the ipso-substituted compounds 1a and 2a, the ortho 
protons are significantly less upfield shifted in 1a than in 2a, suggesting the possible 
presence of a CH—O interaction in compound 1a.  
  
Comparison of Model System 1 in D2O and Chloroform. Comparison of the 
pyridinium ring upfield shifts of model system 1 in chloroform and D2O reveals similar 
magnitudes of #$ for both solvents (Figure 7.4a-d).  The similarity of the patterns in 
upfield shifting of the pyridinium ring suggests similar conformations of molecules 1a-d 
in both chloroform and D2O. This points towards the absence of significant competing 
NH—O and CH—O interactions in chloroform. 
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Figure 7.4. Upfield shifting of the pyridinium rings of (a) compound 1a in D2O and 
CDCl3; (b) compound 1b; (c) compound 1c; (d) compound 1d. 
 
Upfield Shifts of Ring A in Chloroform and D2O. Upfield shifting of the upper biaryl 
ring A is more sensitive to solvent effects than the pyridinium ring C. While the pattern 
of upfield shifting is similar among 1a-d in chloroform and D2O, the magnitude of the 
shift is consistently higher in CDCl3 (Figure 7.5a-d), indicating possible conformational 
differences between the two environments. However, since the pattern of interaction 
remains much the same between chloroform and D2O, it is likely that the preferred 
conformations of the molecules are similar in both solvents but that the populations of the 
stacked conformations differ. 
c) d) 
a) b) 
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O
H1
H2
H3
H4
OH
O
9  
Figure 7.5. Upfield shifting of the upper biaryl ring of (a) compound 1a in D2O and 
CDCl3; (b) compound 1b; (c) compound 1c; (d) compound 1d.  #$ measured relative to 
control compound 9. 
 
Crystal Structure of Ipso Compound. Crystals of the ipso compound 1a were obtained 
by slow evaporation from CDCl3.  The resulting crystal structure indicated that, instead of 
the stacking orientation proposed for 1a-d in D2O (Fig. 7.2), the preferred orientation in 
the solid state orients the methoxy group over the pyridinium ring with aromatic rings A 
and C in an offset stacked conformation (Figure 7.6). This raises the proposition that the 
same conformation may be well populated in organic solvent. This is because, in addition 
to the cation-! interaction, the lone pairs of oxygen are able to donate into the electron-
deficient !-system. This would not be the case in D2O, where solvation of the methoxy 
group would be favored over !-donation. This effect, known as an oxygen-arene 
interaction, has been demonstrated and quantified in a series of elegant studies by Reich 
and co-workers.10 They find that, in some cases, the interaction is worth ~0.5 kcal/mol. 
                                                
10 Gung, B. W.; Xue, X. W.; Reich, H. J. J. Org. Chem. 2005, 70, 7232 – 7237. 
D2O 
CDCl3 
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As a result, additive effects between this interaction and the cation-! interaction must be 
present in our system, and are likely influencing the orientations of the stacked 
conformers in CDCl3. 
 
Figure 7.6. Crystal structure of compound 1a. 
 
Molecular Modeling. To determine whether the preference for the stacking interaction 
observed in compounds 1a-d arises from a stronger driving force for interaction or from 
differences in conformational strain, and to demonstrate energetic differences between 
the different stacked orientations, we performed a computational study of compounds 
based on model system 1. The goal of this study is to quantitate energy differences 
between the cation-! and conformationally feasible NH—O or CH—O interactions in 
chloroform in the absence of a tether (Figure 7.7). Following literature methodology11 the 
interaction energies between anisole and 2, 3, 4, and N-methyl pyridine were calculated 
                                                
11 Biot, C.; Buisine, E.; Rooman, M. J. Am. Chem. Soc. 2003, 125, 13988-13994. 
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in the gas phase and in chloroform at the MP2/6-31g** level (see Experimental).12 
Starting conformations for the geometry optimizations were based on optimized 
structures of compounds 1a-d and optimized in the absence of spatial or geometric 
constraints (Figure 7.8) in order to achieve optimal interaction energies for the cation-pi, 
NH-O, and CH-O interactions in question. Counterions were omitted from these 
calculations due to the ambiguity of their placement in the starting complexes. Although 
some anions have shown considerable damping of cation-! interactions binding in 
organic solvents due binding with the cation,13 it is less likely that a diffuse positive 
charge, such as that on a pyridinium ring, is as sensitive to the presence of the anion as a 
ligand more closely resembling a point charge. 
The results of our calculations show that the cation-! interaction is predicted to be 
energetically competitive with NH—O and CH—O interactions in chloroform and, in the 
case of N-methyl pyridinium, is stronger than the competing CH—O interaction (Table 
7.1). Furthermore, it appears that the stacking orientations that place the methoxy group 
in the immediate vicinity of the pyridinium ring enhance the stacking interaction through 
oxy-arene effects (Table 7.1, Poses 2 and 3). Based upon these results, it appears that in 
model systems 1 and 2, the presence of a molecular tether between the A and C rings 
adds an unfavorable entropic component to forming the proposed hydrogen bonding 
                                                
12 For other computational studies of pyridine complexes, see (a) Yamada, S.; Misono, T.; 
Tsuzuki, S. J. Am. Chem. Soc. 2004, 126, 9862-9872. (b) Mignon, P.; Loverix, S.; De 
Proft, F.; Geerlings, P. J. Phys. Chem. A 2004, 108, 6038-6044. 
 
13 (a) Bartoli, S.; Roelens, S. J. Am. Chem. Soc. 2002, 124, 8307-8315. (b)  Anderson, M. 
A.; Ogbay, B.; Arimoto, R.; Sha, W.; Kisselev, O. G.; Cistola, D. P.; Marshall, G. R. J. 
Am. Chem. Soc. 2006, 128, 7531-7541. 
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interactions, requiring the formation of 9 or 10-membered hydrogen bonded macrocycles. 
Thus, the stacking interaction predominates even in the presence of enthalpically favored 
NH and CH—O hydrogen bonds, and can be further enhanced via an unanticipated 
oxygen-arene interaction. 
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Figure 7.7. Small molecules used to calculate #E of interaction in chloroform and various 
optimized complexes. 
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Figure 7.8. (a) Example gas-phase optimized structure of 1a. (b) Starting conformation 
of anisole/N-methyl pyridinium (10•11) stacked complex based on structure of 1a. 
 
Table 7.1. Calculated magnitudes of !-stacking versus NH or CH–O interactions 
between model compounds in chloroform.a 
Complex #E (cation-!) 
Pose 1 
#E (cation-!) 
Pose 2 
#E (cation-!) 
Pose 3 
#E (NH – O) #E (CH – O) 
10•11 -8.6 -8.6 --- --- -7.3 
10•12 -6.9 -8.1 --- -7.8 --- 
10•13 -5.6 -8.2 -8.0 --- -6.6 
10•14 -8.0 --- --- --- --- 
(a) Structures optimized in Gaussian 03 at MP2/6-31g** level. All values reported in 
kcal/mol. Chloroform modeled implicitly with IEFPCM solvation model. As a result, 
calculations are uncorrected for BSSE. See experimental section for full computational 
details, structures, and accompanying gas-phase calculations.  
 
Titration of 4-ethylpyridine. Finally, we evaluated the chemical shifts of protonated 4-
ethylpyridine in the presence of anisole (Figure 7.9). While only small changes in 
chemical shifts were observed (on the order of 0.01 ppm), the NH—O interaction appears 
to be slightly favored in the 1:1 complex, as expected, based on the magnitude of 
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downfield shifting of the amine proton. Upon increased anisole concentration, the 
competing interactions (indicated by upfield shifting of the pyridine protons versus 
downfield shifting of the NH) demonstrate similar chemical shifts. This is in agreement 
with our calculations, which suggest modest energetic differences between the cation-! 
and competing non-covalent interactions. 
 
Figure 7.9. Changes in chemical shifts of 4-ethylpyridine in the presence of n equivalents 
of anisole (n = 1-8).  
D. Conclusions.  
In summary, a series of compounds has been designed to investigate the 
magnitude of a cation-! interaction versus NH—or CH—O interactions in organic 
solution. While NH—and CH—O interactions may play a small role in the 
conformational stabilities of these compounds, the cation-! interaction dominates the 
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energetic landscape, even in organic solution. X-ray crystallography suggests that the 
preferred orientation of stacking may differ between water and chloroform. Theoretical 
calculations at the MP2/6-31g** level have helped quantify the relative magnitudes of 
these competing interactions and demonstrates the enhancement of the stacking 
interaction by the oxygen-arene effect. The cation-! interaction between a positively 
charged !-system and an aromatic ring, long known the be important in aqueous 
molecular recognition, is becoming a more popular element of designed catalytic and 
asymmetric induction systems due to its surprising strength and ability to control 
substrate orientation in organic solution. We anticipate that these studies will further 
elucidate its role in the conformational preferences of designed supramolecular systems.     
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E. Experimental Section. 
i. General.  All reagents and solvents were purchased from commercial sources and 
used without additional purification unless otherwise noted. Tetrahydrofuran and 
methylene chloride were dried via a column of neutral alumina under nitrogen prior to 
use. 
ii. Synthesis.  
2-Bromobenzyl alcohol, 3. A round-bottom flask was charged with argon, THF, and 
2-bromobenzaldehyde (1.58 g, 8.56 mmol at room temperature.  To the flask, NaCNBH3 
(538 mg, 8.56 mmol) was added and allowed to stir for one hour. The reaction mixture 
was quenched with 1N HCl (10 mL) and diluted with diethyl ether. The organic layer was 
subsequently washed with 20 mL of water followed by 20 mL of brine.  The organic 
layer was dried over magnesium sulfate and concentrated in vacuo.  The resulting white 
solid was taken on to the synthesis of 4 without further purification. 
2-Bromobenzyl-N-pyridine, 4.  A round-bottom flask was charged with argon, CHCl3 
(25 mL), and 3 (8.56 mmol).  Phosphorous tribromide (271 µL, 2.85 mmol) was added 
and the reaction mixture was allowed to stir for 1.5 hours.  The reaction was quenched 
with water (10 mL).  The reaction was washed with 25 mL portions of sodium 
bicarbonate, water, and brine, respectively.  Finally, the organic layer was dried over 
magnesium sulfate and concentrated in vacuo.  The resulting yellow oil was then taken 
up in 2 mL of pyridine and allowed to stand overnight. The resulting white crystalline 
product was purified with successive washes of diethyl ether (1.27 g, 60% yield). 1H 
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NMR (500 MHz, CDCl3) $ 9.42 (d, 2H, J = 6.5 Hz), 8.54 (dd, 1H, J1 = 7.5 Hz, J2 = 7.5 
Hz), 8.20 (d, 1H, J = 5 Hz), 8.11 (dd, 2H, J1 = 6.5 Hz, J2 = 6.5 Hz), 7.62 (d, 1H, J = 8 Hz), 
7.47 (t, 1H, J1 = 7.5 Hz, J2 = 8 Hz), 7.34 (t, 1H, J1 = 8 Hz, J2 = 7.5 Hz), 6.41 (s, 2H); 
13C 
NMR (100 MHz, CDCl3) $ 146, 145, 134, 134, 132, 132, 129, 128, 125, 64; LR-MS 
(FAB): calculated = 248; actual = 247.8. 
1-(biphenyl-2-ylmethyl)-pyridinium bromide, 1a.  A round-bottom flask was 
charged with argon, dioxane (25 mL), compound 4 (215 mg, 0.87 mmol), compound 2 
(88 mg, 0.72 mmol), and 1 mL of H2O at room temperature.  To the flask, Pd(PPh3)4 (4 
mol %) and Na2CO3 (1.4 equiv., 97 mg) were added along with a reflux condenser.   The 
reaction was allowed to reflux for 2 hours. The reaction mixture was concentrated in 
vacuo and triturated with ether. The resulting solution was partitioned with water and 
EtOAc, and the aqueous layer washed with EtOAc (1X). The aqueous layer was 
subsequently frozen, lyophilized, and purified with reverse-phase HPLC 
(water/acetonitrile gradient) to yield 50 mg of a clear oil (28% yield).  1H NMR (500 
MHz, CDCl3) $ 8.31 (d, 2H, J = 6 Hz), 8.28 (t, 1H, J = 7.5 Hz), 7.73 (dd, 2H, J1 = 7 Hz, J2 
= 7.5 Hz ), 7.68 (d, 1H, J = 7 Hz), 7.49 (m, 2H), 7.37 (m, 3H), 7.30 (d, 1H, J = 7.5 Hz), 
7.07 (m, 2H), 5.91 (s, 2H); 13C NMR (100 MHz, CDCl3) $ 145, 144, 143, 139, 131, 131, 
131, 130, 129, 129, 128, 128, 128, 63; LR-MS (FAB): calculated = 246; actual = 245.99.  
(2-bromophenyl)-pyridin-2-yl-methanol, 6a.  A dry round bottom flask charged with 
argon and a stirbar was filled with isopropylmagnesium chloride (2 M in THF, 5.2 mL, 
10.4 mmol) followed by the dropwise addition of 2-bromopyridine (1 mL, 10.4 mmol) 
while stirring at room temperature.  After one hour 2-bromobenzaldehyde (1.34 mL, 11.5 
mmol) was added and stirred for another two hours while monitored by TLC (1:1 
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Hexanes/EtOAc). The reaction was quenched with 10 mL 1N HCl.  The aqueous layer 
was washed with ether and then neutralized with 1N NaOH resulting in a cloudy solution. 
The suspension was then extracted into ether.  The resulting organic layer was then 
washed with water and brine followed by drying over magnesium sulfate and 
concentrated in vacuo, recovering 1.45 g of an off-white colored powder (52% yield). 
Product carried on to next step without further purification. 1H NMR (400 MHz, CDCl3) 
$ 8.56 (d, 1H, J = 5 Hz), 7.61 (t, 1H, J = 7 Hz), 7.56 (d, 1H J1 = 7 Hz), 7.33 (d, 1H, J = 8 
Hz) 7.23 (m, 2H), 7.11 (t, 1H, J = 8 Hz), 6.73 (d, 1H, J = 2 Hz), 5.48 (d. 1H, J = 2 Hz); 
LR-MS (ESI): calculated = 264.1; actual = 264.0.  
(2-Bromophenyl)-pyridin-3-yl-methanol, 6b. See synthesis of 6a. (69%yield). 1H 
NMR (300 MHz, CDCl3) $ 8.66 (s, 1H), 8.50 (d, 1H, J = 5 Hz), 7.70 (dt, 1H, J1 = 7 Hz, J2 
= 2 Hz), 7.61 (dd, 1H, J1 = 7 Hz, J2 = 2 Hz), 7.56 (d, 1H, J = 7 Hz), 7.38 (t, 1H, J = 2 Hz), 
7.26 (m, 1H), 7.19 (t, 1H, J1 = 7 Hz, J2 = 2 Hz), 6.35 (s, 1H); LR-MS (ESI): calculated = 
264.1; actual = 264.0.  
(2-Bromophenyl)-pyridin-4-yl-methanol, 6c. In a separatory funnel, 4-bromopyridine 
hydrochloride (2.5 g, 12.8 mmol) was deprotonated with 20 mL of 2M K2CO3 and 
extracted into 20mL of dichloromethane.  The organic layer was dried over MgSO4 and 
evaporated.  The resulting oil was taken up into 20 mL of THF in a round-bottom flask 
and placed under an atmosphere of nitrogen.  While stirred at room temperature 
isopropylmagnesium chloride (2M in THF, 6.4 mL, 12.8 mmol) was added dropwise and 
stirred for 1 hour.  After one hour, 2-bromobenzaldehyde (1.58 mL, 12.8mmol) was 
added and stirred for another two hours while monitored by TLC (1:1 hexanes/ethyl 
acetate). The reaction was quenched with 10 mL 1N HCl.  The aqueous layer is washed 
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with ether then neutralized with 1N NaOH resulting in a cloudy solution. The suspension 
was then extracted into ether.  The resulting organic layer was then washed with water 
and brine followed by drying over magnesium sulfate and concentrated in vacuo, giving 
1.05 g of an off-white colored powder (31% yield). Product carried on to next step 
without further purification. 1H NMR (300 MHz, CDCl3) $ 8.54 (d, 2H, J = 6 Hz), 7.57 
(d, 1H, J1 = 8 Hz, J2 = 2 Hz), 7.46 (d, 1H, J1 = 7 Hz, J2 = 2 Hz), 7.35 (m 3H), 7.18 (t, 1H, 
J1 = 7 Hz, J2 = 2 Hz), 6.24 (s, 1H). 
Acetic acid (2-bromo-phenyl)-pyridin-2-yl-methyl ester, 7a.  A round-bottom flask 
charged with anhydrous methylene chloride, compound 6a (394 mg, 1.49 mmol), acetic 
anhydride (167 µL, 181 mg, 1.78 mmol), pyridine (143 µL, 140 mg, 1.78 mmol), and 
DMAP (36 mg, 0.298 mmol) and stirred overnight at room temperature.  The reaction 
mixture was quenched with water and adjusted to neutral pH.  The water was extracted 
with methylene chloride and the organic layer was dried over magnesium sulfate and 
concentrated in vacuo.  The product was purified by column chromatography with 1:1 
hexanes : ethyl acetate as the mobile phase resulting in 122 mg of a yellow oil (52% 
yield). 1H NMR (300 MHz, CDCl3) $ 8.63 (d, 1H, J = 5 Hz), 7.69 (dd, 1H, J1 = 8 Hz, J2 = 
2 Hz), 7.57 (dd, 1H, J1 = 2 Hz, J2 = 2 Hz), 7.49 (dd, 1H, J1 = 8 Hz, J2 = 2 Hz), 7.43 (d, 1H, 
J = 3 Hz), 7.33 (t, 1H, J = 7 Hz), 7.21 (m, 3H), 2.20 (s, 3H). LR-MS (CI): calculated = 
305.0; actual = 306.0.  
Acetic acid (2-bromo-phenyl)-pyridin-3-yl-methyl ester, 7b. See synthesis of 7a. 
(84% yield). 1H NMR (300 MHz, CDCl3) $ 8.66 (s, 1H), 8.70 (d, 1H, J = 5 Hz), 7.70 (dd, 
1H, J1 = 8 Hz, J2 = 2Hz), 7.57 (d, 1H, J = 8 Hz), 7.52 (d, 1H, J = 8 Hz), 7.43 (t, 1H, J = 7 
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Hz), 7.29 (m, 1H), 7.20 (m, 2H), 2.17 (s, 3H); LR-MS (ESI): calculated = 305.0; actual = 
305.0. 
Acetic acid (2-bromo-phenyl)-pyridin-4-yl-methyl ester, 7c. See synthesis of 7a. 
(84% yield). 1H NMR (300 MHz, CDCl3) $ 8.73 (d, 2H, J = 6 Hz), 7.74 (d, 1H, J1 = 8 Hz, 
J2 = 1 Hz), 7.50 (m, 2H), 7.42 (d, 1H, J = 6 Hz), 7.35 (m, 1H), 7.31 (s, 2H), 5.44 (s, 3H). 
2-Bromobenzyl-2-pyridine, 8a.  In a round bottom flask charged with Ar and a stirbar 
was added 4a (167mg, 0.55mmol) and t-BuOH (61mg, 0.8mmol, 78µL) in 5mL of THF. 
This was followed by the addition with SmI2 (1.6mmol, 16.4mL, 0.1M in THF) dropwise 
over approximately 10 minutes.  The mixture was stirred for 2 hours while monitored by 
TLC (10:1 hexanes/ethyl acetate).  The reaction was quenched with water and extracted 
with ether followed by washes with water and brine.  The organic layer was dried over 
magnesium sulfate and concentrated in vacuo.  The resulting oil was purified by column 
chromatography (10:1 hexanes : ethyl acetate) to give 56 mg of product (46% yield). 1H 
NMR (500 MHz, CDCl3, protonated with HBF4) $ 14.04, (broad singlet, 1H), 8.85 (d, 1H 
J = 6 Hz), 8.35 (dd, 1H, J1 = 8 Hz, J2 = 8 Hz), 7.89 (dd, 1H, J1 = 6.8 Hz, J2 = 6.8 Hz) 7.63 
(d, 1H, J = 8 Hz), 7.58 (d, 1H, J = 8 Hz), 7.52 (d, 1H, J = 8 Hz), 7.41 (dd, 1H, J1 = 7.5 Hz, 
J2 = 7.5 Hz), 7.28 (dd, 1H, J1 = 8.5 Hz, J2 = 6.5 Hz), 4.64 (s, 2H);
 13C NMR (100 MHz, 
CDCl3) $ 156, 147, 142, 134, 133, 133, 131, 129, 127, 125, 125, 40; LR-MS (ESI): 
calculated = 248; actual = 247.83. 
2-Bromobenzyl-3-pyridine, 8b. See synthesis of 8a. 1H NMR (500 MHz, CDCl3, 
protonated with HBF4) $ 14.09, (broad singlet, 1H), 8.76 (s, 1H), 8.72 (s, 1H) 8.26 (d, 
1H, J = 8 Hz), 7.91 (t, 1H, J1 = 6.5 Hz, J2 = 7.5 Hz), 7.61 (d, 1H, J = 8 Hz), 7.37 (d, 2H, J 
= 4 Hz), 7.23 (dd, 1H, J = 8.25), 4.35 (s, 2H); 13C NMR (100 MHz, CDCl3) $ 147, 142, 
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141, 140, 136, 134, 132, 130, 129, 127, 125, 39; LR-MS (ESI): calculated = 248; actual = 
247.83. 
2-Bromobenzyl-4-pyridine, 8c. See synthesis of 8a. 1H NMR (500 MHz, CDCl3, 
protonated with HBF4) $ 13.69 (broad triplet, 1H), 8.73 (s, 2H), 7.73 (d, 2H, J = 6 Hz) 
7.64 (d, 1H, J = 8 Hz), 7.39 (dd, 1H, J1 = 7.5 Hz, J2 = 7.5 Hz), 7.33 (d, 1H, J = 6.75 Hz), 
7.26 (dd, 1H, J1 = 8.5 Hz, J2 = 7.5 Hz) 4.41 (s, 2H);
 13C NMR (100 MHz, CDCl3) $ 162, 
142, 135, 134, 132, 130, 129, 127, 125, 42; LR-MS (ESI): calculated = 248; actual = 
247.83. 
2-(biphenyl-2-ylmethyl)-pyridine, 1b. A round-bottom flask was filled with argon, 
20mL benzene, compound 8a (92 mg, 0.37 mmol), and compound 2 (54 mg, 0.45 mmol) 
at room temperature.  To the flask Pd(PPh3)4 (23mg, 0.02mmol) and 2 mL of 2M K2CO3 
were added.  The reaction was allowed to stir overnight under reflux.  Upon cooling, 5 
mL of 30% H2O2 was added and stirred for 30 minutes.  The reaction mixture was 
extracted into ether and washed with 20 mL of water followed by 20 mL of brine.  The 
organic layer was dried over magnesium sulfate and concentrated in vacuo.  The resulting 
oil was purified by column chromatography (10:1 hexanes : ethyl acetate) to give a 
yellow oil. 1H NMR (500 MHz, CDCl3, protonated with HBF4) $ 12.86, (broad singlet, 
1H), 8.405 (s, 1H), 8.12 (t, 1H, J = 8 Hz), 7.67 (t, 1H, J = 6.5 Hz), 7.40 (s, 1H), 7.37 (m, 
2H), 7.30 (dd, 2H, J1 = 7 Hz, J2 = 6 Hz), 7.25 (m, 2H), 7.12 (d, 1H, J = 8 Hz), 7.07 (d, 2H, 
J = 7 Hz), 4.43 (s, 2H); 13C NMR (100 MHz, CDCl3) $ 156, 146, 143, 141, 140, 132, 131, 
131, 129, 129, 129, 129, 128, 127, 125, 38; LR-MS (ESI): calculated = 246; actual = 
246.05. 
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3-(biphenyl-2-ylmethyl)-pyridine, 1c. See synthesis of 1b.  1H NMR (500 MHz, 
CDCl3, protonated with HBF4) $ 13.53 (broad singlet, 1H), 8.58 (d, 1H, J = 4 Hz), 8.16 
(s, 1H), 7.79 (d, 1H, J = 8 Hz), 7.71 (dd, 1H, J1 = 6 Hz, J2 = 7.5 Hz), 7.34 (m, 6H), 7.25 
(m, 1H), 7.09 (d, 2H, J = 6.5 Hz), 4.17 (s, 2H); 13C NMR (100 MHz, CDCl3) $ 147, 143, 
141, 141, 140, 135, 131, 131, 129, 129, 129, 128, 128, 128, 127, 37; LR-MS (ESI): 
calculated = 246; actual = 246.05. 
4-(biphenyl-2-ylmethyl)-pyridine, 1d. See synthesis of 1b. 1H NMR (500 MHz, 
CDCl3, protonated with HBF4) $ 13.42 (broad singlet, 1H), 8.53 (s, 2H), 7.38 (d, 1H, J = 
4 Hz), 7.37 (d, 1H, J = 4 Hz), 7.34 (m, 5H), 7.29 (m, 2H), 7.08 (d, 2H, J = 7.5 Hz), 4.22 
(s, 2H); 13C NMR (100 MHz, CDCl3) $ 164, 143, 141, 141, 134, 131, 131, 129, 129, 129, 
128, 128, 127, 40; LR-MS (ESI): calculated = 246; actual = 245.87. 
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iii. 1HNMR Spectra of Model Systems and Reference Compounds 
Figure 7.10. 1HNMR of 2-Bromobenzyl-N-pyridine, 4. 
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Figure 7.11. 1HNMR of 2-Bromobenzyl-2-pyridine, 8a. 
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Figure 7.12. 1HNMR of 2-Bromobenzyl-3-pyridine, 8b. 
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Figure 7.13. 1HNMR of 2-Bromobenzyl-4-pyridine, 8c. 
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Figure 7.14. 1HNMR of 1-(biphenyl-2-ylmethyl)-pyridinium bromide, 1a. 
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Figure 7.15. 1HNMR of 2-(biphenyl-2-ylmethyl)-pyridine, 1b. 
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Figure 7.16. 1HNMR of 3-(biphenyl-2-ylmethyl)-pyridine, 1c. 
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Figure 7.17. 1HNMR of 4-(biphenyl-2-ylmethyl)-pyridine, 1d. 
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iv. Molecular Modeling.  Gas phase and implicit solvent calculations (IEF-
PCM=Chloroform) were performed using Gaussian 03 (B 04).14 Low energy structures 
were determined by optimizations of anisole and Ipso-, 2-, 3-, or 4-methylpyridine alone 
and in complex at the MP2/6-31g** level. Starting orientations for the optimizations 
were chosen based on model structures of experimental compounds 1a-d. Structures were 
optimized separately for gas phase and solution phase calculations (i.e., solvated energies 
were not measured with single-point calculations in implicit solvent on gas phase 
optimized structures). Following methodology of Rooman, et al,15 interaction energies 
were measured by the following equation: 
#EMP2 = EA-B - EA - EB 
Where EA-B is the MP2 energy of the optimized complex, EB is the MP2 energy of 
optimized monomer B, and EA is the MP2 energy of optimized monomer A. While gas 
phase calculations were corrected for basis-set superposition error (BSSE), BSSE 
corrections are unavailable for implicit solvent calculations, resulting in overestimations 
                                                
14 Gaussian 03, Revision B.04, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. 
E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, Jr., J. A.; Vreven, T.; Kudin, K. N.; 
Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, 
M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; 
Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; 
Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; 
Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; 
Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; 
Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, 
M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; 
Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; 
Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, 
M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; 
Chen, W.; Wong, M. W.; Gonzalez, C.; and Pople, J. A.; Gaussian, Inc., Wallingford CT, 
2004. 
15 Biot, C.; Buisine, E.; Rooman, M. J. Am. Chem. Soc. 2003, 125, 13988. 
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of the energies of complexation. However, the relative magnitudes of interaction should 
still be the same, allowing a qualitative analysis of interaction preferences. 
Table 7.2. Gas Phase interaction energies for anisole/methyl pyridine complexes. 
 IpsoStkGas IpsoCHOGas 
#E (MP2) kcal/mol -15.39 -14.93 
BSSE Corrected (kcal/mol) -10.59 -11.18 
   
 2pyStkGas 2pyNHOGas 
#E (MP2) kcal/mol -20.47 -20.32 
BSSE Corrected (kcal/mol) -9.78 -16.58 
   
 3pyStkGas 3pyCHOGas 
#E (MP2) kcal/mol -19.34 -14.1 
BSSE Corrected (kcal/mol) -9.09 -10.5 
   
 4pyStkGas  
#E (MP2) kcal/mol -15.1  
BSSE Corrected (kcal/mol) -10.08  
 
 
In the gas phase, there were two cases in which structures starting from stacked 
conformations optimized to other conformations (3pyStkGas and 2pyStkGas).  This is 
consistent with literature precedent for the preferred orientations of aromatic rings in the 
gas phase.16 Additionally, optimized complexes displaying NH and CH--O interactions 
differed significantly from their starting geometries, reflecting orientation preferences not 
achievable with the tethered model systems. 
 
                                                
16 Hunter, C.A.; Lawson, K.R.; Perkins, J.; Urch, C.J. J. Chem. Soc., Perkin Trans. 2, 
2001, 651-669. 
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Scheme 7.2. Optimized Gas Phase complexes (see Table 7.2 above). 
   
 
 
 
 
 
  
IpsoStkGas IpsoCHOGas 
4pyStkGas 
3pyStkGas 3pyCHOGas 
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v. 4-ethylpyridine/anisole titration. 500 uL of 4-ethylpyridine (TCI America) 
was added to 500 uL of distilled, deionized water. HBF4 was added dropwise until the 
solution reached pH 1 (Congo Red). The resulting solution was frozen and lyophilized for 
72 hours. Dry CDCl3 (2 mL) was added to the resulting oil, resulting in a two-phase 
mixture of CDCl3 and 4-ethylpyridine. The CDCl3 layer was separated out and 
determined by integration against TMS to be approximately 55 mM in protonated 4-
ethylpyridine. A solution of anisole was dried with MgSO4, and added to the 4-ethyl 
pyridine sample in increments of 1-2 equivalents. Changes in chemical shifts were 
measured relative to those of protonated 4-ethylpyridine alone in chloroform. 1H NMR 
(600 MHz, CDCl3) $ 13.28 (dd, broad, 1H), 8.76 (dd, 2H,  J1 = 5.4 Hz, J2 = 5.4 Hz), 7.83 
(d, 2H, J = 6 Hz), 2.96 (q, 2H), 1.36 (t, 3H). 
 
 
2pyStkGas 2pyNHOGas 
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vi. X-ray Crystallographic Data (Dr. Peter S. White, UNC) 
Table 7.3.  Crystal data and structure refinement for c05378. 
Identification code  c05378 
Empirical formula  C19 H18 Br N O 
Formula weight  356.25 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 14.253(2) Å %= 90°. 
 b = 8.2825(14) Å &= 107.277(9)°. 
 c = 14.4981(17) Å ' = 90°. 
Volume 1634.3(4) Å3 
Z 4 
Density (calculated) 1.448 Mg/m3 
Absorption coefficient 3.426 mm-1 
F(000) 728 
Crystal size 0.13 x 0.06 x 0.03 mm3 
Theta range for data collection 3.25 to 60.00°. 
Index ranges -15<=h<=15, -5<=k<=8, -15<=l<=15 
Reflections collected 5369 
Independent reflections 2082 [R(int) = 0.0773] 
Completeness to theta = 60.00° 85.8 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2082 / 0 / 200 
Goodness-of-fit on F2 1.082 
Final R indices [I>2sigma(I)] R1 = 0.0684, wR2 = 0.1580 
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R indices (all data) R1 = 0.0975, wR2 = 0.1751 
Largest diff. peak and hole 1.032 and -1.026 e.Å-3 
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Table 7.4.  Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters (Å2x 103) for c05378.  U(eq) is defined as 
one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
Br(1) 9461(1) 1311(1) 7826(1) 24(1) 
C(1) 4183(8) 108(12) 5990(7) 38(3) 
O(2) 3891(5) 1782(7) 5908(4) 25(1) 
C(3) 3666(6) 2471(11) 6678(6) 21(2) 
C(4) 3775(7) 1690(11) 7576(6) 25(2) 
C(5) 3523(7) 2499(11) 8309(6) 25(2) 
C(6) 3136(7) 4044(11) 8167(6) 27(2) 
C(7) 3022(7) 4818(11) 7268(6) 24(2) 
C(8) 3275(6) 4059(11) 6519(6) 19(2) 
C(9) 3129(7) 4893(10) 5591(6) 20(2) 
C(10) 3914(7) 5589(11) 5340(6) 20(2) 
C(11) 3745(8) 6480(12) 4464(7) 32(2) 
C(12) 2821(7) 6582(11) 3836(6) 26(2) 
C(13) 2025(7) 5881(10) 4072(6) 22(2) 
C(14) 2158(6) 5048(10) 4922(6) 19(2) 
C(15) 1268(7) 4415(11) 5154(6) 24(2) 
N(16) 1282(6) 2630(9) 5334(5) 21(2) 
C(17) 1394(6) 1601(11) 4656(6) 22(2) 
C(18) 1397(7) -26(11) 4792(6) 26(2) 
C(19) 1248(6) -653(11) 5623(6) 23(2) 
C(20) 1102(7) 431(11) 6320(6) 24(2) 
C(21) 1110(7) 2046(11) 6148(6) 23(2) 
________________________________________________________________________________
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Table 7.5.   Bond lengths [Å] and angles [°] for c05378. 
_____________________________________________________ 
C(1)-O(2)  1.442(12) 
O(2)-C(3)  1.374(10) 
C(3)-C(8)  1.420(13) 
C(3)-C(4)  1.420(12) 
C(4)-C(5)  1.391(13) 
C(5)-C(6)  1.385(14) 
C(6)-C(7)  1.419(13) 
C(7)-C(8)  1.391(13) 
C(8)-C(9)  1.471(12) 
C(9)-C(10)  1.400(13) 
C(9)-C(14)  1.440(12) 
C(10)-C(11)  1.426(13) 
C(11)-C(12)  1.363(13) 
C(12)-C(13)  1.405(13) 
C(13)-C(14)  1.376(12) 
C(14)-C(15)  1.500(13) 
C(15)-N(16)  1.501(12) 
N(16)-C(17)  1.346(11) 
N(16)-C(21)  1.363(11) 
C(17)-C(18)  1.361(13) 
C(18)-C(19)  1.385(13) 
C(19)-C(20)  1.414(13) 
C(20)-C(21)  1.361(13) 
C(3)-O(2)-C(1) 117.6(7) 
O(2)-C(3)-C(8) 115.3(7) 
O(2)-C(3)-C(4) 124.5(8) 
C(8)-C(3)-C(4) 120.1(8) 
C(5)-C(4)-C(3) 119.9(8) 
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C(6)-C(5)-C(4) 120.9(8) 
C(5)-C(6)-C(7) 119.1(8) 
C(8)-C(7)-C(6) 121.9(9) 
C(7)-C(8)-C(3) 118.2(8) 
C(7)-C(8)-C(9) 120.1(8) 
C(3)-C(8)-C(9) 121.7(8) 
C(10)-C(9)-C(14) 118.0(8) 
C(10)-C(9)-C(8) 121.7(8) 
C(14)-C(9)-C(8) 120.3(8) 
C(9)-C(10)-C(11) 120.6(8) 
C(12)-C(11)-C(10) 120.1(9) 
C(11)-C(12)-C(13) 120.1(8) 
C(14)-C(13)-C(12) 121.3(9) 
C(13)-C(14)-C(9) 119.8(8) 
C(13)-C(14)-C(15) 118.3(8) 
C(9)-C(14)-C(15) 121.7(7) 
C(14)-C(15)-N(16) 114.5(7) 
C(17)-N(16)-C(21) 119.9(8) 
C(17)-N(16)-C(15) 119.7(7) 
C(21)-N(16)-C(15) 120.3(7) 
N(16)-C(17)-C(18) 121.1(8) 
C(17)-C(18)-C(19) 120.2(8) 
C(18)-C(19)-C(20) 118.5(9) 
C(21)-C(20)-C(19) 118.8(8) 
C(20)-C(21)-N(16) 121.4(8) 
_____________________________________________________________ 
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Table 7.6.   Anisotropic displacement parameters (Å2x 103)for c05378.  
The anisotropic displacement factor exponent takes the form:  
-2!2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
Br(1) 33(1)  20(1) 20(1)  2(1) 9(1)  2(1) 
C(1) 50(7)  24(7) 40(6)  -2(4) 15(5)  6(5) 
O(2) 46(4)  10(4) 19(3)  -1(2) 9(3)  6(3) 
C(3) 19(5)  17(6) 21(5)  1(3) -1(4)  3(4) 
C(4) 39(6)  5(6) 31(5)  2(3) 9(4)  2(4) 
C(5) 30(6)  25(6) 19(5)  4(4) 4(4)  2(4) 
C(6) 42(6)  25(6) 17(5)  -8(4) 14(4)  1(4) 
C(7) 34(6)  4(5) 32(6)  -4(3) 9(4)  -1(4) 
C(8) 18(5)  18(6) 19(4)  1(3) -1(4)  -5(4) 
C(9) 33(6)  8(5) 24(5)  -1(3) 16(4)  3(4) 
C(10) 29(5)  12(5) 16(4)  -1(3) 2(4)  -2(4) 
C(11) 50(7)  15(6) 42(6)  1(4) 30(5)  -2(5) 
C(12) 44(6)  12(6) 26(5)  3(3) 14(5)  -5(4) 
C(13) 36(6)  4(5) 28(5)  3(3) 11(4)  7(4) 
C(14) 26(5)  5(5) 24(5)  0(3) 4(4)  5(4) 
C(15) 32(6)  13(5) 24(5)  -2(4) 4(4)  8(4) 
N(16) 32(5)  16(5) 15(4)  0(3) 7(3)  -3(3) 
C(17) 29(5)  19(6) 21(4)  -2(4) 11(4)  0(4) 
C(18) 34(6)  21(6) 23(5)  -1(4) 9(4)  2(4) 
C(19) 27(5)  6(5) 35(5)  2(3) 10(4)  2(4) 
C(20) 26(5)  19(6) 29(5)  4(4) 13(4)  -6(4) 
C(21) 29(6)  27(6) 16(4)  -1(4) 11(4)  4(4) 
______________________________________________________________________________
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Table 7.7.   Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (Å2x 103) for c05378. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1A) 4779 -23 6536 57 
H(1B) 4314 -237 5394 57 
H(1C) 3654 -552 6097 57 
H(4) 4020 617 7675 30 
H(5) 3619 1984 8916 30 
H(6) 2949 4578 8666 32 
H(7) 2766 5885 7174 28 
H(10) 4565 5467 5756 24 
H(11) 4277 7002 4318 39 
H(12) 2716 7129 3238 32 
H(13) 1382 5985 3636 27 
H(15A) 679 4677 4610 29 
H(15B) 1205 4982 5733 29 
H(17) 1473 2017 4073 27 
H(18) 1503 -732 4316 31 
H(19) 1244 -1787 5721 27 
H(20) 999 40 6899 28 
H(21) 994 2781 6605 28 
________________________________________________________________________________
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Table 7.8.  Torsion angles [°] for c05378. 
________________________________________________________________ 
C(1)-O(2)-C(3)-C(8) -173.0(8) 
C(1)-O(2)-C(3)-C(4) 5.2(12) 
O(2)-C(3)-C(4)-C(5) -179.9(8) 
C(8)-C(3)-C(4)-C(5) -1.7(13) 
C(3)-C(4)-C(5)-C(6) 2.1(14) 
C(4)-C(5)-C(6)-C(7) -1.7(14) 
C(5)-C(6)-C(7)-C(8) 1.0(14) 
C(6)-C(7)-C(8)-C(3) -0.6(13) 
C(6)-C(7)-C(8)-C(9) 178.9(8) 
O(2)-C(3)-C(8)-C(7) 179.3(8) 
C(4)-C(3)-C(8)-C(7) 1.0(12) 
O(2)-C(3)-C(8)-C(9) -0.2(12) 
C(4)-C(3)-C(8)-C(9) -178.6(8) 
C(7)-C(8)-C(9)-C(10) 103.0(10) 
C(3)-C(8)-C(9)-C(10) -77.4(11) 
C(7)-C(8)-C(9)-C(14) -75.5(11) 
C(3)-C(8)-C(9)-C(14) 104.1(10) 
C(14)-C(9)-C(10)-C(11) 2.5(13) 
C(8)-C(9)-C(10)-C(11) -176.0(8) 
C(9)-C(10)-C(11)-C(12) -3.8(14) 
C(10)-C(11)-C(12)-C(13) 3.3(14) 
C(11)-C(12)-C(13)-C(14) -1.6(14) 
C(12)-C(13)-C(14)-C(9) 0.4(13) 
C(12)-C(13)-C(14)-C(15) 176.5(8) 
C(10)-C(9)-C(14)-C(13) -0.9(12) 
C(8)-C(9)-C(14)-C(13) 177.6(8) 
C(10)-C(9)-C(14)-C(15) -176.8(8) 
C(8)-C(9)-C(14)-C(15) 1.7(12) 
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C(13)-C(14)-C(15)-N(16) 123.7(9) 
C(9)-C(14)-C(15)-N(16) -60.3(10) 
C(14)-C(15)-N(16)-C(17) -56.3(11) 
C(14)-C(15)-N(16)-C(21) 128.5(8) 
C(21)-N(16)-C(17)-C(18) -3.9(13) 
C(15)-N(16)-C(17)-C(18) -179.2(8) 
N(16)-C(17)-C(18)-C(19) 2.4(14) 
C(17)-C(18)-C(19)-C(20) -0.5(13) 
C(18)-C(19)-C(20)-C(21) 0.2(13) 
C(19)-C(20)-C(21)-N(16) -1.8(14) 
C(17)-N(16)-C(21)-C(20) 3.6(13) 
C(15)-N(16)-C(21)-C(20) 178.8(8) 
________________________________________________________________ 
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